© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Mitochondrial translation	2.04E01	4.17E-01	-5.692	CHCHD1,DAP3,ERAL1,GADD45GIP1,MRPL10,MRPL11,MRPL13,MRPL14,MRPL17,MRPL18,MRPL19,MRPL21,MRPL22,MRPL23,MRPL27,MRPL28,MRPL34,MRPL36,MRPL41,MRPL42,MRPL43,MRPL49,MRPL52,MRPL57,MRPL9,MRPS10,MRPS11,MRPS12,MRPS2,MRPS22,MRPS26,MRPS27,MRPS33,MRPS34,MRPS35,MRPS5,MRPS6,MTIF3,OXA1L,TUFM	
Processing of Capped Intron-Containing Pre-mRNA	1.99E01	2.47E-01	-4.628	ALYREF,BUD13,CCAR1,CDC40,CHTOP,CLP1,CPSF3,CRNKL1,CSTF3,CWC27,CWF19L2,DDX23,DDX39A,DDX41,DDX46,DHX15,DHX16,DHX8,EIF4A3,EIF4E,FUS,GPATCH1,GTF2F1,HNRNPF,HNRNPL,IK,LENG1,LSM4,LSM5,LSM7,LUC7L3,METTL14,NCBP2,NUP43,NUP54,NUP58,NUP93,PHF5A,PNN,POLR2C,POLR2F,PPIL1,PRPF4,PTBP1,PUF60,RBM22,RBM39,RBM42,RBM5,RBM8A,RNPS1,RNU4-1,SAP18,SART1,SF3B2,SF3B4,SF3B5,SNIP1,SNRNP48,SNRPB,SNRPD2,SNRPE,SNRPN,SRSF2,SRSF8,TFIP11,THOC5,TPR,TXNL4A,UBL5,ZMAT2	
Cell Cycle Checkpoints	1.44E01	2.21E-01	-4.648	ABRAXAS1,ANAPC10,ATM,BLM,BUB1,BUB3,CCNE1,CCNE2,CDC27,CDC45,CDC6,CDCA8,CENPA,CENPO,CLASP2,CLIP1,COP1,DNA2,EXO1,GTSE1,KAT5,KIF2C,MCM2,MCM3,MCM5,MRE11,NDEL1,NSL1,NUDC,NUF2,NUP43,ORC1,ORC5,PHF20,PKMYT1,PPP2CA,PPP2R5D,PPP2R5E,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RCC2,RFC2,RHNO1,RMI1,UBE2E1,XPO1,YWHAG,ZWINT	
Synthesis of DNA	1.25E01	2.94E-01	-4.564	ANAPC10,CCNE1,CCNE2,CDC27,CDC6,CDT1,CUL1,DNA2,GINS4,MCM2,MCM3,MCM5,ORC1,ORC5,POLD1,POLD2,POLD3,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RFC2,SKP1,SKP2,UBE2E1	
Mitotic G1 phase and G1/S transition	1.12E01	2.67E-01	-4.158	ABL1,AKT1,CCNE1,CCNE2,CDC45,CDC6,CDK4,CDT1,CUL1,DYRK1A,E2F2,E2F4,ORC1,ORC5,PPP2CA,PPP2R2A,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RBL1,SKP1,SKP2,TFDP1,TK1	
Mitotic Metaphase and Anaphase	1.09E01	2.09E-01	-4.714	ANAPC10,BANF1,BUB1,BUB3,CDC27,CDCA8,CENPA,CENPO,CLASP2,CLIP1,KIF2C,KPNB1,NDEL1,NSL1,NUDC,NUF2,NUP43,NUP54,NUP58,NUP93,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RAN,RCC1,RCC2,SPAST,TUBA1B,UBE2E1,UBE2I,VPS4A,VRK2,XPO1,ZWINT	
Neddylation	1.07E01	2.03E-01	-4.525	ASB8,CAND1,CCNF,CISH,COMMD1,COMMD5,COMMD8,COMMD9,COP1,COPS5,COPS7A,CUL1,CUL3,DCAF10,DCAF13,DCAF7,DCUN1D3,DCUN1D4,DDB1,DPP3,ELOC,FBXL13,FBXL20,FBXL4,FBXO6,FBXW7,FEM1B,GPS1,KBTBD6,KEAP1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,UBE2D2,VCP,WDR5,WSB1	
Sirtuin Signaling Pathway	1.04E01	1.89E-01	2.535	ACLY,AKT1,APEX1,ARG2,ATG13,ATG4C,ATP5F1A,ATP5F1E,ATP5PF,BAX,CYC1,ESRRA,GABPB1,GADD45A,GLUD1,H1-1,H3-3A/H3-3B,H4C11,IDH2,MAPK3,NDRG1,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,NR1H2,NR1H3,PGAM1,POLR1A,POLR2F,PPID,RELA,SDHC,SIRT5,SP1,STAT3,TIMM10,TIMM17A,TIMM44,TIMM8B,TOMM22,TOMM34,TOMM40L,TOMM5,TUBA1B,ZBTB14	
Mitotic Prometaphase	9.91E00	2.12E-01	-3.202	ACTR1A,AKAP9,BUB1,BUB3,CDCA8,CENPA,CENPO,CEP135,CEP70,CLASP2,CLIP1,CSNK1D,CSNK2A2,CSNK2B,DCTN1,HAUS1,HAUS4,HAUS6,KIF2C,MZT2A,MZT2B,NCAPD2,NCAPH,NDEL1,NME7,NSL1,NUDC,NUF2,NUP43,PCNT,PLK4,PPP2CA,PPP2R5D,PPP2R5E,PRKACA,RCC2,SSNA1,TUBA1B,TUBG1,TUBGCP3,XPO1,YWHAG,ZWINT	
Mitotic G2-G2/M phases	9.64E00	2.11E-01	-3.395	ACTR1A,AKAP9,CEP135,CEP70,CSNK1D,CUL1,DCTN1,GTSE1,HAUS1,HAUS4,HAUS6,MZT2A,MZT2B,NME7,PCNT,PKMYT1,PLK4,PPP2CA,PPP2R2A,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RAB8A,SKP1,SSNA1,TUBA1B,TUBG1,TUBGCP3,XPO1,YWHAG	
Class I MHC mediated antigen processing and presentation	9.16E00	1.65E-01	-4.064	ANAPC10,ASB8,BLMH,CCNF,CDC27,CHUK,CUL1,CUL3,ELOC,FBXL13,FBXL20,FBXL4,FBXO6,FBXW7,FGA,FGG,HECTD2,HECTD3,ITCH,KBTBD6,KEAP1,MYLIP,NCF1,NPEPPS,PDIA3,PJA2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RBCK1,RNF114,RNF4,RNF41,SEC23B,SEC24B,SEC24C,SEC31A,SKP1,SKP2,STX4,TAP1,TRAF7,TRIM41,TRIM69,UBA6,UBE2D2,UBE2E1,UBE2H,UBE2J2,VAMP8,WSB1	
Huntington's Disease Signaling	8.9E00	1.8E-01	0.243	AKT1,AP2A2,APAF1,ATF2,ATP5F1A,ATP5F1E,ATP5PF,BAX,CASP10,CASP5,CASP7,CASP8,CLTB,CREB3,CYCS,DCTN1,DNM2,GNB4,GOSR1,GRB2,HDAC4,HDAC7,HIP1,HSPA1A/HSPA1B,HSPA6,IFT57,MAPK3,PIK3R3,PIK3R5,POLR2C,POLR2F,PRKCI,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SDHC,SHC1,SOS2,SP1,YKT6	
RNA Polymerase II Transcription	8.86E00	2.28E-01	-4.459	AFF4,ALYREF,CCNK,CDC40,CDC73,CHTOP,CLP1,CPSF3,CSTF3,CTDP1,DDX39A,EIF4A3,ELOA,ELOC,ERCC2,GTF2A2,GTF2F1,MLLT1,NCBP2,NELFE,PAF1,POLR2C,POLR2F,RBM8A,RNPS1,SNRPB,SNRPE,SRSF2,SUPT16H,SUPT4H1,SUPT6H,TAF7,TCEA1,THOC5	
PTEN Regulation	8.78E00	2.27E-01	-4.315	AKT1,ATF2,CBX4,CSNK2A2,CSNK2B,EZH2,HDAC7,LAMTOR3,MAPK3,MLST8,MOV10,PHC2,PML,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RNF146,RRAGA,SUZ12,TNRC6A,TNRC6C,TRIM27,WWP2	
KEAP1-NFE2L2 pathway	8.44E00	2.75E-01	-4.600	AKT1,CSNK2A2,CSNK2B,CUL1,CUL3,DPP3,KEAP1,MAFK,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,VCP	
Histone Modification Signaling Pathway	8.32E00	1.73E-01	-0.980	ATF2,ATM,BAP1,BAZ1B,BAZ2A,BPTF,BRWD1,BUB1,CBX4,CHUK,CSNK2A2,CSNK2B,EZH1,EZH2,H1-1,H3-3A/H3-3B,H4C11,HASPIN,HAT1,HDAC4,HDGFL2,HP1BP3,KAT5,KDM2A,KDM6B,KMT2E,KMT5A,KMT5B,LRWD1,MLLT10,MSH6,NFKB2,ORC1,PHF19,PHF2,PHF20,PHF23,PRDM2,PRMT5,RNF20,RNF40,RPS6KA5,SETD2,SETDB2,SIRT5,SMARCA4,SND1,TRIM33,VEGFC,WDR5,YWHAG	
RHO GTPase cycle	8.29E00	1.51E-01	-5.093	ABR,AKAP13,ANKFY1,ANLN,ARAP1,ARFGAP3,ARHGAP1,ARHGAP19,ARHGAP25,ARHGAP26,ARHGAP31,ARHGAP5,ARHGAP9,ARHGEF11,ARHGEF2,CCT6A,CCT7,CDC42,CDC42EP4,CDC42SE2,CUL3,ELMO2,FAM91A1,FMNL1,GIT2,GJA1,GOLGA3,GPS1,GRB2,HINT2,HMOX2,IQGAP3,KIDINS220,MAP3K11,MTX1,NCF1,NDUFS3,NET1,NSFL1C,NUDC,OBSCN,OSBPL11,PIK3R3,PKN1,PKN2,PKN3,PREX1,RAB7A,RHOB,RHOQ,RNF20,SCFD1,SENP1,SHKBP1,SOS2,SPATA13,STK10,STK38,TUBA1B,TXNL1,VANGL1,VAV1,VAV3,VCP,VRK2,WASL,WWP2,YKT6	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	8.19E00	2.34E-01	-4.382	ATP5F1A,ATP5F1E,ATP5MC3,ATP5PD,ATP5PF,ATP5PO,COX5A,COX8A,CYB5B,CYC1,CYCS,ECSIT,ETFB,ETFDH,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NUBPL,SDHC,UQCRC1,UQCRH	
FLT3 Signaling in Hematopoietic Progenitor Cells	8E00	2.8E-01	-2.294	AKT1,ATF2,CREB3,EIF4E,EIF4EBP1,GRB2,MAP2K2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,SHC1,SOS2,STAT3,STAT5A,STAT5B	
Acute Phase Response Signaling	7.91E00	2E-01	-3.024	AKT1,APOA2,APOH,C1QA,C1QC,C1S,C3,CHUK,CRP,ECSIT,FGA,FGG,GRB2,HMOX1,HMOX2,IL1R1,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,NOLC1,NRAS,ORM1,ORM2,PIK3R3,PTPN11,RAF1,RAP1A,RELA,RIPK1,SAA1,SHC1,SOCS4,SOS2,STAT3,TRADD	
Oxidative Phosphorylation	7.72E00	2.41E-01	-4.315	ATP5F1A,ATP5F1E,ATP5MC3,ATP5PD,ATP5PF,ATP5PO,COX5A,COX7A2,COX8A,CYB5B,CYC1,CYCS,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,SDHC,UQCRC1,UQCRH	
S Phase	7.53E00	2.5E-01	-3.674	AKT1,CCNE1,CCNE2,CDK4,CUL1,E2F4,ESCO1,ESCO2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,TFDP1	
Interleukin-1 family signaling	7.51E00	2.25E-01	-4.536	ALOX5,CHUK,CUL1,IL1R1,MAP3K3,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,PTPN11,PTPN2,PTPN6,PTPN7,RELA,SKP1,SKP2,STAT3,TBK1,TNIP2	
Neutrophil degranulation	7.3E00	1.43E-01	-5.821	ACAA1,ACLY,ALDH3B1,ALOX5,AMPD3,AP1M1,AP2A2,APAF1,ARHGAP9,ASAH1,BST2,C3,C3AR1,CAND1,CCT8,CD300A,CMTM6,COMMD9,CPPED1,CSNK2B,CSTB,DNAJC3,DYNLT1,FCER1G,FGR,GPI,GSDMD,HK3,HMOX2,HSPA1A/HSPA1B,HSPA6,IMPDH1,KCNAB2,KPNB1,LAMP1,LAMTOR3,LCN2,MANBA,MAPK14,MIF,MVP,NRAS,OLFM4,ORM1,ORM2,OSTF1,PDXK,PGAM1,PLEKHO2,PSMA5,PSMC3,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PTPN6,RAB44,RAB5C,RAB7A,RAP1A,RNASE3,SCAMP1,SIGLEC9,STK10,VAMP8,VAT1,VCP	
JAK/STAT Signaling	7.3E00	2.68E-01	-2.558	AKT1,CISH,GRB2,JAK3,MAP2K2,MAPK3,NFKB2,NRAS,PIAS1,PIK3R3,PIK3R5,PTPN11,PTPN6,RAF1,RAP1A,RELA,SHC1,SOCS4,SOS2,STAT3,STAT5A,STAT5B	
Ribonucleotide Reductase Signaling Pathway	7.26E00	1.99E-01	-1.915	AFAP1-AS1,AKT1,ATF2,ATM,BRAF,CCNF,CDK4,CREB3,CTNNB1,CUL1,E2F2,E2F4,E2F8,EIF4E,EIF4EBP1,H3-3A/H3-3B,MAPK14,MAPK3,MLST8,NFKB2,NFYC,NRAS,PARP10,PARP14,PARP4,PIK3R3,PIK3R5,SETD2,SKP1,SKP2,SMARCA4,SMARCD1,SP1,STAT3	
DNA Replication Pre-Initiation	7.17E00	2.4E-01	-4.200	ANAPC10,CDC27,CDC6,CDT1,KPNB1,MCM2,MCM3,MCM5,ORC1,ORC5,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,UBE2E1	
Acute Myeloid Leukemia Signaling	7.08E00	2.53E-01	-1.528	AKT1,BRAF,CEBPA,EIF4EBP1,GRB2,IDH2,KITLG,MAP2K2,MAP2K5,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PML,RAF1,RAP1A,RELA,RPS6KB2,SOS2,STAT3,STAT5A,STAT5B	
Prostate Cancer Signaling	6.93E00	2.28E-01	-3.530	ABL1,AKT1,ATF2,CCNE1,CCNE2,CHUK,CREB3,CTNNB1,E2F2,E2F4,GRB2,HDAC4,HDAC7,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RBL1,RELA,SOS2,TFDP1	
HER-2 Signaling in Breast Cancer	6.9E00	1.76E-01	-1.859	AKT1,BRAF,CASP7,CCNE1,CCNE2,CDC42,CDK4,CHUK,COX5A,COX7A2,COX8A,ELF2,FCER1G,FGR,GRB2,GSK3A,HCK,KPNB1,MAP2K2,MAPK3,MLST8,NFKB2,NFKBIE,NRAS,NUP43,NUP54,NUP58,NUP93,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RBL1,RELA,RPS6KB2,SOS2,SP1,STAT3,TPR	
Cyclins and Cell Cycle Regulation	6.9E00	2.56E-01	-1.732	ABL1,ATM,CCNE1,CCNE2,CDK4,CUL1,E2F2,E2F4,E2F8,HDAC4,HDAC7,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RBL1,SKP1,SKP2,TFDP1,TGFB2	
NIK-->noncanonical NF-kB signaling	6.9E00	3E-01	-3.771	CHUK,CUL1,NFKB2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1	
Inhibition of ARE-Mediated mRNA Degradation Pathway	6.74E00	1.96E-01	-0.243	AKT1,CNOT10,CNOT3,CNOT8,DIS3,EXOSC4,EXOSC7,FASLG,MAPK14,MAPK3,PARN,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,YWHAG	
Signaling by NTRK1 (TRKA)	6.72E00	2.59E-01	-2.400	AP2A2,BRAF,CRK,DNM2,DUSP7,GRB2,KIDINS220,MAP2K2,MAP2K5,MAPK14,MAPK3,MAPKAPK3,NRAS,PPP2CA,PPP2R5D,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,SHC1,STAT3	
Regulation of mitotic cell cycle	6.71E00	2.5E-01	-3.411	ANAPC10,BUB3,CDC14A,CDC27,CUL1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,UBE2E1	
IL-2 Signaling	6.66E00	2.9E-01	-3.000	AKT1,CSNK2A2,CSNK2B,GRB2,JAK3,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,SHC1,SOS2,STAT5A,STAT5B,SYK	
Small Cell Lung Cancer Signaling	6.62E00	2.4E-01	-2.714	ABL1,AKT1,APAF1,CCNE1,CCNE2,CDK4,CHUK,CYC1,CYCS,E2F2,E2F4,HDAC4,HDAC7,NFKB2,NFKBIE,PIK3R3,PIK3R5,RBL1,RELA,RXRA,SKP2,TFDP1,TRAF3	
Role of Tissue Factor in Cancer	6.59E00	1.79E-01	-1.151	AKT1,BRAF,CHUK,EIF4E,FGA,FGG,FGR,HCK,ITGA6,LIMK1,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NRAS,P4HB,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PTPN11,RAF1,RAP1A,RBL1,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,STAT5A,STAT5B,TFPI,TGFB2,VEGFC	
NGF Signaling	6.47E00	2.17E-01	-3.138	AKT1,ATF2,BAX,CDC42,CHUK,CREB3,CRK,GRB2,MAP2K2,MAP3K11,MAP3K3,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RELA,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SHC1,SOS2	
C-type lectin receptors (CLRs)	6.35E00	2E-01	-4.041	AHCYL1,C8orf44-SGK3/SGK3,CASP8,CHUK,CUL1,FCER1G,NFKB2,NRAS,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RAF1,RELA,RPS6KA5,SKP1,SYK,UBE2D2	
Degradation of beta-catenin by the destruction complex	6.35E00	2.39E-01	-4.146	CSNK1A1,CTNNB1,CUL1,PPP2CA,PPP2R5D,PPP2R5E,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2	
BAG2 Signaling Pathway	6.34E00	2.47E-01	-0.378	HSPA1A/HSPA1B,HSPA6,MAPK14,MAPK3,NFKB2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RELA,SP1	
Regulation of RUNX2 expression and activity	6.17E00	2.6E-01	-3.300	CUL1,ESRRA,FBXW7,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2	
ERK/MAPK Signaling	6.17E00	1.72E-01	-1.219	ATF2,BRAF,CREB3,CRK,EIF4E,EIF4EBP1,ELF2,GRB2,H3-3A/H3-3B,ITGA6,LAMTOR3,MAP2K2,MAPK3,MKNK1,NRAS,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PRKACA,PRKCI,RAF1,RAP1A,RAPGEF3,RPS6KA1,RPS6KA5,SHC1,SOS2,SRF,STAT3,VRK2,YWHAG	
Chronic Myeloid Leukemia Signaling	6.15E00	1.58E-01	-3.618	ABL1,ADAR,ADCY3,AKT1,CDK4,CEBPA,CHUK,CRK,CTNNB1,DVL3,E2F2,E2F4,E2F8,GRB2,HCK,HDAC4,HDAC7,ITCH,KLF4,LIG3,MAP2K2,MAPK3,MLST8,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PTPN11,PTPN6,RAF1,RAN,RAP1A,RBL1,RCC1,RELA,SKP2,SOS2,STAT3,STAT5A,STAT5B,TFDP1,TGFB2	
Insulin Receptor Signaling	6.15E00	2E-01	-2.600	ACLY,AKT1,CRK,EIF2B1,EIF4E,EIF4EBP1,GRB2,GSK3A,GYS1,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PRKACA,PRKCI,PTPN11,RAF1,RAP1A,RHOQ,RPS6KB2,SHC1,SOS2,STX4,STXBP4	
Pancreatic Adenocarcinoma Signaling	6.03E00	2.06E-01	-2.840	ABL1,AKT1,CCNE1,CCNE2,CDC42,CDK4,E2F2,E2F4,E2F8,GRB2,HDAC4,HDAC7,HMOX1,JAK3,MAP2K2,MAPK3,NFKB2,PIK3R3,PIK3R5,RAF1,RBL1,RELA,STAT3,TFDP1,TGFB2,VEGFC	
TWEAK Signaling	6.02E00	3.51E-01	-1.941	APAF1,BAG4,CASP7,CASP8,CHUK,CYCS,FADD,NFKB2,NFKBIE,RELA,RIPK1,TRADD,TRAF3	
Cellular response to hypoxia	5.98E00	2.53E-01	-3.441	CITED2,EGLN1,ELOC,HIGD1A,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,UBE2D2	
Hedgehog 'off' state	5.85E00	2.12E-01	-2.985	ADCY3,CSNK1A1,CUL1,IFT57,IFT88,ITCH,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,TUBA1B	
Protein Sorting Signaling Pathway	5.85E00	1.8E-01	-1.768	ADCY3,AP1M1,AP3D1,ARCN1,ARFGEF1,CDC42,CLTB,COPB2,COPE,COPG1,DNM2,FGR,GCC1,HCK,HMOX1,MIA2,PREB,PRKACA,SAR1A,SEC23B,SEC24B,SEC24C,SEC31A,SNX1,SNX13,SNX24,SNX6,SNX8,TMED2,TMED3,VPS35,WASHC5	
Melanocyte Development and Pigmentation Signaling	5.85E00	2.24E-01	-1.706	ADCY3,ATF2,CREB3,CRK,GRB2,KITLG,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKACA,PTPN11,PTPN6,RAF1,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SHC1,SOS2	
Coronavirus Pathogenesis Pathway	5.84E00	1.72E-01	1.521	ABL1,BAX,BST2,CASP8,CCL2,CCNE1,CCNE2,CDK4,CHUK,E2F2,E2F4,E2F8,EIF4E,FASLG,HDAC4,HDAC7,KPNB1,MAPK14,MAPK3,NFKB2,NFKBIE,OAS1,OAS2,RAB7A,RBL1,RELA,RIPK1,RPS19,RPS27L,STAT3,TBK1,TFDP1,TICAM1,TRAF3,TRIM25	
MAPK6/MAPK4 signaling	5.73E00	2.28E-01	0.378	CDC14A,CDC42,MOV10,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,TNRC6A,TNRC6C,XPO1	
Mitochondrial protein import	5.72E00	2.66E-01	-4.123	ATP5F1A,CHCHD10,CHCHD2,CHCHD3,CHCHD4,CHCHD7,CYC1,GFER,HSPD1,MTX1,NDUFB8,TIMM10,TIMM17A,TIMM44,TIMM8B,TOMM22,TOMM5	
Senescence Pathway	5.66E00	1.51E-01	-0.160	AKT1,ANAPC10,ATM,BRAF,CACNB1,CCNE1,CCNE2,CDC27,CDK4,CHUK,DHCR24,E2F2,E2F4,E2F8,EIF4E,EIF4EBP1,ELF2,EZH2,GADD45A,MAP2K2,MAP2K5,MAPK14,MAPK3,MAPKAPK3,MRE11,NFKB2,NRAS,PCGF6,PHF19,PIK3R3,PIK3R5,PML,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RAP1A,RBL1,RPS6KA5,SAA1,SMAD5,TBK1,TGFB2	
RAF/MAP kinase cascade	5.65E00	1.56E-01	-4.427	BRAF,BRAP,CUL3,DUSP5,DUSP7,FGA,FGG,GRB2,JAK3,KITLG,LAMTOR3,LAT,MAP2K2,MAP3K11,MAPK3,NRAS,PEA15,PHB1,PPP2CA,PPP2R5D,PPP2R5E,PPP5C,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,PTPN7,RAF1,RAP1A,RGL1,SHC1	
Autophagy	5.64E00	1.66E-01	-3.430	AKT1,ATF2,ATG13,ATM,CAMKK2,CREB3,GORASP2,GSK3A,KAT5,LAMP1,MAP2K2,MAPK3,MLST8,NFKB2,PIK3R3,PIK3R5,PLEKHM1,PPM1D,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,RAB7A,RAF1,RB1CC1,RIPK1,TBK1,TFEB,TGFB2,TICAM1,TRAF3,VAMP8,VPS16,VPS18	
Hedgehog 'on' state	5.63E00	2.33E-01	-3.578	CDC73,CSNK1A1,CUL3,GRK2,IQCE,ITCH,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5	
ERB2-ERBB3 Signaling	5.62E00	2.62E-01	-2.668	AKT1,GRB2,GSK3A,JAK3,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SOS2,SP1,STAT3,STAT5A,STAT5B	
Metabolism of polyamines	5.55E00	2.71E-01	-3.500	AZIN1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SRM	
GPVI-mediated activation cascade	5.48E00	3.43E-01	-1.155	CDC42,FCER1G,LAT,LCP2,PIK3R3,PIK3R5,PTPN11,PTPN6,RHOB,SYK,VAV1,VAV3	
Microautophagy Signaling Pathway	5.44E00	1.81E-01	-3.900	BAG6,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RAB7A,RHOT1,SEC23B,SEC24B,SEC24C,SEC31A,TFEB,VAMP8,VPS16,VPS18,VPS25,VPS36,VPS4A,VPS4B	
IGF-1 Signaling	5.32E00	2.1E-01	-3.130	AKT1,CSNK2A2,CSNK2B,GRB2,IGFBP2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKACA,PRKCI,PTPN11,RAF1,RAP1A,RPS6KB2,SHC1,SOCS4,SOS2,SRF,STAT3,YWHAG	
Deadenylation-dependent mRNA decay	5.28E00	2.73E-01	-1.291	CNOT10,CNOT3,CNOT8,DIS3,EIF4A3,EIF4E,EIF4G1,EXOSC4,EXOSC7,HBS1L,LSM4,LSM5,LSM7,PARN,TUT4	
Signaling by NOTCH4	5.27E00	2.29E-01	-3.441	ACTA2,AKT1,CUL1,FBXW7,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1	
Cell Cycle: G1/S Checkpoint Regulation	5.24E00	2.46E-01	2.887	ABL1,ATM,CCNE1,CCNE2,CDK4,CUL1,E2F2,E2F4,E2F8,HDAC4,HDAC7,PAK1IP1,RBL1,SKP1,SKP2,TFDP1,TGFB2	
Estrogen Receptor Signaling	5.22E00	1.34E-01	-2.655	ADCY3,AKT1,ARG2,ATF2,ATP5F1A,ATP5F1E,CACNB1,CCNC,CDK8,CREB3,CYC1,EIF2B1,EIF4E,EIF4EBP1,GNAI2,GNB4,GRB2,GSK3A,JAK3,LIMK1,MAP2K2,MAPK3,MED1,MED13,MYL6B,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RELA,RPS6KB2,SDHC,SHC1,SOS2,SP1,THRAP3,VEGFC	
RHO GTPases Activate Formins	5.2E00	1.87E-01	-2.746	BUB1,BUB3,CDC42,CDCA8,CENPA,CENPO,CLASP2,CLIP1,DVL3,FMNL1,KIF2C,NDEL1,NSL1,NUDC,NUF2,NUP43,PPP2CA,PPP2R5D,PPP2R5E,RCC2,RHOB,SCAI,SRF,TUBA1B,XPO1,ZWINT	
Neutrophil Extracellular Trap Signaling Pathway	5.19E00	1.35E-01	-4.627	AKT1,ARG2,ATP5F1A,ATP5F1E,C1QA,C1QC,CASP10,CASP5,CASP7,CASP8,CYC1,FGR,GSDMD,HCK,MAP2K2,MAP2K5,MAPK14,MAPK3,MLKL,NCF1,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PPID,PRKCI,RAF1,RIPK1,SDHC,SIGLEC9,SYK,TIMM10,TIMM17A,TIMM44,TIMM8B,TOMM22,TOMM34,TOMM40L,TOMM5	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	5.18E00	1.68E-01	-3.024	AKT1,APOA2,APOB,ARG2,CDC42,CHUK,JAK3,MAP3K11,MAP3K3,MAPK14,MAPK3,NCF1,NFKB2,NFKBIE,ORM1,ORM2,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PRKCI,PTPN6,RAP1A,RELA,RHOB,RHOQ,RHOT1	
Telomerase Signaling	5.11E00	2.04E-01	-0.500	ABL1,AKT1,ELF2,GRB2,HDAC4,HDAC7,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RAP1A,SHC1,SOS2,SP1,TERF2	
CNTF Signaling	5.07E00	2.63E-01	-2.840	AKT1,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,STAT3	
FAT10 Signaling Pathway	5.07E00	2.63E-01	NaN	PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,UBA6	
ISG15 antiviral mechanism	5.06E00	2.39E-01	-1.698	EIF4A3,EIF4E,EIF4G1,KPNA3,KPNA5,KPNB1,MAPK3,MX1,MX2,NUP43,NUP54,NUP58,NUP93,PIN1,TPR,TRIM25,UBE2E1	
Cell Cycle Regulation by BTG Family Proteins	5.05E00	3.16E-01	-1.633	CCNE1,CCNE2,CDK4,E2F2,E2F4,E2F8,NOCT,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E	
Hedgehog ligand biogenesis	4.96E00	2.46E-01	-4.000	P4HB,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,VCP	
Death Receptor Signaling	4.85E00	2.08E-01	-2.982	ACTA2,APAF1,CASP10,CASP7,CASP8,CHUK,CYC1,CYCS,FADD,FASLG,LIMK1,NFKB2,NFKBIE,PARP10,PARP14,PARP4,RELA,RIPK1,TBK1,TRADD	
Deubiquitination	4.85E00	1.48E-01	-4.003	ABRAXAS1,ACTL6A,ADRM1,BAP1,FOXK2,H2AC25,KDM1B,KEAP1,MBD5,MYSM1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RAD23B,RHOT1,RIPK1,RNF146,RUVBL1,SKP2,STAMBPL1,TADA2B,TNIP2,TRAF3,TRIM25,USP48,VCP,WDR20,WDR48	
Natural Killer Cell Signaling	4.85E00	1.62E-01	-2.475	AKT1,CDC42,FASLG,FCER1G,GRB2,HCST,HSPA1A/HSPA1B,HSPA6,JAK3,LAT,LCP2,LIMK1,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,MICB,NFKB2,NRAS,PIK3R3,PIK3R5,PTPN11,PTPN6,RAF1,RAP1A,RELA,SOS2,SYK,VAV1,VAV3,WASL	
Protein Ubiquitination Pathway	4.83E00	1.47E-01	-2.920	ANAPC10,BAP1,CUL1,DNAJC14,DNAJC2,DNAJC3,DNAJC6,DNAJC7,ELOC,FBXW7,HSPA1A/HSPA1B,HSPA6,HSPD1,HSPH1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SKP1,SKP2,TAP1,UBE2D2,UBE2E1,UBE2H,UBE2I,UBE2J2,USP32,USP45,USP48,USP53	
TCF dependent signaling in response to WNT	4.8E00	1.61E-01	-4.243	AKT1,ASH2L,CDC73,CSNK1A1,CSNK2A2,CSNK2B,CTNNB1,CUL3,CXXC4,DVL3,KAT5,PPP2CA,PPP2R5D,PPP2R5E,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RNF146,RUVBL1,SMARCA4,XPO1	
Regulation of Apoptosis	4.79E00	2.64E-01	-3.742	PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5	
Role of IL-17F in Allergic Inflammatory Airway Diseases	4.72E00	2.77E-01	-2.309	ATF2,CCL2,CCL4,CREB3,CXCL10,MAP2K2,MAPK3,NFKB2,RAF1,RELA,RPS6KA1,RPS6KA2,RPS6KA5	
TNFR2 non-canonical NF-kB pathway	4.69E00	2.35E-01	-3.500	PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,TNFRSF11A,TRAF3	
RNA polymerase II transcribes snRNA genes	4.68E00	2.17E-01	-2.828	CCNK,GTF2A2,GTF2F1,INTS10,INTS3,INTS5,NABP2,NCBP2,PHAX,POLR2C,POLR2F,RNU4-1,RPAP2,SNAPC1,SP1,SSU72,SUPT4H1,ZNF143	
Interleukin-15 signaling	4.66E00	5E-01	-1.890	GRB2,JAK3,SHC1,SOS2,STAT3,STAT5A,STAT5B	
Colanic Acid Building Blocks Biosynthesis	4.66E00	5E-01	-1.890	GFUS,GMDS,GMPPA,GPI,PMM1,UGDH,UGP2	
Regulation of eIF4 and p70S6K Signaling	4.66E00	1.63E-01	-1.069	AKT1,EIF1,EIF2B1,EIF3I,EIF3J,EIF4A3,EIF4E,EIF4EBP1,EIF4G1,ELP5,GRB2,ITGA6,MAP2K2,MAPK14,MAPK3,MKNK1,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RAP1A,RPS19,RPS27L,SHC1,SOS2	
PPAR Signaling	4.65E00	1.96E-01	1.964	AIP,CHUK,CITED2,GRB2,IL1R1,MAP2K2,MAPK3,MED1,NFKB2,NFKBIE,NR1H3,NRAS,RAF1,RAP1A,RELA,RXRA,SCAND1,SHC1,SOS2,STAT5A,STAT5B	
Metabolism of non-coding RNA	4.59E00	2.55E-01	-2.673	DDX20,GEMIN4,NCBP2,NUP43,NUP54,NUP58,NUP93,PHAX,PRMT5,RNU4-1,SNRPB,SNRPD2,SNRPE,TPR	
UFMylation Signaling Pathway	4.59E00	2.42E-01	-0.775	ABCG1,AKT1,ATM,EIF4A3,EIF4E,EIF4G1,ELP5,H3-3A/H3-3B,H4C11,KAT5,MRE11,NFKB2,NR1H3,UFC1,UFM1	
mTOR Signaling	4.55E00	1.54E-01	-1.043	AKT1,ATG13,CDC42,EIF3I,EIF3J,EIF4A3,EIF4E,EIF4EBP1,EIF4G1,FKBP1A,HMOX1,MAPK3,MLST8,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RAP1A,RHOB,RHOQ,RHOT1,RPS19,RPS27L,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,VEGFC	
Signaling by CSF3 (G-CSF)	4.53E00	3.33E-01	-2.530	ELOC,GRB2,HCK,PTPN11,SHC1,STAT3,STAT5A,STAT5B,SYK,UBE2D2	
TP53 Regulates Transcription of DNA Repair Genes	4.53E00	2.29E-01	-2.000	AP1M1,ATF2,ATM,CCNK,CTDP1,ELOA,ELOC,ERCC2,GTF2F1,MLH1,NELFE,POLR2C,POLR2F,SUPT16H,SUPT4H1,TCEA1	
GM-CSF Signaling	4.53E00	2.29E-01	-2.500	AKT1,CISH,GRB2,HCK,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,SHC1,SOS2,STAT3,STAT5B	
MicroRNA Biogenesis Signaling Pathway	4.52E00	1.6E-01	-1.826	ABL1,ADAR,AKT1,ATM,DIS3,EWSR1,EXOSC4,EXOSC7,FUS,HMOX1,KHSRP,MAPK14,MAPK3,NRAS,NUP43,NUP54,NUP58,NUP93,PIK3R3,PIK3R5,PIWIL4,POLR2C,POLR2F,RAN,RAP1A,SMAD5,TGFB2,TPR,TSNAX,TUT4	
Cell Cycle Control of Chromosomal Replication	4.5E00	2.5E-01	-1.069	CDC45,CDC6,CDK14,CDK17,CDK4,CDK8,CDT1,DNA2,MCM2,MCM3,MCM5,ORC1,ORC5,POLD1	
Transcriptional regulation by RUNX1	4.49E00	1.71E-01	-4.315	ABL1,ACTL6A,CBX4,CSNK2A2,CSNK2B,ELF2,ITCH,LMO2,PHC2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SMARCA4,SMARCD1,SOCS4	
Neurotrophin/TRK Signaling	4.48E00	2.18E-01	-1.698	AKT1,ATF2,CDC42,CREB3,GRB2,MAP2K2,MAP2K5,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RPS6KA1,SHC1,SOS2	
Signaling by the B Cell Receptor (BCR)	4.47E00	1.65E-01	-4.158	AHCYL1,CHUK,CUL1,FKBP1A,GRB2,IGKV3-20,NFKBIE,NRAS,PIK3AP1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,PTPN6,RELA,SKP1,SYK,VAV1	
Kinetochore Metaphase Signaling Pathway	4.46E00	1.91E-01	-0.943	ANAPC10,ARPP19,BUB1,BUB3,CDC27,CDCA8,CENPA,CENPO,CENPW,KAT5,KIF2C,MAD2L2,NSL1,NUF2,PPP1R10,PPP1R14A,PPP1R14B,PPP2R5D,PPP2R5E,SKA3,ZWINT	
Non-Small Cell Lung Cancer Signaling	4.45E00	2.02E-01	-1.897	ABL1,AKT1,CDK4,E2F2,E2F4,GRB2,HDAC4,HDAC7,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RBL1,RXRA,SOS2,TFDP1	
Oncostatin M Signaling	4.45E00	2.79E-01	-2.887	GRB2,JAK3,MAP2K2,MAPK3,MT2A,NRAS,RAF1,RAP1A,SHC1,STAT3,STAT5A,STAT5B	
PDGF Signaling	4.39E00	2.07E-01	-2.828	ABL1,ACP1,CRK,CSNK2A2,CSNK2B,GRB2,JAK3,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SOS2,SRF,STAT3	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	4.34E00	1.88E-01	-1.528	ABL1,ABRAXAS1,ATM,BLM,DNA2,EXO1,KAT5,MRE11,POLD1,POLD2,POLD3,POLK,RAD51AP1,RFC2,RHNO1,RMI1,RNF4,SPIDR,SUMO2,TIMELESS,UBE2I	
IL-6 Signaling	4.33E00	1.78E-01	-3.128	AKT1,CHUK,CRP,CSNK2A2,CSNK2B,GRB2,IL1R1,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RELA,SHC1,SOS2,SRF,STAT3	
Endocannabinoid Cancer Inhibition Pathway	4.3E00	1.7E-01	-1.000	ADCY3,AKT1,ATF2,CAMKK2,CASP10,CASP5,CASP7,CASP8,CCNE1,CCNE2,CREB3,CTNNB1,GNAI2,MAP2K2,MAP2K5,MAPK14,MAPK3,MLST8,NSMAF,PIK3R3,PIK3R5,PRKACA,RAF1,TRIB3,VEGFC	
Estrogen-mediated S-phase Entry	4.28E00	3.46E-01	-2.828	CCNE1,CCNE2,CDK4,E2F2,E2F4,E2F8,RBL1,SKP2,TFDP1	
Nucleotide Excision Repair	4.25E00	1.96E-01	-1.606	COPS5,COPS7A,DDB1,ERCC2,GPS1,LIG3,PIAS1,POLD1,POLD2,POLD3,POLK,POLR2C,POLR2F,RAD23B,RFC2,SUMO2,TCEA1,UBE2I,USP45	
MSP-RON Signaling in Cancer Cells Pathway	4.21E00	1.71E-01	-2.711	ACTA2,AKT1,ATF2,BRAF,CREB3,CTNNB1,ELF2,GRB2,ITGA6,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,RPS6KA2,SOS2,SP1,STAT3,VEGFC,YWHAG	
Interleukin-7 signaling	4.2E00	3.81E-01	-1.633	BRWD1,CISH,JAK3,PIK3R3,SMARCA4,STAT3,STAT5A,STAT5B	
Nucleotide salvage	4.2E00	3.81E-01	-2.121	ADA,ADAL,AMPD3,GMPR2,TK1,TK2,UCK1,UCK2	
Cilium Assembly	4.19E00	1.52E-01	-1.671	ACTR1A,AKAP9,ARL3,CCT6A,CCT7,CCT8,CEP135,CEP70,CSNK1D,DCTN1,DYNC2I2,DYNLT5,EXOC3,EXOC7,EXOC8,HAUS1,HAUS4,HAUS6,IFT57,IFT74,IFT80,IFT88,PCNT,PLK4,PRKACA,RAB8A,SSNA1,TCP1,TUBA1B,TUBG1,YWHAG	
Integrin signaling	4.13E00	3.33E-01	-2.333	AKT1,CRK,FGA,FGG,GRB2,RAP1A,RAPGEF3,SHC1,SYK	
Fc epsilon receptor (FCERI) signaling	4.11E00	1.5E-01	-3.413	AHCYL1,CHUK,CUL1,FCER1G,GRB2,IGKV3-20,LAT,LCP2,MAPK3,NRAS,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RELA,SHC1,SKP1,SYK,UBE2D2,VAV1,VAV3	
Glioma Signaling	4.08E00	1.76E-01	-2.309	ABL1,AKT1,CDK4,E2F2,E2F4,E2F8,GRB2,HDAC4,HDAC7,IDH2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RBL1,SHC1,SOS2,TFDP1	
ABC-family proteins mediated transport	4E00	1.88E-01	-3.900	ABCA8,ABCC1,ABCG1,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RNF185,VCP	
RAN Signaling	3.99E00	4.12E-01	-0.378	IPO5,KPNA3,KPNA5,KPNB1,RAN,RCC1,XPO1	
Protein Kinase A Signaling	3.97E00	1.24E-01	1.406	ACP1,ADCY3,AKAP13,AKAP7,AKAP9,ANAPC10,APEX1,ATF2,BRAF,CDC27,CHUK,CREB3,CREM,CTNNB1,DUSP5,DUSP7,GDE1,GDPD1,GNAI2,GNB4,GSK3A,GYS1,H1-1,H3-3A/H3-3B,MAP2K2,MAPK3,MYL6B,NFKB2,NFKBIE,PDE12,PDE4A,PDE4D,PDE7A,PDIA3,PLCD3,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PRKACA,PRKCI,PTPN11,PTPN2,PTPN6,PTPN7,PTPRE,RAF1,RAP1A,RELA,TGFB2,YWHAG	
Intrinsic Pathway for Apoptosis	3.95E00	2.36E-01	-3.051	AKT1,APAF1,BAK1,BAX,CASP7,CASP8,CYCS,GSDMD,MAPK3,NMT1,STAT3,TFDP1,YWHAG	
Interleukin-3, Interleukin-5 and GM-CSF signaling	3.95E00	2.36E-01	-3.606	CRK,GRB2,HCK,JAK3,PIK3R3,PRKACA,PTPN11,PTPN6,SHC1,STAT5A,STAT5B,SYK,VAV1	
DNA Damage Bypass	3.94E00	2.5E-01	-2.309	DDB1,MAD2L2,PCLAF,POLD1,POLD2,POLD3,POLI,POLK,RFC2,TRIM25,VCP,WDR48	
Interferon gamma signaling	3.93E00	1.91E-01	-3.771	FCGR1BP,GBP3,MT2A,OAS1,OAS2,OASL,PIAS1,PML,PTPN11,PTPN2,PTPN6,TRIM14,TRIM22,TRIM25,TRIM26,TRIM38,TRIM68,TRIM8	
FasL/ CD95L signaling	3.9E00	8E-01	-2.000	CASP10,CASP8,FADD,FASLG	
Thrombopoietin Signaling	3.89E00	2.22E-01	-3.207	GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN11,RAF1,RAP1A,SHC1,STAT3,STAT5A,STAT5B	
Sumoylation Pathway	3.89E00	1.84E-01	0.775	CBX4,CDC42,CEBPA,FASLG,NFKB2,PIAS1,PML,RAN,RCC1,RFC2,RHOB,RHOQ,RHOT1,RNF4,SAE1,SENP1,SP1,SUMO2,UBE2I	
Prolactin Signaling	3.87E00	1.89E-01	-2.668	CCDC51,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN11,RAF1,RAP1A,SHC1,SOCS4,SOS2,SP1,STAT3,STAT5A,STAT5B	
Growth Hormone Signaling	3.87E00	2.11E-01	-2.324	CEBPA,MAPK3,PIK3R3,PIK3R5,PRKCI,PTPN6,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SOCS4,SRF,STAT3,STAT5A,STAT5B	
EGF Signaling	3.86E00	2.32E-01	-3.051	AKT1,CSNK2A2,CSNK2B,GRB2,MAPK14,MAPK3,PIK3R3,PIK3R5,RAF1,SHC1,SOS2,SRF,STAT3	
TP53 Regulates Transcription of Cell Cycle Genes	3.84E00	2.45E-01	-1.732	ARID3A,BAX,CCNE1,CCNE2,CNOT10,CNOT3,CNOT8,E2F4,E2F8,GADD45A,RBL1,TFDP1	
Apoptosis Signaling	3.83E00	1.83E-01	0.000	APAF1,BAK1,BAX,CASP10,CASP7,CASP8,CHUK,CYC1,CYCS,FASLG,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,RAF1,RAP1A,RELA,RPS6KA1	
Mitochondrial Dysfunction	3.8E00	1.28E-01	3.507	ARG2,ATF2,ATP5F1A,ATP5F1E,ATP5MC3,ATP5PD,ATP5PF,ATP5PO,BAX,CACNB1,COX5A,COX7A2,COX8A,CREB3,CYB5B,CYC1,CYCS,FBXW7,FUS,IDH2,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,OGDH,PIK3R3,PIK3R5,PRKACA,RAPGEF3,RHOT1,SDHC,TARDBP,TOMM22,TOMM34,UQCRC1,UQCRH	
COPII-mediated vesicle transport	3.79E00	2.08E-01	-0.258	CSNK1D,PPP6C,PPP6R3,PREB,RAB1A,SCFD1,SEC23B,SEC23IP,SEC24B,SEC24C,SEC31A,TMED2,TRAPPC2L,TRAPPC3,YKT6	
Glucose metabolism	3.79E00	2E-01	-3.000	GNPDA1,GOT1,GPI,HK3,MDH1,NUP43,NUP54,NUP58,NUP93,PFKFB4,PPP2CA,PPP2R5D,PRKACA,SLC25A11,TPI1,TPR	
Role of BRCA1 in DNA Damage Response	3.79E00	2E-01	2.111	ABRAXAS1,ATM,BLM,E2F2,E2F4,E2F8,FANCE,FANCG,GADD45A,MLH1,MRE11,MSH6,RBL1,RFC2,SMARCA4,SMARCD1	
Signaling by SCF-KIT	3.75E00	2.56E-01	-2.714	FES,GRB2,KITLG,NRAS,PIK3R3,PTPN11,PTPN6,STAT3,STAT5A,STAT5B,VAV1	
Salvage Pathways of Pyrimidine Ribonucleotides	3.75E00	1.86E-01	-1.886	AK9,APOBEC3G,BRAF,CDADC1,CDK4,CDK8,CSNK1A1,CSNK1D,DYRK1A,LIMK1,MAK,MAP2K2,MAPK3,NME6,NME7,PKN1,UCK1,UCK2	
Induction of Apoptosis by HIV1	3.74E00	2.15E-01	-2.496	APAF1,BAK1,BAX,CASP8,CHUK,CYC1,CYCS,FADD,FASLG,NFKB2,NFKBIE,RELA,RIPK1,TRADD	
LXR/RXR Activation	3.73E00	1.71E-01	-1.213	ABCG1,APOA2,APOB,APOH,ARG2,C3,CCL2,ECHS1,FDFT1,FGA,IL1R1,MYLIP,NFKB2,NR1H2,NR1H3,ORM1,ORM2,RELA,RXRA,SAA1,SCD	
OAS antiviral response	3.72E00	5.56E-01	-2.236	OAS1,OAS2,OASL,PDE12,RNASEL	
Role of CHK Proteins in Cell Cycle Checkpoint Control	3.7E00	2.24E-01	0.333	ATM,ATMIN,E2F2,E2F4,E2F8,MRE11,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RFC2,TLK2	
TNFR1 Signaling	3.67E00	2.35E-01	-2.309	APAF1,CASP7,CASP8,CDC42,CHUK,CYCS,FADD,NFKB2,NFKBIE,RELA,RIPK1,TRADD	
Granzyme A Signaling	3.65E00	2.03E-01	3.873	APEX1,H1-1,LMNB2,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3	
Signaling by ROBO receptors	3.64E00	1.72E-01	-3.130	ABL1,CDC42,CLASP2,ELOC,PRKACA,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,SOS2	
VEGF Signaling	3.63E00	1.82E-01	-1.500	ACTA2,ACTN4,AKT1,EIF1,EIF2B1,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,PTPN6,RAF1,RAP1A,SHC1,SOS2,VEGFC	
Cristae formation	3.61E00	2.9E-01	-3.000	ATP5F1A,ATP5F1E,ATP5MC3,ATP5PD,ATP5PF,ATP5PO,CHCHD3,IMMT,MTX1	
NER (Nucleotide Excision Repair, Enhanced Pathway)	3.61E00	1.87E-01	-1.000	COPS5,COPS7A,DDB1,DNA2,ERCC2,GPS1,LIG3,POLD1,POLD2,POLD3,POLK,POLR2C,POLR2F,RAD23B,RFC2,TCEA1,UBE2I	
PI3K/AKT Signaling	3.6E00	1.45E-01	-1.225	AKT1,CHUK,CTNNB1,EIF4E,EIF4EBP1,GRB2,GSK3A,GYS1,IL1R1,ITGA6,JAK3,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RAP1A,RELA,RPS6KB2,SHC1,SOS2,YWHAG	
TCR signaling	3.58E00	1.67E-01	-3.273	CHUK,CUL1,LAT,LCP2,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,RELA,SKP1,UBE2D2	
ATM Signaling	3.58E00	1.8E-01	0.905	ABL1,ATF2,ATM,BLM,CREB3,GADD45A,H4C11,HP1BP3,KAT5,MAPK14,MRE11,PPM1D,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,TLK2	
Transcriptional regulation of white adipocyte differentiation	3.53E00	1.9E-01	-2.500	ADIRF,CCNC,CDK4,CDK8,CEBPA,EGR2,KLF4,MED1,MED11,MED13,MED19,MED9,RELA,RXRA,THRAP3,ZNF467	
PEDF Signaling	3.53E00	1.9E-01	-3.357	AKT1,CASP7,CASP8,CHUK,FASLG,MAPK14,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,SRF	
Angiopoietin Signaling	3.52E00	1.97E-01	-1.732	AKT1,CHUK,CRK,GRB14,GRB2,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PTPN11,RAP1A,RELA,STAT5A,STAT5B	
Necroptosis Signaling Pathway	3.51E00	1.55E-01	-2.858	CASP10,CASP8,CHUK,FADD,FASLG,FKBP1A,GLUD1,MLKL,PGAM5,PPID,RBCK1,RBL1,RIPK1,TICAM1,TIMM10,TIMM17A,TIMM44,TIMM8B,TOMM22,TOMM34,TOMM40L,TOMM5,TRADD,TRPM7	
Spliceosomal Cycle	3.5E00	2.26E-01	-3.317	BUD13,DDX23,DDX46,DHX15,DHX16,DHX8,EIF4A3,RBM8A,SF3B2,SF3B4,SF3B5,SNIP1	
Cytosolic sensors of pathogen-associated DNA	3.47E00	2.39E-01	-2.111	AIM2,CHUK,CTNNB1,DDX41,LRRFIP1,MRE11,NFKB2,RELA,RIPK1,TBK1,TICAM1	
Role of RIG1-like Receptors in Antiviral Innate Immunity	3.47E00	2.39E-01	-2.530	CASP10,CASP8,CHUK,FADD,NFKB2,NFKBIE,RELA,RIPK1,TBK1,TRAF3,TRIM25	
LPS-stimulated MAPK Signaling	3.47E00	1.88E-01	-2.500	ATF2,CDC42,CHUK,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA,SRF	
Role of JAK1 and JAK3 in γc Cytokine Signaling	3.45E00	2.03E-01	-3.207	FES,GRB2,JAK3,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAP1A,SHC1,STAT3,STAT5A,STAT5B,SYK	
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	3.44E00	1.81E-01	-3.153	ACTA2,AKT1,ARPC5L,CDC42,CRK,FGR,HCK,HMOX1,LCP2,MAPK3,NCF1,PIK3R3,PRKCI,RPS6KB2,SYK,VAV1,VAV3	
Cachexia Signaling Pathway	3.44E00	1.22E-01	-4.621	ADCY3,AKT1,CASP10,CASP5,CASP7,CASP8,CCL2,CHUK,CRP,EIF1,EIF2B1,FASLG,FGA,FGG,GSK3A,HSPA1A/HSPA1B,HSPA6,IL1R1,LCN2,MAPK14,MAPK3,NFKB2,P4HB,PIK3R3,PIK3R5,PRKACA,PRKCI,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5,STAT3,STAT5A,STAT5B,TGFB2	
Mismatch Repair	3.4E00	4E-01	-2.449	EXO1,MLH1,MSH6,POLD1,POLD2,POLD3	
Renin-Angiotensin Signaling	3.39E00	1.65E-01	-2.828	ADCY3,ATF2,CCL2,GRB2,MAP2K2,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PRKACA,PRKCI,PTPN6,RAF1,RAP1A,RELA,SHC1,SOS2,STAT3	
MAPK targets/ Nuclear events mediated by MAP kinases	3.39E00	2.73E-01	-1.667	ATF2,DUSP7,MAPK14,MAPK3,PPP2CA,PPP2R5D,RPS6KA1,RPS6KA2,RPS6KA5	
Ovarian Cancer Signaling	3.38E00	1.52E-01	-1.604	ABL1,AKT1,BRAF,CDK4,CTNNB1,E2F2,E2F4,GJA1,HDAC4,HDAC7,MAP2K2,MAPK3,MLH1,MSH6,NRAS,PIK3R3,PIK3R5,PRKACA,RAF1,RAP1A,RBL1,RPS6KB2,TFDP1,VEGFC	
HIPPO signaling	3.35E00	1.84E-01	0.816	CSNK1D,CUL1,ITCH,NF2,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,SKP1,SKP2,SMAD5,YWHAG	
IL-3 Signaling	3.33E00	1.9E-01	-2.840	AKT1,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN6,RAF1,RAP1A,SHC1,STAT3,STAT5A,STAT5B	
XBP1(S) activates chaperone genes	3.3E00	2.29E-01	-0.302	ACADVL,DCTN1,DNAJC3,GFPT1,GSK3A,PDIA5,PREB,SEC31A,SERP1,SHC1,SSR1	
Germ Cell-Sertoli Cell Junction Signaling	3.28E00	1.47E-01	NaN	ACTA2,ACTN4,AKT1,CDC42,CTNNB1,EPN1,ITGA6,KEAP1,LIMK1,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,RAP1A,RHOB,RHOQ,RHOT1,TGFB2,TUBA1B,TUBG1,WASL	
HIF1α Signaling	3.28E00	1.39E-01	-1.134	AKT1,APEX1,BRAF,COPS5,EGLN1,EIF4E,EIF4EBP1,ELOC,GPI,HK3,HMOX1,HSPA1A/HSPA1B,HSPA6,MAP2K2,MAP2K5,MAPK3,MKNK1,NCF1,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAN,RAP1A,RPS6KB2,STAT3,TGFB2,VEGFC	
Cellular response to heat stress	3.27E00	1.75E-01	-2.309	ATM,BAG4,DNAJC2,DNAJC7,FKBP4,HSPA1A/HSPA1B,HSPA6,HSPH1,MAPK3,MLST8,MRPL18,NUP43,NUP54,NUP58,NUP93,RPS19BP1,TPR	
SUMOylation of chromatin organization proteins	3.27E00	2.14E-01	-0.577	CBX4,HDAC4,NUP43,NUP54,NUP58,NUP93,PHC2,PIAS1,SUMO2,SUZ12,TPR,UBE2I	
Glioblastoma Multiforme Signaling	3.24E00	1.46E-01	-1.606	AKT1,CCNE1,CCNE2,CDC42,CDK4,CTNNB1,E2F2,E2F4,E2F8,GRB2,MAP2K2,MAPK3,NF2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,RAF1,RAP1A,RHOB,RHOQ,RHOT1,SHC1,SOS2	
Nuclear Cytoskeleton Signaling Pathway	3.24E00	1.36E-01	-2.556	ACTA2,ACTR1A,ATM,CAPZA2,CSNK2A2,CSNK2B,CTNNB1,CUL1,DCTN1,DCTN4,DCTN5,FGR,HCK,ITGA6,KIF1C,KIF20B,KIF23,KIF2C,LMNB2,NFKB2,NUP43,NUP54,NUP58,NUP93,SKP1,SKP2,SRF,SYNE1,TPR,TUBA1B	
Prolactin receptor signaling	3.23E00	3.75E-01	-1.342	CUL1,PTPN11,SKP1,SKP2,STAT5A,STAT5B	
Caspase activation via Death Receptors in the presence of ligand	3.23E00	3.75E-01	-2.449	CASP8,FADD,FASLG,RIPK1,TICAM1,TRADD	
PFKFB4 Signaling Pathway	3.22E00	2.24E-01	-0.302	ATF2,CREB3,GPI,HK3,MAP2K2,MAP2K5,MAPK3,PFKFB4,PRKACA,RPS6KA5,TGFB2	
UVA-Induced MAPK Signaling	3.22E00	1.73E-01	-1.508	ATM,CYCS,MAPK14,MAPK3,NRAS,PARP10,PARP14,PARP4,PDIA3,PIK3R3,PIK3R5,PLCD3,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2	
MTOR signalling	3.22E00	2.86E-01	-1.414	AKT1,EIF4E,EIF4EBP1,EIF4G1,FKBP1A,LAMTOR3,MLST8,RRAGA	
Signaling by FGFR2	3.19E00	1.92E-01	-3.207	BRAF,GRB2,GTF2F1,HNRNPF,MAPK3,MKNK1,NCBP2,NRAS,POLR2C,POLR2F,PPP2CA,PTBP1,PTPN11,SHC1	
CD27 Signaling in Lymphocytes	3.19E00	2.11E-01	-1.265	APAF1,CASP8,CHUK,CYC1,CYCS,MAP2K2,MAP2K5,MAP3K11,MAP3K3,NFKB2,NFKBIE,RELA	
IL-9 Signaling	3.18E00	2.57E-01	-2.828	CISH,JAK3,NFKB2,PIK3R3,PIK3R5,RELA,STAT3,STAT5A,STAT5B	
Ceramide Signaling	3.13E00	1.76E-01	-0.832	AKT1,CYCS,MAPK3,NFKB2,NRAS,NSMAF,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAF1,RAP1A,RELA	
Role of PKR in Interferon Induction and Antiviral Response	3.13E00	1.54E-01	-1.886	APAF1,ATF2,BAX,CASP5,CASP8,CHUK,CYC1,CYCS,DNAJC3,FADD,FASLG,HSPA1A/HSPA1B,HSPA6,MAPK14,MAPK3,NFKB2,NFKBIE,RELA,SP1,STAT3,TRAF3	
Endocannabinoid Developing Neuron Pathway	3.12E00	1.57E-01	-2.357	ADCY3,AKT1,ATF2,BRAF,CREB3,CTNNB1,GNAI2,GNB4,MAP2K2,MAP2K5,MAPK14,MAPK3,MLST8,NRAS,PIK3R3,PIK3R5,PRKACA,RAF1,RAP1A,STAT3	
Insulin Secretion Signaling Pathway	3.11E00	1.27E-01	-1.915	ADCY3,ATF2,CACNB1,CREB3,EIF1,EIF2B1,EIF4A3,EIF4E,EIF4EBP1,EIF4G1,ELP5,FGR,GOSR1,HCK,JAK3,MAPK14,MAPK3,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAP1A,RPS6KA5,RPS6KB2,SEC11A,SRP19,SRP68,SSR1,SSR3,STAT3,STAT5A,STAT5B,YKT6	
PPARα/RXRα Activation	3.11E00	1.39E-01	0.853	ACAA1,ADCY3,AIP,AP2A2,APOA2,CAND1,CHUK,GRB2,IL1R1,MAP2K2,MAPK14,MAPK3,MED1,NFKB2,NFKBIE,NRAS,PDIA3,PLCD3,PRKACA,RAF1,RAP1A,RELA,RXRA,SHC1,SOS2,STAT5B,TGFB2	
Fc Epsilon RI Signaling	3.11E00	1.61E-01	-2.065	AKT1,FCER1G,GRB2,LAT,LCP2,MAP2K2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN11,RAF1,RAP1A,SOS2,SYK,VAV1,VAV3	
STAT5 Activation	3.1E00	5.71E-01	-2.000	GRB2,PTPN11,STAT5A,STAT5B	
Interferon Signaling	3.09E00	2.5E-01	-1.667	BAK1,BAX,IFI35,MX1,OAS1,PIAS1,PTPN2,RELA,TAP1	
Glucocorticoid Receptor Signaling	3.08E00	1.08E-01	NaN	AKT1,ARG2,ATP5F1A,ATP5F1E,CCL2,CEBPA,CHUK,CYC1,ERCC2,FGG,FKBP4,FKBP5,GABPB1,GJA1,GRB2,GTF2A2,GTF2F1,H3-3A/H3-3B,HSPA1A/HSPA1B,HSPA6,IL1R1,JAK3,KRT23,MAP2K2,MAPK14,MAPK3,MED1,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,POLR2C,POLR2F,PRKACA,RAF1,RAP1A,RELA,RPS6KA5,RXRA,SDHC,SHC1,SMARCA4,SMARCD1,SOS2,STAT3,STAT5A,STAT5B,TAF7,TGFB2,UBE2I	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	3.06E00	2.16E-01	1.000	ABL1,ATM,CKS2,CUL1,GADD45A,PKMYT1,PPM1D,RPS6KA1,SKP1,SKP2,YWHAG	
CD40 Signaling	3.05E00	1.94E-01	-2.496	CHUK,JAK3,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,RELA,STAT3,TRAF3	
Polyamine Regulation in Colon Cancer	3.05E00	2.03E-01	-1.732	AKT1,AZIN1,BRAF,CSNK2A2,CSNK2B,CTNNB1,MAP2K2,MAP2K5,MAPK3,MLST8,RAF1,SRM	
Hepatic Fibrosis Signaling Pathway	3.03E00	1.15E-01	-2.343	ACTA2,AKT1,ATF2,BRAF,CACNB1,CCL2,CDC42,CHUK,CREB3,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,DVL3,EZH2,GNAI2,IL1R1,ITGA6,MAP2K2,MAP2K5,MAPK14,MAPK3,MYL6B,NCF1,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKACA,PRKCI,RAF1,RAP1A,RELA,RHOB,RHOQ,RHOT1,RIPK1,RPS6KB2,SDHC,SOS2,SP1,STAT3,TGFB2,TRADD,TRPM7,VEGFC	
Regulation of mRNA stability by proteins that bind AU-rich elements	3.02E00	2.27E-01	-1.265	AKT1,DIS3,EIF4G1,EXOSC4,EXOSC7,HSPA1A/HSPA1B,KHSRP,MAPK14,PARN,XPO1	
COPI-mediated anterograde transport	3.01E00	1.67E-01	-0.728	ACTR1A,ARCN1,ARFGAP3,CAPZA2,COG6,COPB2,COPE,COPG1,DCTN1,DCTN4,DCTN5,GOSR1,RAB1A,TMED2,TMED3,TUBA1B,YKT6	
SUMOylation of DNA damage response and repair proteins	3.01E00	1.84E-01	-1.069	BLM,CBX4,HDAC7,NSMCE3,NUP43,NUP54,NUP58,NUP93,PHC2,PIAS1,PML,SUMO2,TPR,UBE2I	
MyD88-independent TLR4 cascade	2.99E00	2.43E-01	-1.667	CASP8,CHUK,FADD,PTPN11,RIPK1,TBK1,TICAM1,TRAF3,UBE2D2	
Endometrial Cancer Signaling	2.98E00	2E-01	-2.111	AKT1,CTNNB1,GRB2,MAP2K2,MAPK3,MLH1,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SOS2	
Docosahexaenoic Acid (DHA) Signaling	2.94E00	1.28E-01	-0.354	ADCY3,AKT1,APAF1,ATF2,BAX,BRAF,CASP7,CASP8,CREB3,CYCS,FADD,FASLG,GSK3A,HMOX1,MAP2K2,MAPK3,MLST8,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PRKACA,PRKCI,RAF1,RELA,RPS6KB2,RXRA,STXBP3,STXBP4,TGFB2	
Tumoricidal Function of Hepatic Natural Killer Cells	2.93E00	2.92E-01	-1.890	APAF1,BAX,CASP7,CASP8,CYCS,FADD,FASLG	
FGF Signaling	2.93E00	1.74E-01	-1.807	AKT1,ATF2,CREB3,CRK,GRB2,MAPK14,MAPK3,PIK3R3,PIK3R5,PTPN11,PTPN6,RAF1,RPS6KA5,SOS2,STAT3	
Mouse Embryonic Stem Cell Pluripotency	2.92E00	1.63E-01	-2.668	AKT1,CTNNB1,DVL3,GRB2,JAK3,MAP2K2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,SMAD5,SOS2,STAT3	
Tight Junction Signaling	2.91E00	1.39E-01	NaN	ACTA2,AKT1,ARHGEF2,CDC42,CDK4,CEBPA,CPSF3,CSTF3,CTNNB1,GOSR1,MARK2,MYL6B,NFKB2,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,PRKCI,RELA,SAFB,STX4,TGFB2,YKT6	
Macrophage Alternative Activation Signaling Pathway	2.91E00	1.37E-01	-2.746	ACLY,ATF2,CREB3,EIF4EBP1,FCER1G,GRB2,H3-3A/H3-3B,JAK3,KDM6B,KLF4,MAPK14,MAPK3,MLST8,NFKB2,NFKBIE,NR1H2,NR1H3,PIK3R3,PIK3R5,RELA,RPS6KA1,RPS6KA5,RXRA,STAT3,SYK,TGFB2	
SUMOylation of ubiquitinylation proteins	2.9E00	2.37E-01	-1.000	NUP43,NUP54,NUP58,NUP93,PIAS1,PML,TPR,TRIM27,UBE2I	
PTEN Signaling	2.9E00	1.46E-01	1.789	AKT1,CDC42,CHUK,CSNK2A2,CSNK2B,FASLG,GRB2,GSK3A,ITGA6,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,RPS6KB2,SHC1,SOS2,TNFRSF11A	
NF-κB Activation by Viruses	2.9E00	1.79E-01	-2.673	AKT1,CHUK,ITGA6,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA,RIPK1	
IL-7 Signaling Pathway	2.9E00	1.79E-01	-1.941	AKT1,BAK1,BAX,GRB2,GSK3A,JAK3,MAPK14,MAPK3,PIK3R3,PIK3R5,SHC1,SOS2,STAT5A,STAT5B	
Transcriptional regulation by RUNX3	2.87E00	1.67E-01	-4.000	CTNNB1,HDAC4,PSMA5,PSMB10,PSMB4,PSMB5,PSMC3,PSMC4,PSMC5,PSMD1,PSMD11,PSMD12,PSMD13,PSMD14,PSMD4,PSMD5	
Interleukin-2 family signaling	2.86E00	2.17E-01	-3.162	GRB2,HAVCR2,JAK3,PIK3R3,PTPN6,SHC1,STAT3,STAT5A,STAT5B,SYK	
tRNA Splicing	2.86E00	2.17E-01	0.000	APEX1,GDE1,GDPD1,PDE12,PDE4A,PDE4D,PDE7A,TSEN15,TSEN2,TSEN34	
DNA damage-induced 14-3-3σ Signaling	2.86E00	2.17E-01	-0.632	AKT1,APAF1,ATM,CASP10,CASP5,CASP7,CASP8,CCNE1,CCNE2,COP1	
Cytoprotection by HMOX1	2.85E00	1.94E-01	-2.111	ABCC1,BLVRA,COX5A,COX8A,CYCS,HMOX1,HMOX2,MAFK,MED1,RXRA,STAT3,TXNIP	
Heme Degradation	2.85E00	7.5E-01	NaN	BLVRA,HMOX1,HMOX2	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	2.84E00	1.77E-01	-2.138	CASP10,CASP8,CHUK,FADD,ITCH,NFKB2,PIN1,RELA,RIPK1,SAA1,TBK1,TRAF3,TRIM25,UBE2D2	
Renal Cell Carcinoma Signaling	2.84E00	1.77E-01	-1.941	AKT1,CDC42,CRK,ELOC,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,SOS2	
CDK5 Signaling	2.83E00	1.57E-01	-0.775	ABL1,ADCY3,ITGA6,MAP2K2,MAPK14,MAPK3,NRAS,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,RAF1,RAP1A	
Signaling by Erythropoietin	2.82E00	2.8E-01	-2.646	GRB2,NRAS,PIK3R5,SHC1,STAT5A,STAT5B,VAV1	
Intra-Golgi and retrograde Golgi-to-ER traffic	2.82E00	1.33E-01	-1.347	ACTR1A,ARCN1,ARFGAP3,CAPZA2,COG6,COPB2,COPE,COPG1,CYTH4,DCTN1,DCTN4,DCTN5,GCC1,GOLGA5,GOLIM4,GOSR1,KIF1C,KIF20B,KIF23,KIF2C,MAN1A2,NAA38,RAB1A,TMED2,TMED3,TUBA1B,YKT6	
Toll Like Receptor 3 (TLR3) Cascade	2.8E00	2.5E-01	-1.414	CASP8,CHUK,FADD,RIPK1,TBK1,TICAM1,TRAF3,UBE2D2	
E3 ubiquitin ligases ubiquitinate target proteins	2.78E00	2E-01	-1.508	CDC73,PAF1,RNF181,RNF20,RNF40,RRAGA,SHPRH,UBE2D2,UBE2E1,UBE2J2,VCP	
Lymphotoxin β Receptor Signaling	2.78E00	2E-01	-2.121	AKT1,APAF1,CHUK,CYC1,CYCS,MAPK3,NFKB2,PIK3R3,PIK3R5,RELA,TRAF3	
p53 Signaling	2.77E00	1.63E-01	0.333	AKT1,APAF1,ATM,BAX,CCNK,CDK4,CSNK1D,CTNNB1,GADD45A,MAPK14,MED1,PIAS1,PIK3R3,PIK3R5,PML,TP53I3	
Protein folding	2.77E00	1.63E-01	-3.000	CCNE1,CCNE2,CCT6A,CCT7,CCT8,CSNK2A2,CSNK2B,DCAF7,FBXO6,FBXW7,GNB4,PFDN6,RGS9,STAT3,TCP1,TUBA1B	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	2.75E00	1.27E-01	-0.365	ACTA2,AKT1,ARPC5L,CD2AP,CDC42,CTNNB1,GJA1,GSK3A,IL1R1,ITGA6,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,RAP1A,RELA,SP1,TGFB2,WASL	
Neuregulin Signaling	2.75E00	1.54E-01	-2.500	AKT1,CRK,GRB2,ITGA6,MAP2K2,MAPK3,NRAS,PIK3R3,PRKCI,PTPN11,RAF1,RAP1A,RNF41,RPS6KB2,SHC1,SOS2,STAT5A,STAT5B	
Signaling by FGFR3	2.74E00	2.25E-01	-2.333	BRAF,GALNT3,GRB2,MAPK3,MKNK1,NRAS,PPP2CA,PTPN11,SHC1	
NLR signaling pathways	2.71E00	1.96E-01	-2.714	AIM2,CASP8,CHUK,HMOX1,ITCH,MAPK14,MEFV,NFKB2,NLRC4,RELA,TXNIP	
Activation of the pre-replicative complex	2.71E00	2.42E-01	-2.121	CDC45,CDC6,CDT1,MCM2,MCM3,MCM5,ORC1,ORC5	
DHCR24 Signaling Pathway	2.7E00	1.46E-01	-3.578	AKT1,APOA2,APOB,APOH,C3,DHCR24,FGA,HMOX1,NFKB2,NR1H2,NR1H3,NRAS,ORM1,ORM2,PIK3R3,PIK3R5,PRKCI,RAP1A,RXRA,SAA1	
Eicosanoid Signaling	2.69E00	1.21E-01	-2.694	ABCC1,ADCY3,AKT1,ALOX5,AP1M1,ATF2,BRAF,CCDC51,CREB3,CTNNB1,GNAI2,GNB4,GSK3A,KLF4,MAP2K2,MAPK14,MAPK3,MAPKAPK3,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RAPGEF3,RPS6KA1,RPS6KA2,VEGFC	
BEX2 Signaling Pathway	2.68E00	1.71E-01	-0.277	AKT1,BAK1,CTNNB1,LGALS1,LMO2,NFKB2,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RELA,STAT3,VEGFC	
Pyridoxal 5'-phosphate Salvage Pathway	2.67E00	1.85E-01	-1.732	BRAF,CDK4,CDK8,CSNK1A1,CSNK1D,DYRK1A,LIMK1,MAK,MAP2K2,MAPK3,PDXK,PKN1	
Hereditary Breast Cancer Signaling	2.67E00	1.45E-01	0.894	AKT1,ATM,BLM,CDK4,FANCE,FANCG,GADD45A,MLH1,MRE11,MSH6,NRAS,PIK3R3,PIK3R5,POLR2C,POLR2F,RAP1A,RFC2,TGFB2,TUBG1,VEGFC	
Regulation of lipid metabolism by PPARalpha	2.66E00	1.51E-01	-2.357	APOA2,CCNC,CDK8,ESRRA,FDFT1,MED1,MED11,MED13,MED19,MED9,NFYC,NR1H2,NR1H3,RGL1,RXRA,SP1,THRAP3,TRIB3	
Cholecystokinin/Gastrin-mediated Signaling	2.66E00	1.51E-01	-1.213	ATF2,CDC42,CREM,GRB2,MAP2K2,MAP2K5,MAPK14,MAPK3,NRAS,PRKCI,RAF1,RAP1A,RHOB,RHOQ,RHOT1,SHC1,SOS2,SRF	
Activation of gene expression by SREBF (SREBP)	2.66E00	2.2E-01	-3.000	FDFT1,FDPS,MED1,MVK,NFYC,PMVK,RXRA,SCD,SP1	
Role of IL-17A in Arthritis	2.65E00	1.93E-01	NaN	ATF2,CCL2,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,RELA,RPS6KA1	
ERK5 Signaling	2.64E00	1.76E-01	-1.387	AKT1,ATF2,CREB3,MAP2K5,MAP3K3,NRAS,PTPN11,RAP1A,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,YWHAG	
Ephrin A Signaling	2.63E00	1.44E-01	-1.342	ACP1,AKT1,BRAF,CDC42,FGR,HCK,LIMK1,MAP2K2,MAPK3,MYL6B,PIK3R3,PIK3R5,PRKACA,PTPN11,RAF1,RAP1A,STAT3,TGFB2,VAV1,VAV3	
Synaptogenesis Signaling Pathway	2.62E00	1.17E-01	-2.744	ADCY3,AKT1,AP2A2,ARPC5L,ATF2,BRAF,CACNB1,CDC42,CLASP2,CREB3,CRK,CTNNB1,EIF4EBP1,FGR,GOSR1,GRB2,HCK,LIMK1,MAPK14,MAPK3,NAP1L4,NRAS,PIK3R3,PIK3R5,PRKACA,RAB5C,RAF1,RAP1A,RPS6KB2,SGTA,SHC1,SNCG,SOS2,STXBP3,STXBP4,WASL,YKT6	
Oncogene Induced Senescence	2.62E00	2.35E-01	-1.633	CDK4,E2F2,MAPK3,MOV10,SP1,TFDP1,TNRC6A,TNRC6C	
4-1BB Signaling in T Lymphocytes	2.62E00	2.35E-01	-1.890	ATF2,CHUK,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,RELA	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	2.61E00	1.82E-01	-2.333	AKT1,CRK,GNAI2,KPNA3,MAP2K2,MAPK3,MLH1,NFKB2,NFKBIE,PIK3R3,PIK3R5,RELA	
ATF4 activates genes in response to endoplasmic reticulum stress	2.61E00	2.59E-01	-0.378	CCL2,DIS3,EXOSC4,EXOSC7,KHSRP,NFYC,PARN	
Myelination Signaling Pathway	2.6E00	1.16E-01	-2.596	AKT1,ARHGAP1,ARHGAP5,ARHGAP9,ATF2,BRAF,CDC42,CNP,CREB3,CTNNB1,EGR2,EIF4E,EIF4EBP1,FGR,FKBP1A,GRB2,HCK,HDAC4,HDAC7,ITGA6,MAP2K2,MAPK3,MLST8,NDRG1,NFKB2,NRAS,PIK3R3,PIK3R5,PRKACA,PTPN11,RAF1,RAP1A,RAPGEF3,RPS6KB2,SCD,SMAD5,SMARCA4,SOS2	
Interleukin-9 signaling	2.6E00	4.44E-01	-2.000	JAK3,STAT3,STAT5A,STAT5B	
Salvage Pathways of Pyrimidine Deoxyribonucleotides	2.6E00	4.44E-01	-2.000	APOBEC3G,TK1,TK2,TYMP	
Regulation of TP53 Activity through Phosphorylation	2.58E00	1.61E-01	-2.324	ATM,BLM,CSNK2A2,CSNK2B,DNA2,EXO1,KAT5,MAPK14,MRE11,PIN1,RFC2,RHNO1,RMI1,SUPT16H,TAF7	
Cardiac β-adrenergic Signaling	2.58E00	1.33E-01	1.291	ADCY3,AKAP13,AKAP7,AKAP9,APEX1,CACNB1,GDE1,GDPD1,GNAI2,GNB4,GRK2,PDE12,PDE4A,PDE4D,PDE7A,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA	
AMPK Signaling	2.58E00	1.24E-01	-0.471	AK2,AK3,AK9,AKT1,ATF2,CAMKK2,CREB3,EIF4EBP1,GNAI2,GNB4,GYS1,MAPK14,MLST8,PFKFB4,PIK3R3,PIK3R5,PPM1D,PPM1M,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,RAB1A,RAB2A,RAB7A,RAB8A,SMARCA4,SMARCD1	
NR1H2 and NR1H3-mediated signaling	2.57E00	2E-01	-2.530	ABCG1,KDM1B,MOV10,MYLIP,NR1H2,NR1H3,RXRA,SCD,TNRC6A,TNRC6C	
Melanoma Signaling	2.57E00	2E-01	-1.897	AKT1,BRAF,CDK4,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A	
MYC Mediated Apoptosis Signaling	2.57E00	2E-01	-1.265	APAF1,BAX,CASP8,CHUK,CYCS,FADD,FASLG,NFKB2,PRKACA,TRADD	
ILK Signaling	2.56E00	1.29E-01	-1.043	ACTA2,ACTN4,AKT1,ATF2,CDC42,CREB3,CTNNB1,GSK3A,MAPK3,MYL6B,NFKB2,PIK3R3,PIK3R5,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RELA,RHOB,RHOQ,RHOT1,RPS6KA5,TESK1,VEGFC	
IL-17A Signaling in Airway Cells	2.55E00	1.79E-01	-2.887	AKT1,CHUK,JAK3,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,RELA,STAT3	
Integrin Signaling	2.54E00	1.27E-01	-1.961	ABL1,ACTA2,ACTN4,AKT1,ARHGAP26,ARHGAP5,ARPC5L,BRAF,CDC42,CRK,GRB2,ITGA6,MAP2K2,MAP3K11,MAPK3,NEDD9,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RHOB,RHOQ,RHOT1,SHC1,SOS2,WASL	
Hypoxia Signaling in the Cardiovascular System	2.54E00	1.71E-01	-1.633	AKT1,ATF2,ATM,COPS5,CREB3,CSNK1D,NFKBIE,P4HB,UBE2D2,UBE2E1,UBE2H,UBE2I,UBE2J2	
HGF Signaling	2.53E00	1.44E-01	-2.183	AKT1,ATF2,CDC42,ELF2,GRB2,ITGA6,MAP2K2,MAP3K11,MAP3K3,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN11,RAF1,RAP1A,SOS2,STAT3	
SUMOylation of intracellular receptors	2.51E00	2.5E-01	-1.134	HDAC4,NR1H2,NR1H3,PIAS1,RXRA,SUMO2,UBE2I	
Regulation of cholesterol biosynthesis by SREBP (SREBF)	2.5E00	3.33E-01	-0.447	INSIG1,KPNB1,RAN,SEC24B,SEC24C	
Metabolism of nitric oxide: NOS3 activation and regulation	2.5E00	3.33E-01	-1.342	AKT1,DDAH1,DDAH2,DNM2,WASL	
ERBB4 Signaling	2.5E00	1.76E-01	-2.309	AKT1,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,SHC1,SOS2	
Gα12/13 Signaling	2.49E00	1.43E-01	-1.886	AKT1,CDC42,CHUK,CTNNB1,F2RL3,LPAR1,MAP2K2,MAPK3,MYL6B,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,VAV1,VAV3	
P2Y Purinergic Receptor Signaling Pathway	2.49E00	1.43E-01	-1.886	ADCY3,AKT1,ATF2,CREB3,GNAI2,GNB4,MAP2K2,MAPK3,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RELA	
Oxidative Stress Induced Senescence	2.48E00	1.63E-01	-2.111	CBX4,CDK4,E2F2,EZH2,KDM6B,MAPK14,MAPK3,MAPKAPK3,MOV10,PHC2,SUZ12,TFDP1,TNRC6A,TNRC6C	
SPINK1 General Cancer Pathway	2.44E00	1.74E-01	-1.732	AKT1,JAK3,MAP2K2,MAPK3,MT1F,MT2A,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,STAT3	
UVB-Induced MAPK Signaling	2.44E00	1.92E-01	-1.667	AKT1,EIF4E,EIF4EBP1,H3-3A/H3-3B,MAPK14,MAPK3,PIK3R3,PIK3R5,PRKCI,RPS6KA5	
Serotonin Receptor Signaling	2.43E00	1.07E-01	-2.828	ACAT1,ADCY3,AKT1,ARFGEF1,ATF2,BRAF,CACNB1,CCNE1,CCNE2,CD38,CDC42,COPS5,CREB3,EIF4EBP1,FGA,FGG,FGR,GCH1,GNAI2,GNB4,H3-3A/H3-3B,HCK,HMOX1,KCNH2,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NRAS,PCBD1,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RAPGEF3,RBL1,RHOB,RHOQ,RHOT1,RPS6KB2,SRF,STAT3,TGFB2	
Opioid Signaling Pathway	2.43E00	1.18E-01	-1.616	ADCY3,AKT1,AP2A2,ATF2,BRAF,CACNB1,CDC42,CLTB,CREB3,CTNNB1,FGR,GNAI2,GNB4,GRK2,HCK,MAP2K2,MAP2K5,MAPK3,NFKB2,NRAS,OGFR,PRKACA,PRKCI,RAF1,RAP1A,RGS3,RGS9,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SOS2,SRF	
Gap Junction Signaling	2.4E00	1.14E-01	-1.859	ACTA2,ADCY3,AKT1,ATF2,CASP7,CREB3,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,GJA1,GNAI2,GRB2,GSK3A,KCNH2,LPAR1,MAP2K2,MAP2K5,MAPK3,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RELA,SKP2,SMAD5,SOS2,SP1,TUBA1B,TUBG1	
Major pathway of rRNA processing in the nucleolus and cytosol	2.4E00	1.29E-01	-3.674	CSNK1D,DCAF13,DDX49,DIS3,EBNA1BP2,EXOSC4,EXOSC7,IMP4,ISG20L2,LTV1,MPHOSPH6,NIP7,PES1,RCL1,RIOK3,RPL22L1,RPL26L1,RPS19,RPS27L,RRP36,RRP7A,TSR1,UTP11,UTP3	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	2.39E00	1.65E-01	-1.941	ATF2,BAX,BRAF,CCL2,CXCL10,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,PLAAT4,PLB1,RAF1	
Cardiac Hypertrophy Signaling	2.36E00	1.19E-01	-1.890	ADCY3,AKT1,ATF2,CACNB1,CDC42,EIF2B1,EIF4E,GNAI2,GNB4,GRB2,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,MAPKAPK3,MYL6B,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,RAF1,RAP1A,RHOB,RHOQ,RHOT1,RPS6KA1,SRF,TGFB2	
Rap1 signalling	2.36E00	3.12E-01	-1.342	PRKACA,RAF1,RAP1A,RAPGEF3,SIPA1	
14-3-3-mediated Signaling	2.35E00	1.42E-01	-2.324	AKT1,BAX,GRB2,GSK3A,MAP2K2,MAPK3,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKCI,RAF1,RAP1A,RPS6KA1,TUBA1B,TUBG1,YWHAG	
Interferon alpha/beta signaling	2.34E00	1.69E-01	-3.464	ADAR,BST2,IFI35,KPNB1,MX1,MX2,OAS1,OAS2,OASL,PTPN11,PTPN6,RNASEL	
Signaling by VEGF	2.34E00	1.48E-01	-2.000	AHCYL1,AKT1,CDC42,CRK,CTNNB1,ELMO2,MAPK14,MAPKAPK3,MLST8,NCF1,NRAS,PRKACA,TRIB3,VAV1,VAV3,VEGFC	
EIF2 Signaling	2.34E00	1.22E-01	-1.698	ACTA2,AKT1,ATF5,EIF1,EIF2B1,EIF3I,EIF3J,EIF4A3,EIF4E,EIF4G1,ELP5,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTBP1,RAF1,RAP1A,RPL22L1,RPL26L1,RPS19,RPS27L,SHC1,SOS2,TRIB3,WARS1	
3-phosphoinositide Biosynthesis	2.33E00	1.24E-01	-3.130	ACP1,DUSP23,DUSP5,EPHX2,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PI4K2B,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
ESR-mediated signaling	2.32E00	1.44E-01	-3.153	ATF2,FKBP4,FKBP5,GTF2A2,GTF2F1,KAT5,MAPK3,MED1,MOV10,POLR2C,POLR2F,PPID,PPP5C,SP1,TNRC6A,TNRC6C,USF1	
Adrenomedullin signaling pathway	2.32E00	1.26E-01	-1.800	ADCY3,AKT1,BAX,BRAF,C3,GRB2,GSK3A,KCNH2,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,RAF1,RAP1A,RELA,RXRA,SHC1,SOS2	
RAF-independent MAPK1/3 activation	2.31E00	2.61E-01	-1.633	DUSP5,DUSP7,MAP2K2,MAPK3,PEA15,PTPN11	
Metabolism of porphyrins	2.31E00	2.61E-01	-0.816	ABCC1,BLVRA,FLVCR1,HMOX1,HMOX2,UROD	
IL-8 Signaling	2.31E00	1.24E-01	-2.558	AKT1,BAX,BRAF,CDC42,CHUK,CSTB,EIF4EBP1,GNAI2,GNB4,HMOX1,LIMK1,MAP2K2,MAPK3,NCF1,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA,RHOB,RHOQ,RHOT1,VEGFC	
SUMOylation of RNA binding proteins	2.3E00	1.96E-01	-1.000	CBX4,NUP43,NUP54,NUP58,NUP93,PHC2,SUMO2,TPR,UBE2I	
UDP-D-xylose and UDP-D-glucuronate Biosynthesis	2.28E00	1E00	NaN	UGDH,UXS1	
GDP-L-fucose Biosynthesis I (from GDP-D-mannose)	2.28E00	1E00	NaN	GFUS,GMDS	
RANK Signaling in Osteoclasts	2.26E00	1.54E-01	-3.051	AKT1,CHUK,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,RAF1,RELA,TNFRSF11A	
Sphingosine-1-phosphate Signaling	2.25E00	1.42E-01	-0.775	ADCY3,AKT1,ASAH1,CASP10,CASP5,CASP7,CASP8,CDC42,GNAI2,MAPK3,PDIA3,PIK3R3,PIK3R5,PLCD3,RHOB,RHOQ,RHOT1	
p38 MAPK Signaling	2.25E00	1.42E-01	-1.155	ATF2,CREB3,FADD,FASLG,H3-3A/H3-3B,IL1R1,MAPK14,MAPKAPK3,MKNK1,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SRF,TGFB2,TIFA,TRADD	
Estrogen-Dependent Breast Cancer Signaling	2.25E00	1.59E-01	-2.496	AKT1,ATF2,CREB3,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAP1A,RELA,SP1,STAT5A,STAT5B	
Ephrin Receptor Signaling	2.24E00	1.24E-01	-2.711	ABL1,ACP1,AKT1,ARPC5L,ATF2,CDC42,CREB3,CRK,GNAI2,GNB4,GRB2,ITGA6,LIMK1,MAP2K2,MAPK3,NRAS,PTPN11,RAF1,RAP1A,RGS3,SHC1,SOS2,STAT3,VEGFC,WASL	
Signaling by Leptin	2.23E00	3.64E-01	-2.000	PTPN11,STAT3,STAT5A,STAT5B	
Processing and activation of SUMO	2.23E00	3.64E-01	0.000	SAE1,SENP1,SUMO2,UBE2I	
Growth hormone receptor signaling	2.22E00	2.5E-01	-2.449	CISH,MAPK3,PTPN6,STAT3,STAT5A,STAT5B	
IL-22 Signaling	2.22E00	2.5E-01	-2.449	AKT1,MAPK14,MAPK3,STAT3,STAT5A,STAT5B	
Folate Signaling Pathway	2.2E00	1.79E-01	-2.530	AHCY,GART,JAK3,KLF4,MAPK3,NFKB2,OAS2,PAICS,SHMT1,STAT3	
Arginine Biosynthesis IV	2.2E00	5E-01	NaN	ASL,ASS1,GLUD1	
Selenocysteine Biosynthesis II (Archaea and Eukaryotes)	2.2E00	5E-01	NaN	SARS1,SEPHS1,SEPHS2	
GDP-mannose Biosynthesis	2.2E00	5E-01	NaN	GMPPA,GPI,PMM1	
Activation of IRF by Cytosolic Pattern Recognition Receptors	2.19E00	1.69E-01	-0.905	ADAR,ATF2,CHUK,FADD,NFKB2,NFKBIE,PIN1,RELA,RIPK1,TBK1,TRAF3	
Thrombin Signaling	2.19E00	1.2E-01	-3.266	ADCY3,AKT1,ARHGEF11,ARHGEF2,CDC42,F2RL3,GNAI2,GNB4,GRB2,MAP2K2,MAPK14,MAPK3,MYL6B,NFKB2,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKCI,RAF1,RAP1A,RELA,RHOB,RHOQ,RHOT1,SHC1	
cAMP-mediated signaling	2.18E00	1.19E-01	-0.408	ADCY3,AKAP13,AKAP7,AKAP9,APEX1,ATF2,BRAF,CCR4,CREB3,CREM,GDE1,GDPD1,GNAI2,GRK2,LAMTOR3,LPAR1,MAP2K2,MAPK3,PDE12,PDE4A,PDE4D,PDE7A,PRKACA,RAF1,RAP1A,RAPGEF3,RPS6KA1,STAT3	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	2.18E00	1.26E-01	-2.668	ACP1,DUSP23,DUSP5,EPHX2,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	2.18E00	1.26E-01	-2.668	ACP1,DUSP23,DUSP5,EPHX2,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
ERBB Signaling	2.17E00	1.51E-01	-2.138	AKT1,CDC42,GRB2,MAP2K2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,SHC1,SOS2	
3-phosphoinositide Degradation	2.17E00	1.24E-01	-2.828	ACP1,DUSP23,DUSP5,EPHX2,MTMR14,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
RIPK1-mediated regulated necrosis	2.17E00	2.19E-01	-1.890	CASP8,FADD,FASLG,ITCH,MLKL,RIPK1,TRADD	
NRF2-mediated Oxidative Stress Response	2.16E00	1.18E-01	-2.357	ABCC1,ACTA2,AKR1A1,AKT1,CBR1,CCT7,CLPP,CUL3,DNAJC14,DNAJC3,DNAJC6,DNAJC7,FKBP5,HMOX1,KEAP1,MAFK,MAP2K2,MAP2K5,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PRDX1,PRKCI,RAF1,RAP1A,VCP	
Superpathway of Inositol Phosphate Compounds	2.16E00	1.18E-01	-3.411	ACP1,DUSP23,DUSP5,EPHX2,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PI4K2B,PIK3R3,PIK3R5,PLCD3,PPIP5K2,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
Transcriptional Regulation by VENTX	2.16E00	2E-01	-0.707	ANAPC10,CDC27,CTNNB1,MOV10,RELA,TNRC6A,TNRC6C,UBE2E1	
Mitotic Prophase	2.16E00	1.46E-01	-0.775	ARPP19,BANF1,GORASP2,KMT5A,MAPK3,NUP43,NUP54,NUP58,NUP93,PPP2CA,PPP2R2D,RAB1A,RAB2A,TPR,VRK2	
Role of MAPK Signaling in the Pathogenesis of Influenza	2.16E00	1.55E-01	NaN	AKT1,ATF2,BAX,CCL2,CXCL10,MAP2K2,MAPK14,MAPK3,NRAS,PLAAT4,PLB1,RAF1,RAP1A	
VEGF Family Ligand-Receptor Interactions	2.16E00	1.55E-01	-1.941	AKT1,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,SHC1,SOS2,VEGFC	
TNF signaling	2.15E00	1.75E-01	-1.897	BAG4,CASP8,CHUK,FADD,NSMAF,RBCK1,RIPK1,TBK1,TRADD,UBE2D2	
Xenobiotic Metabolism General Signaling Pathway	2.14E00	1.33E-01	-2.357	AKT1,CUL3,HMOX1,KEAP1,MAP2K2,MAP2K5,MAP3K11,MAP3K3,MAPK14,MAPK3,NR1H2,NR1H3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RXRA	
Pyroptosis Signaling Pathway	2.13E00	1.49E-01	-3.207	AIM2,BAX,CASP5,CASP8,GBP3,GSDMD,IL1R1,MAPK14,MEFV,NFKB2,NLRC4,PRKACA,TRAF3,TXNIP	
Gastrin-CREB signalling pathway via PKC and MAPK	2.12E00	2.78E-01	-2.236	GRB2,MAPK3,NRAS,RPS6KA1,RPS6KA2	
Mismatch Repair in Eukaryotes	2.12E00	2.78E-01	-2.236	EXO1,MLH1,MSH6,POLD1,RFC2	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	2.12E00	2.78E-01	-1.342	ACAT1,FDPS,FNTB,MVK,PMVK	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	2.11E00	1.84E-01	-1.000	CCNC,CCNK,CDK8,E2F4,MAPK3,RBL1,SP1,TFDP1,TRIM33	
Leptin Signaling in Obesity	2.1E00	1.58E-01	-2.828	ADCY3,AKT1,GRB2,MAP2K2,MAPK3,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PTPN11,STAT3	
GDNF Family Ligand-Receptor Interactions	2.1E00	1.58E-01	-1.732	CDC42,DOK4,GRB2,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SOS2	
Dopamine-DARPP32 Feedback in cAMP Signaling	2.1E00	1.24E-01	-1.147	ADCY3,ATF2,CACNB1,CAMKK2,CREB3,CREM,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,GNAI2,PDIA3,PLCD3,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,PRKCI	
Iron uptake and transport	2.1E00	1.72E-01	-0.632	ATP6V0E1,ATP6V1B2,CAND1,CUL1,FLVCR1,HMOX1,HMOX2,IREB2,LCN2,SKP1	
Signaling by FGFR4	2.09E00	1.95E-01	-2.121	BRAF,GRB2,MAPK3,MKNK1,NRAS,PPP2CA,PTPN11,SHC1	
Mechanisms of Viral Exit from Host Cells	2.09E00	1.95E-01	NaN	ACTA2,LMNB2,PRKCI,SH3GL1,VPS25,VPS36,VPS4A,XPO1	
Mitotic Roles of Polo-Like Kinase	2.09E00	1.64E-01	-1.000	ANAPC10,CDC27,KIF23,PKMYT1,PLK4,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRC1	
Relaxin Signaling	2.09E00	1.29E-01	-0.905	ADCY3,AKT1,APEX1,BRAF,GDE1,GDPD1,GNAI2,GNB4,MAPK3,NFKB2,NFKBIE,PDE12,PDE4A,PDE4D,PDE7A,PIK3R3,PIK3R5,PRKACA,RAP1A,RELA	
Erythropoietin Signaling Pathway	2.08E00	1.25E-01	-2.132	AKT1,APAF1,CTNNB1,FASLG,GRB2,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKCI,PTPN6,RAF1,RAP1A,RELA,SHC1,SOS2,STAT5A,STAT5B,TGFB2	
Clathrin-mediated Endocytosis Signaling	2.08E00	1.2E-01	NaN	ACTA2,AP1M1,AP2A2,AP3D1,APOA2,APOB,ARPC5L,CD2AP,CDC42,CLTB,CSNK2A2,CSNK2B,DNM2,EPN1,GRB2,HIP1,ORM1,ORM2,PIK3R3,PIK3R5,RAB5C,RAB7A,SH3GL1,VEGFC,WASL	
CLEAR Signaling Pathway	2.06E00	1.12E-01	-0.898	AKT1,ASAH1,ATF2,ATP6V0E1,ATP6V1B2,BLOC1S1,CREB3,GSK3A,HPS5,LAMP1,LAMTOR3,MAPK14,MAPK3,MLST8,NRAS,PML,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RAB7A,RAP1A,RRAGA,RXRA,TFEB,TGFB2,TNFRSF11A,VPS18,VPS35,YWHAG	
FAT10 Cancer Signaling Pathway	2.06E00	1.8E-01	-1.414	AKT1,CHUK,CTNNB1,MAD2L2,NFKB2,NFKBIE,RELA,STAT3,TGFB2	
HMGB1 Signaling	2.04E00	1.26E-01	-1.342	AKT1,CCL2,CDC42,FASLG,HAT1,IL1R1,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAP1A,RELA,RHOB,RHOQ,RHOT1,SP1,TGFB2	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	2.04E00	2.31E-01	NaN	NFKB2,PTPN2,PTPN6,RAF1,RELA,STAT3	
D-myo-inositol-5-phosphate Metabolism	2.03E00	1.21E-01	-2.828	ACP1,DUSP23,DUSP5,EPHX2,MTMR6,NOCT,NUDT15,NUDT5,PGAM5,PLCD3,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PPP5C,PSPH,PTPN11,PTPN2,PTPN6,PTPN7,UBLCP1	
Sertoli Cell-Sertoli Cell Junction Signaling	2.02E00	1.15E-01	-3.402	ACTA2,ACTN4,AKT1,ATF2,CDC42,CREB3,CTNNB1,EPN1,GJA1,GRB2,IL1R1,ITGA6,KEAP1,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NFKB2,NRAS,PALS2,PIK3R3,PIK3R5,RAF1,RAP1A,RPS6KA1,TUBA1B,TUBG1	
SUMOylation of SUMOylation proteins	2.02E00	2.06E-01	-0.378	NUP43,NUP54,NUP58,NUP93,SUMO2,TPR,UBE2I	
Costimulation by the CD28 family	2.01E00	1.54E-01	-2.887	AKT1,CDC42,GRB2,MLST8,PIK3R3,PPP2CA,PPP2R5D,PPP2R5E,PTPN11,PTPN6,TRIB3,VAV1	
PAK Signaling	2E00	1.37E-01	-2.324	CDC42,GRB2,ITGA6,LIMK1,MAP2K2,MAPK3,MYL6B,NRAS,PAK1IP1,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SOS2,WASL	
TP53 Regulates Metabolic Genes	1.99E00	1.48E-01	-2.496	AKT1,COX5A,COX8A,CYCS,GPI,LAMTOR3,MLST8,MOV10,PRDX1,RRAGA,TNRC6A,TNRC6C,YWHAG	
ID1 Signaling Pathway	1.98E00	1.19E-01	-0.816	AKT1,BAX,BHLHA15,BRAF,CCNE1,CDK4,CTNNB1,CUL3,FGR,HCK,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SMAD5,STAT3,TGFB2,VEGFC,WDR48,ZNF148	
Reelin Signaling in Neurons	1.98E00	1.3E-01	-2.828	AKT1,ARHGEF11,ARHGEF2,ARPC5L,CDC42,CRK,FGR,HCK,LIMK1,MAP2K2,MAP2K5,MAP3K11,MAPK3,NDEL1,PIK3R3,PIK3R5,RAP1A,WASL	
Iron homeostasis signaling pathway	1.98E00	1.3E-01	NaN	ATP6V0E1,ATP6V1B2,CIAO1,CIAO2B,CUL1,FLVCR1,HMOX1,HMOX2,IREB2,JAK3,MAPK3,SKP1,SKP2,SLC48A1,SMAD5,STAT3,STAT5A,STAT5B	
Urea Cycle	1.98E00	4.29E-01	NaN	ARG2,ASL,ASS1	
DNA Methylation and Transcriptional Repression Signaling	1.98E00	1.43E-01	-1.387	CDK14,CDK17,CDK4,CDK8,E2F2,E2F4,E2F8,GADD45A,RBL1,RELA,SAP18,SAP30,SP1,TET3	
Aryl Hydrocarbon Receptor Signaling	1.97E00	1.26E-01	-1.213	AIP,ALDH3B1,ALDH4A1,APAF1,ATM,BAX,CCNE1,CCNE2,CDK4,FASLG,MAPK3,MED1,NFKB2,RBL1,RELA,RXRA,SMARCA4,SP1,TFDP1,TGFB2	
Role of NFAT in Cardiac Hypertrophy	1.95E00	1.16E-01	-1.528	ADCY3,AKT1,CACNB1,CSNK1A1,GNAI2,GNB4,GRB2,HDAC4,HDAC7,MAP2K2,MAPK14,MAPK3,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RCAN1,RCAN3,SHC1,SOS2,TGFB2	
Adipogenesis pathway	1.95E00	1.29E-01	0.943	AKT1,CEBPA,CTNNB1,EGR2,ERCC2,EZH2,FBXW7,HAT1,HDAC4,HDAC7,NOCT,RPS6KA1,SAP18,SAP30,SAP30L,SMAD5,STAT5B,TXNIP	
Cytosolic iron-sulfur cluster assembly	1.94E00	3.08E-01	-2.000	CIAO1,CIAO2B,ERCC2,POLD1	
UDP-N-acetyl-D-galactosamine Biosynthesis II	1.94E00	3.08E-01	-2.000	GNPDA1,GPI,HK3,UAP1	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	1.94E00	1.2E-01	-2.294	AKT1,BRAF,CDC42,CHUK,FASLG,GRB2,JAK3,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RELA,SHC1,SOS2,STAT3,TGFB2	
Cohesin Chromatin Regulation Pathway	1.93E00	1.13E-01	-2.117	ANAPC10,ATM,BUB1,CCNC,CDC27,CDCA8,CDK8,CEBPA,CTCF,ESCO1,ESCO2,HASPIN,HP1BP3,MED1,MED11,MED13,MED19,MED9,NCAPD2,NCAPH,PCDH1,POLR2C,POLR2F,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E	
G alpha (12/13) signalling events	1.93E00	1.5E-01	-1.732	ABR,AKAP13,ARHGEF11,ARHGEF2,GNB4,NET1,OBSCN,PREX1,RHOB,SOS2,VAV1,VAV3	
IL-17A Signaling in Fibroblasts	1.93E00	1.5E-01	-2.887	ACTA2,ARID5A,CCL2,CHUK,LCN2,MAPK14,MAPK3,NFKB2,NFKBIE,P4HB,RELA,STAT3	
Dopamine Receptor Signaling	1.93E00	1.5E-01	NaN	ADCY3,GCH1,PCBD1,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA	
Inflammasome pathway	1.92E00	2.5E-01	-2.236	AIM2,CASP5,CASP8,NFKB2,NLRC4	
Leukocyte Extravasation Signaling	1.91E00	1.19E-01	-2.294	ABL1,ACTA2,ACTN4,ARHGAP1,ARHGAP5,ARHGAP9,CDC42,CRK,CTNNB1,GNAI2,MAP2K2,MAPK14,NCF1,PIK3R3,PIK3R5,PRKCI,PTPN11,RAP1A,RAPGEF3,SIPA1,VAV1,VAV3,WASL	
TP53 Regulates Transcription of Cell Death Genes	1.91E00	1.82E-01	-2.121	APAF1,ATM,BAX,CASP10,NDRG1,NLRC4,TP53I3,TRIAP1	
BER (Base Excision Repair) Pathway	1.91E00	1.82E-01	-2.121	APEX1,LIG3,MAP2K2,MAP2K5,MAPK3,MPG,RFC2,SP1	
Colorectal Cancer Metastasis Signaling	1.89E00	1.11E-01	-1.460	ADCY3,AKT1,BAX,BRAF,CDC42,CTNNB1,E2F4,GNAI2,GNB4,GRB2,GRK2,JAK3,MAP2K2,MAPK3,MLH1,MSH6,NFKB2,NRAS,PIK3R3,PIK3R5,PRKACA,RAP1A,RELA,RHOB,RHOQ,RHOT1,SOS2,STAT3,TGFB2,VEGFC	
Apelin Endothelial Signaling Pathway	1.89E00	1.28E-01	-3.153	ADCY3,AKT1,CCL2,GNAI2,GNB4,HDAC4,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA,RPS6KB2,SP1	
FLT3 Signaling	1.88E00	1.94E-01	-2.646	AKT1,GRB2,HCK,NRAS,PTPN11,SLA,SYK	
Ferroptosis Signaling Pathway	1.88E00	1.3E-01	-2.183	ALOX5,BAP1,BRAF,CARS1,FDFT1,GCH1,HMOX1,IREB2,KEAP1,MAP2K2,MAPK3,NRAS,RAF1,RAP1A,RBL1,SP1,STAT3	
Xenobiotic Metabolism Signaling	1.88E00	1.09E-01	NaN	AIP,ALDH3B1,ALDH4A1,CITED2,CUL3,DNAJC7,HDAC4,HMOX1,HS2ST1,KEAP1,MAP2K2,MAP2K5,MAP3K11,MAP3K3,MAPK14,MAPK3,MED1,NFKB2,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RAF1,RAP1A,RELA,RXRA,SCAND1	
RHO GTPases activate PKNs	1.88E00	2.14E-01	-0.816	PKN1,PKN2,PKN3,PPP1R14A,RHOB,YWHAG	
BMP signaling pathway	1.87E00	1.43E-01	-1.732	ATF2,GRB2,GREM1,MAP2K2,MAPK14,MAPK3,NFKB2,NRAS,PRKACA,RAF1,RAP1A,RELA,SMAD5	
SUMOylation of DNA replication proteins	1.85E00	1.78E-01	-0.707	CDCA8,NUP43,NUP54,NUP58,NUP93,SUMO2,TPR,UBE2I	
Pyrophosphate hydrolysis	1.83E00	6.67E-01	NaN	PPA1,PPA2	
Processing of Capped Intronless Pre-mRNA	1.8E00	2.07E-01	-1.633	CLP1,CPSF3,CSTF3,NCBP2,SNRPB,SNRPE	
Superpathway of Cholesterol Biosynthesis	1.8E00	2.07E-01	-2.449	ACAT1,DHCR24,FDFT1,FDPS,MVK,PMVK	
Mitochondrial biogenesis	1.8E00	1.56E-01	-0.632	ATF2,CYCS,ESRRA,GABPB1,GLUD1,IDH2,MAPK14,MED1,RXRA,SIRT5	
TRAIL signaling	1.8E00	3.75E-01	NaN	CASP10,CASP8,FADD	
Serine biosynthesis	1.8E00	3.75E-01	NaN	PSAT1,PSPH,SERINC3	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	1.79E00	1.64E-01	-1.667	ACTR1A,CAPZA2,DCTN1,DCTN4,DCTN5,FKBP4,FKBP5,HSPA1A/HSPA1B,TUBA1B	
Signaling by PTK6	1.79E00	1.64E-01	-2.333	AKT1,ARAP1,CCNE1,CDK4,CRK,ELMO2,KHDRBS2,NRAS,STAT3	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	1.77E00	1.32E-01	-1.291	ATF2,ATP6V0E1,ATP6V1B2,BAX,BRAF,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,NRAS,PLAAT4,PLB1,RAF1,RAP1A	
Resolution of Abasic Sites (AP sites)	1.76E00	1.84E-01	-2.646	APEX1,LIG3,MPG,POLD1,POLD2,POLD3,RFC2	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	1.74E00	2.27E-01	-2.236	BAG6,HMOX1,SERP1,SGTA,UBE2J2	
CXCR4 Signaling	1.73E00	1.19E-01	-3.153	ADCY3,AKT1,ARHGEF11,CDC42,CRK,ELMO2,GNAI2,GNB4,MAP2K2,MAPK3,MYL6B,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RHOB,RHOQ,RHOT1	
Gene Silencing by RNA	1.73E00	1.37E-01	-1.387	IPO8,NUP43,NUP54,NUP58,NUP93,PIWIL4,POLR2C,POLR2F,RAN,TNRC6A,TNRC6C,TPR,TSNAX	
Bladder Cancer Signaling	1.71E00	1.29E-01	-0.816	ABL1,CDK4,E2F2,E2F4,HDAC4,HDAC7,MAP2K2,MAPK3,NRAS,RAF1,RAP1A,RBL1,RPS6KA5,TFDP1,VEGFC	
RAC Signaling	1.7E00	1.24E-01	-2.673	ARPC5L,CDC42,IQGAP3,ITGA6,LIMK1,MAP2K2,MAP3K11,MAPK3,NCF1,NFKB2,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA	
Gαq Signaling	1.68E00	1.18E-01	-2.500	AKT1,CDC42,CHUK,GNAI2,GNB4,GRK2,GYS1,HMOX1,MAP2K2,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,PRKCI,RAF1,RELA,RHOB,RHOQ,RHOT1	
Nonsense-Mediated Decay (NMD)	1.67E00	1.28E-01	-2.840	EIF4A3,EIF4G1,NCBP2,PPP2CA,PPP2R2A,RBM8A,RNPS1,RPL22L1,RPL26L1,RPS19,RPS27L,SMG5,SMG7,UPF2,UPF3A	
Signaling by CSF1 (M-CSF) in myeloid cells	1.67E00	1.94E-01	-2.449	GRB2,HCK,PTPN11,SHC1,STAT3,THOC5	
PD-1, PD-L1 cancer immunotherapy pathway	1.66E00	1.31E-01	2.496	AKT1,CSNK2A2,CSNK2B,FBXO38,JAK3,LAT,LCP2,PIK3R3,PIK3R5,PTPN11,SKP2,STAT5A,STAT5B,TGFB2	
TREM1 Signaling	1.66E00	1.43E-01	-3.317	AKT1,CASP5,CCL2,GRB2,MAPK3,NFKB2,NLRC4,RELA,STAT3,STAT5A,STAT5B	
Cardiac Hypertrophy Signaling (Enhanced)	1.66E00	9.59E-02	-2.188	ADCY3,AKAP13,AKT1,APEX1,ATF2,CACNB1,CHUK,CTNNB1,DVL3,EIF2B1,EIF4E,EIF4EBP1,FASLG,GDE1,GDPD1,GNAI2,GNB4,GSK3A,HDAC4,HDAC7,IL1R1,ITGA6,MAP2K2,MAP2K5,MAP3K11,MAP3K3,MAPK14,MAPK3,MAPKAPK3,MKNK1,NFKB2,NRAS,PDE12,PDE4A,PDE4D,PDE7A,PDIA3,PIK3R3,PIK3R5,PKN1,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RCAN1,RELA,RPS6KA5,RPS6KB2,SRF,STAT3,TGFB2	
NAFLD Signaling Pathway	1.66E00	1.11E-01	-2.200	AKT1,APOB,BAK1,BAX,CASP7,CASP8,CHUK,FASLG,GSK3A,GYS1,JAK3,MLST8,NFKB2,NR1H3,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,SCD,SOCS4,STAT3,TGFB2	
Cancer Drug Resistance by Drug Efflux	1.65E00	1.55E-01	-1.000	ABCC1,AKT1,BRAF,MAP2K2,MAPK3,NRAS,PIK3R3,RAF1,RAP1A	
Interleukin-1 processing	1.65E00	3.33E-01	NaN	GSDMD,NFKB2,RELA	
Pathogenesis of Multiple Sclerosis	1.65E00	3.33E-01	NaN	CCL4,CXCL10,CXCL9	
Pyrimidine Ribonucleotides Interconversion	1.64E00	1.75E-01	-0.816	AK9,NME6,NME7,NTPCR,NUDT15,NUDT16,NUDT5	
Remodeling of Epithelial Adherens Junctions	1.63E00	1.47E-01	-1.000	ACTA2,ACTN4,ARPC5L,CLIP1,CTNNB1,DNM2,RAB5C,RAB7A,TUBA1B,TUBG1	
Aldosterone Signaling in Epithelial Cells	1.63E00	1.16E-01	-1.897	AHCY,CCDC51,DNAJC14,DNAJC2,DNAJC3,DNAJC6,DNAJC7,HSPA1A/HSPA1B,HSPA6,HSPD1,HSPH1,MAP2K2,MAPK3,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKCI,RAF1,SOS2	
Endothelin-1 Signaling	1.63E00	1.13E-01	-3.411	ADCY3,BRAF,CASP10,CASP5,CASP7,CASP8,GNAI2,GRB2,HMOX1,MAPK14,MAPK3,NRAS,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PRKCI,RAF1,RAP1A,SHC1	
VDR/RXR Activation	1.62E00	1.41E-01	0.447	CCNC,CEBPA,CXCL10,GADD45A,KLF4,MED1,PRKCI,PSMC5,RXRA,SP1,TGFB2	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	1.62E00	1.04E-01	-2.043	ADAM32,AKT1,ATF2,BRAF,CDC42,CHUK,CREB3,CTNNB1,GRB2,HCST,IL1R1,LCP2,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKBIE,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,RHOB,RHOQ,RHOT1,SHC1,SOS2,SRF,SYK,TNFRSF11A,VAV3	
MSP-RON Signaling in Macrophages Pathway	1.61E00	1.26E-01	-1.069	ATF2,CHUK,CREB3,ETV3,GRB2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAP1A,RELA,SBNO2,SOS2,STAT3	
Granzyme B Signaling	1.61E00	2.5E-01	-1.000	APAF1,CASP8,CYCS,LMNB2	
DNA Double Strand Break Response	1.61E00	1.53E-01	-1.000	ABL1,ABRAXAS1,ATM,BAP1,BAZ1B,KAT5,MRE11,PPP5C,UBE2I	
Signaling by FGFR1	1.59E00	1.6E-01	-2.121	BRAF,GRB2,MAPK3,MKNK1,NRAS,PPP2CA,PTPN11,SHC1	
RNA Polymerase III Transcription	1.59E00	1.71E-01	-1.134	POLR2F,POLR3G,POLR3GL,POLR3H,SNAPC1,SSB,ZNF143	
Mitochondrial Fatty Acid Beta-Oxidation	1.58E00	2.08E-01	-1.342	ACBD6,DECR1,ECHS1,ECI1,NDUFAB1	
Regulation of RUNX1 Expression and Activity	1.58E00	2.08E-01	NaN	MOV10,PML,PTPN11,TNRC6A,TNRC6C	
IL-33 Signaling Pathway	1.58E00	1.14E-01	-1.528	AKT1,ATF2,CASP10,CASP5,CASP7,CASP8,CCL2,CHUK,CREB3,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,PIK3R3,PIK3R5,PRKACA,RPS6KA1,STAT3,SYK,TBK1	
WNT/β-catenin Signaling	1.58E00	1.15E-01	-1.500	AKT1,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CSNK2A2,CSNK2B,CTNNB1,DVL3,GJA1,GSK3A,MARK2,PIN1,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RUVBL2,TGFB2	
fMLP Signaling in Neutrophils	1.57E00	1.22E-01	-2.324	ARPC5L,CDC42,GNAI2,GNB4,MAP2K2,MAPK3,NCF1,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,RELA	
Retinoic acid Mediated Apoptosis Signaling	1.56E00	1.5E-01	-1.414	APAF1,CASP8,CYCS,DAP3,FADD,PARP10,PARP14,PARP4,RXRA	
GADD45 Signaling	1.56E00	1.5E-01	2.333	ATM,CCNE1,CCNE2,CDK4,GADD45A,MAPK14,NFKB2,RELA,TGFB2	
RAR Activation	1.56E00	9.79E-02	-1.852	ADCY3,ADH1B,AKT1,APEX1,ATF2,CDC42,CITED2,CREB3,CSNK2A2,CSNK2B,DHRS9,ERCC2,FASLG,GDE1,GDPD1,MAPK14,MAPK3,MED1,NFKB2,PDE12,PDE4A,PDE4D,PDE7A,PIK3R3,PIK3R5,PML,PRKACA,PSMC5,RELA,RHOB,RHOQ,RHOT1,RPS6KA2,RPS6KA5,RXRA,SCAND1,SMARCA4,SMARCD1,SP1,STAT5A,STAT5B,TGFB2	
Immunogenic Cell Death Signaling Pathway	1.55E00	1.33E-01	-2.887	BAK1,BAX,CASP8,CXCL10,FADD,HSPA1A/HSPA1B,HSPA6,MLKL,NFKB2,PDIA3,PGAM5,RIPK1	
Unfolded protein response	1.55E00	1.33E-01	-1.633	CEBPA,DNAJC14,DNAJC3,DNAJC6,DNAJC7,HSPA1A/HSPA1B,HSPA6,HSPH1,INSIG1,P4HB,UBXN4,VCP	
D-glucuronate Degradation I	1.55E00	5E-01	NaN	AKR1A1,DCXR	
Synaptic Long Term Potentiation	1.55E00	1.21E-01	-1.500	ATF2,CREB3,MAP2K2,MAPK3,NRAS,PDIA3,PLCD3,PPP1R10,PPP1R14A,PPP1R14B,PRKACA,PRKCI,RAF1,RAP1A,RAPGEF3,RPS6KA1	
UVC-Induced MAPK Signaling	1.54E00	1.57E-01	-1.414	BRAF,MAP2K2,MAPK14,MAPK3,NRAS,PRKCI,RAF1,RAP1A	
Amyloid Processing	1.54E00	1.57E-01	NaN	AKT1,CSNK1A1,CSNK1D,CSNK2A2,CSNK2B,MAPK14,MAPK3,PRKACA	
Sleep REM Signaling Pathway	1.54E00	1.26E-01	-1.069	ATF2,CREB3,EIF4E,FASLG,LIMK1,MAPK3,MKNK1,PDE4A,PRKACA,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,TGFB2	
DAP12 interactions	1.53E00	1.67E-01	-1.134	GRB2,LAT,LCP2,NRAS,SHC1,SYK,VAV3	
Protein methylation	1.52E00	2.35E-01	0.000	CAMKMT,EEF1AKMT1,ETFB,VCP	
Signaling by NTRK3 (TRKC)	1.52E00	2.35E-01	-2.000	BAX,GRB2,NRAS,SHC1	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	1.51E00	1.41E-01	-1.897	AKT1,EXOC3,EXOC7,EXOC8,RAB8A,RHOQ,STX4,STXBP3,TUBA1B,YWHAG	
Activation of anterior HOX genes in hindbrain during early embryogenesis	1.51E00	1.36E-01	-0.905	ASH2L,CTCF,DPY30,EGR2,EZH2,MAFB,POLR2C,POLR2F,RXRA,SUZ12,WDR5	
Insulin processing	1.51E00	2E-01	-1.342	EXOC3,EXOC7,EXOC8,P4HB,SLC30A5	
Circadian Rhythm Signaling	1.51E00	1.04E-01	NaN	ADCY3,ATF2,BRAF,CACNB1,CREB3,CSNK1D,CSNK2A2,EIF4E,EIF4EBP1,FGR,GNAI2,GNB4,GSK3A,H3-3A/H3-3B,HCK,MAP2K2,MAP2K5,MAPK3,MKNK1,MLST8,NRAS,PDIA3,PLCD3,PRKACA,PRKCI,RAF1,RAP1A,RPS6KA5	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	1.49E00	1.15E-01	-3.317	C1QA,C1QC,C3,C3AR1,FASLG,MAPK3,NFKB2,NLRC4,OAS1,OAS2,PIK3R3,PIK3R5,PRKCI,RELA,RNASEL,SYK,TGFB2,TICAM1	
Cargo concentration in the ER	1.48E00	1.76E-01	0.000	MIA2,PREB,SEC23B,SEC24B,SEC24C,TMED2	
Pyrimidine Ribonucleotides De Novo Biosynthesis	1.48E00	1.63E-01	-0.816	AK9,NME6,NME7,NTPCR,NUDT15,NUDT16,NUDT5	
Melatonin Signaling	1.48E00	1.39E-01	-1.414	BRAF,GNAI2,MAP2K2,MAP2K5,MAPK3,PDIA3,PLCD3,PRKACA,PRKCI,RAF1	
Ephrin B Signaling	1.48E00	1.39E-01	-1.000	ACP1,CDC42,CTNNB1,GNAI2,GNB4,LIMK1,MAPK3,RGS3,VAV1,VAV3	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	1.47E00	1.21E-01	-2.673	AKT1,CTNNB1,GRB2,JAK3,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SMAD5,SOS2,STAT3	
STAT3 Pathway	1.47E00	1.19E-01	0.258	CISH,IL1R1,MAP2K2,MAP3K11,MAPK14,MAPK3,NDUFA13,NRAS,PTPN2,PTPN6,RAF1,RAP1A,SOCS4,STAT3,TGFB2,TNFRSF11A	
GNRH Signaling	1.45E00	1.1E-01	-1.147	ADCY3,ATF2,CACNB1,CDC42,CREB3,GNAI2,GNB4,GRB2,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NFKB2,NRAS,PRKACA,PRKCI,RAF1,RAP1A,RELA,SOS2	
Interleukin-20 family signaling	1.45E00	1.92E-01	-2.236	JAK3,PTPN11,STAT3,STAT5A,STAT5B	
Branched-chain amino acid catabolism	1.44E00	2.22E-01	-2.000	ACAT1,BCAT1,ECHS1,SLC25A44	
TAK1-dependent IKK and NF-kappa-B activation	1.43E00	1.59E-01	-2.646	ALPK1,CASP8,CHUK,NFKB2,RELA,SAA1,TIFA	
Transcriptional Regulation by NPAS4	1.43E00	1.71E-01	-0.816	MAPK3,MOV10,SRF,TNRC6A,TNRC6C,XPO1	
Sleep NREM Signaling Pathway	1.43E00	1.22E-01	0.535	ADCY3,ATF2,BRAF,CREB3,GNAI2,HDAC4,MAP2K2,MAP2K5,MAPK3,NRAS,PRKACA,RAF1,RAP1A,YWHAG	
MHC class II antigen presentation	1.42E00	1.19E-01	-1.807	ACTR1A,AP1M1,AP2A2,CAPZA2,DCTN1,DCTN4,DCTN5,DNM2,KIF23,KIF2C,RAB7A,SEC24B,SEC24C,SEC31A,TUBA1B	
trans-Golgi Network Vesicle Budding	1.41E00	1.35E-01	-2.530	AP1M1,BLOC1S1,BLOC1S2,CLTB,DNAJC6,DNM2,DTNBP1,RAB5C,STX4,VAMP8	
SUMOylation of immune response proteins	1.4E00	2.73E-01	NaN	NFKB2,RELA,UBE2I	
Purine Nucleotides De Novo Biosynthesis II	1.4E00	2.73E-01	NaN	GART,IMPDH1,PAICS	
IL-12 Signaling and Production in Macrophages	1.39E00	1.05E-01	1.633	AKT1,APOA2,APOB,C3,CAMKK2,CEBPA,CHUK,H3-3A/H3-3B,MAP2K2,MAPK14,MAPK3,NFKB2,ORM1,ORM2,PIK3R3,PIK3R5,PRKCI,RAB7A,RELA,RXRA,STAT3,TGFB2,TNFRSF11A,TNIP2	
Pyroptosis	1.38E00	1.85E-01	-1.342	BAK1,BAX,CASP5,CYCS,GSDMD	
Purine Nucleotides Degradation II (Aerobic)	1.36E00	2.11E-01	NaN	ADA,IMPDH1,LACC1,NT5C2	
Cargo recognition for clathrin-mediated endocytosis	1.35E00	1.21E-01	-2.496	AP2A2,APOB,CLTB,COPS5,COPS7A,EPN1,FCHO2,GPS1,GRB2,GRK2,SH3GL1,STON1,VAMP8	
Paxillin Signaling	1.35E00	1.21E-01	-1.732	ACTA2,ACTN4,CDC42,CRK,GIT2,GRB2,ITGA6,MAPK14,NRAS,PIK3R3,PIK3R5,RAP1A,SOS2	
Formation of xylulose-5-phosphate	1.35E00	4E-01	NaN	AKR1A1,DCXR	
Superpathway of Serine and Glycine Biosynthesis I	1.35E00	4E-01	NaN	PSAT1,SHMT1	
Arginine Degradation I (Arginase Pathway)	1.35E00	4E-01	NaN	ALDH4A1,ARG2	
Citrulline-Nitric Oxide Cycle	1.35E00	4E-01	NaN	ASL,ASS1	
NAD Signaling Pathway	1.35E00	1.13E-01	-2.324	AKT1,CD38,GJA1,H1-1,HSPD1,IDH2,NADK,NFKB2,PARP10,PARP14,PARP4,PIK3R3,PIK3R5,POLR2C,POLR2F,SIRT5,TGFB2	
G Beta Gamma Signaling	1.34E00	1.16E-01	-1.604	AKT1,CACNB1,CDC42,DNM2,GNAI2,GNB4,GRB2,MAPK3,NRAS,PRKACA,PRKCI,RAF1,RAP1A,SHC1,SOS2	
PIP3 activates AKT signaling	1.34E00	1.14E-01	-3.500	AKT1,CHUK,GRB2,GSK3A,KITLG,MAPK3,MLST8,PIK3AP1,PIK3R3,PPP2CA,PPP2R5D,PPP2R5E,PTPN11,RPS6KB2,TRIB3,VAV1	
Gene and protein expression by JAK-STAT signaling after IL-12 stimulation	1.32E00	1.62E-01	-0.816	AIP,CDC42,HNRNPF,MIF,PITPNA,TCP1	
Signaling by Rho Family GTPases	1.32E00	1.01E-01	-3.710	ACTA2,ARHGEF11,ARHGEF2,ARPC5L,CDC42,CDC42EP4,CLIP1,GNAI2,GNB4,ITGA6,LIMK1,MAP2K2,MAP3K11,MAPK3,MYL6B,NCF1,NFKB2,PIK3R3,PIK3R5,PKN1,PRKCI,RAF1,RELA,RHOB,RHOQ,RHOT1,WASL	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	1.32E00	1.13E-01	-3.000	CAMKK2,CASP8,CCL2,CEBPA,CHUK,FADD,IL1R1,MAPK14,MAPK3,MLKL,MLST8,NFKB2,PGAM5,RIPK1,STAT3,VEGFC	
Phagosome Maturation	1.31E00	1.1E-01	NaN	ATP6V0E1,ATP6V1B2,DCTN4,DYNC2I2,DYNLT1,EEA1,GOSR1,LAMP1,NCF1,PRDX1,RAB5C,RAB7A,TAP1,TUBA1B,TUBG1,VPS16,VPS18,YKT6	
Antiproliferative Role of Somatostatin Receptor 2	1.3E00	1.3E-01	-1.667	BRAF,GNB4,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,PTPN11,PTPN6,RAP1A	
Heme signaling	1.3E00	1.49E-01	0.816	APOB,ATF2,HMOX1,MAFK,MED1,RXRA,XPO1	
Phase II - Conjugation of compounds	1.3E00	1.34E-01	-1.000	AHCY,CNDP2,GLYATL2,NNMT,PAPSS2,TPMT,TRMT112,UGDH,UGP2	
Pulmonary Healing Signaling Pathway	1.29E00	1.06E-01	-1.964	BRAF,CDC42,CTNNB1,FGR,GRB2,HCK,IDH2,MAPK14,MAPK3,NFKB2,NRAS,PRKCI,RAF1,RAP1A,SMAD5,SOS2,STAT3,STAT5A,STAT5B,TGFB2,VEGFC	
IL-10 Signaling	1.28E00	1.1E-01	-0.243	AKT1,ARG2,ATF2,BLVRA,CHUK,CREB3,HMOX1,IL1R1,MAFB,MAPK14,NFKB2,NFKBIE,RELA,SP1,STAT3,STAT5A,STAT5B	
Hematoma Resolution Signaling Pathway	1.28E00	1.01E-01	-2.746	C3,CCR4,F2RL3,FASLG,FGA,FGG,HMOX1,MAPK14,MAPK3,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,STAT3,TGFB2,TUBA1B,VPS35	
Myogenesis	1.27E00	1.72E-01	-0.447	ABL1,BNIP2,CDC42,CTNNB1,MAPK14	
mRNA Capping	1.27E00	1.72E-01	-2.236	ERCC2,GTF2F1,NCBP2,POLR2C,POLR2F	
p75 NTR receptor-mediated signalling	1.25E00	1.2E-01	-1.732	ABR,AKAP13,ARHGEF11,ARHGEF2,NET1,OBSCN,PREX1,PRKCI,RELA,SOS2,VAV1,VAV3	
Pancreatic Secretion Signaling Pathway	1.25E00	1.01E-01	-1.800	ADCY3,AHCYL1,AKT1,ARHGEF11,ARHGEF2,CD38,EIF4EBP1,GOSR1,MAPK3,MLST8,PDIA3,PIK3R3,PIK3R5,PLCD3,PPP1R10,PPP1R14A,PPP1R14B,PRKACA,PRKCI,RAP1A,RAPGEF3,RPS6KB2,STXBP3,STXBP4,YKT6	
Thyroid Cancer Signaling	1.24E00	1.27E-01	-1.897	AKT1,BRAF,CTNNB1,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAP1A,SHC1	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.24E00	1.27E-01	-1.265	CRP,MAPK14,MAPK3,PIAS1,PTPN11,STAT3,STAT5A,STAT5B,TGFB2,VEGFC	
Opioid Signalling	1.23E00	1.22E-01	-1.508	ADCY3,AHCYL1,CAMKK2,GNAI2,GNB4,GRK2,PDE4A,PDE4D,PPP2CA,PPP2R5D,PRKACA	
MAP kinase activation	1.23E00	1.54E-01	-1.633	CHUK,CUL1,MAPK14,MAPKAPK3,SKP1,TNIP2	
Regulation of TP53 Expression and Degradation	1.23E00	1.54E-01	-0.816	AKT1,ATM,MLST8,PHF20,PPP2CA,RFFL	
tRNA Charging	1.23E00	1.54E-01	-1.633	AARS1,CARS1,RARS1,SARS1,WARS1,YARS1	
Regulation of TLR by endogenous ligand	1.22E00	1.9E-01	-2.000	APOB,FGA,FGG,GSDMD	
Mitophagy	1.21E00	1.67E-01	-2.236	CSNK2A2,CSNK2B,PGAM5,TOMM22,TOMM5	
Nucleotide catabolism	1.21E00	1.67E-01	-2.236	NT5C2,NUDT15,NUDT16,NUDT5,TYMP	
Advanced glycosylation endproduct receptor signaling	1.21E00	2.31E-01	NaN	CAPZA2,MAPK3,SAA1	
Epithelial Adherens Junction Signaling	1.19E00	1.08E-01	0.000	AKT1,ARPC5L,CDC42,CRK,CTNNB1,KIF23,LIMK1,NF2,NRAS,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAP1A,TGFB2,YWHAG	
UDP-N-acetyl-D-glucosamine Biosynthesis II	1.19E00	3.33E-01	NaN	GFPT1,UAP1	
Chemokine Signaling	1.18E00	1.23E-01	-2.530	CCL2,CCL4,GNAI2,LIMK1,MAP2K2,MAPK14,MAPK3,NRAS,RAF1,RAP1A	
Signaling by EGFR	1.18E00	1.4E-01	-1.890	CDC42,EPN1,GRB2,NRAS,PTPN11,SH3GL1,SHC1	
Antioxidant Action of Vitamin C	1.17E00	1.14E-01	3.051	CHUK,HMOX1,MAPK14,MAPK3,NFKB2,NFKBIE,PDIA3,PLAAT4,PLB1,PLCD3,RELA,STAT5A,STAT5B	
Acetylcholine Receptor Signaling Pathway	1.17E00	1.03E-01	0.000	ADCY3,AKT1,ATF2,CACNB1,CASP10,CASP5,CASP7,CASP8,CREB3,GNAI2,HMOX1,KEAP1,MAPK3,NFKB2,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI	
Asparagine N-linked glycosylation	1.16E00	1.61E-01	-0.447	ASGR2,GFPT1,NUS1,PDIA3,UAP1	
RHO GTPases activate IQGAPs	1.16E00	1.61E-01	-0.447	CDC42,CLIP1,CTNNB1,IQGAP3,TUBA1B	
Endosomal Sorting Complex Required For Transport (ESCRT)	1.16E00	1.61E-01	-1.342	MVB12A,VPS25,VPS36,VPS4A,VPS4B	
RHO GTPases Activate NADPH Oxidases	1.16E00	1.82E-01	-2.000	MAPK14,MAPK3,NCF1,PIN1	
Semaphorin Signaling in Neurons	1.15E00	1.31E-01	NaN	ARHGAP1,CDC42,FES,LIMK1,MAPK3,RHOB,RHOQ,RHOT1	
Regulation of the Epithelial-Mesenchymal Transition Pathway	1.15E00	1.03E-01	NaN	AKT1,BRAF,CTNNB1,DVL3,GRB2,JAK3,MAP2K2,MAP2K5,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PTPN11,RAF1,RAP1A,RELA,SOS2,STAT3,TGFB2	
Actin Nucleation by ARP-WASP Complex	1.15E00	1.18E-01	-0.333	ARPC5L,CDC42,GRB2,ITGA6,NRAS,RAP1A,RHOB,RHOQ,RHOT1,SOS2,WASL	
RET signaling	1.14E00	1.46E-01	-2.449	DOK4,GRB2,PIK3R3,PRKACA,PTPN11,SHC1	
Methylthiopropionate Biosynthesis	1.14E00	1E00	NaN	ADI1	
Acetyl-CoA Biosynthesis III (from Citrate)	1.14E00	1E00	NaN	ACLY	
Transcriptional regulation by RUNX2	1.14E00	1.37E-01	-2.646	ABL1,AKT1,BAX,CDK4,HDAC4,MAPK3,PPM1D	
GP6 Signaling Pathway	1.13E00	1.1E-01	-1.732	AKT1,FCER1G,FGA,FGG,GRB2,GSK3A,LAT,LCP2,PIK3R3,PIK3R5,PRKCI,SYK,VAV1,VAV3	
DNA Double-Strand Break Repair by Homologous Recombination	1.13E00	2.14E-01	NaN	ABL1,ATM,MRE11	
DNA Double-Strand Break Repair by Non-Homologous End Joining	1.13E00	2.14E-01	NaN	ATM,LIG3,MRE11	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	1.13E00	2.14E-01	NaN	IMPDH1,LACC1,NT5C2	
Mevalonate Pathway I	1.13E00	2.14E-01	NaN	ACAT1,MVK,PMVK	
TNFR2 Signaling	1.11E00	1.56E-01	-1.342	CHUK,NFKB2,NFKBIE,RELA,TBK1	
Telomere Maintenance	1.1E00	1.23E-01	-0.333	BLM,DNA2,POLD1,POLD2,POLD3,PPP6C,PPP6R3,RFC2,TERF2	
Senescence-Associated Secretory Phenotype (SASP)	1.1E00	1.23E-01	-2.333	ANAPC10,CDC27,CDK4,MAPK3,RELA,RPS6KA1,RPS6KA2,STAT3,UBE2E1	
Extra-nuclear estrogen signaling	1.1E00	1.23E-01	-2.333	AKT1,GNAI2,GNB4,MAPK3,NRAS,PIK3R3,SHC1,SRF,XPO1	
Glioma Invasiveness Signaling	1.1E00	1.23E-01	-1.414	CDC42,MAPK3,NRAS,PIK3R3,PIK3R5,RAP1A,RHOB,RHOQ,RHOT1	
April Mediated Signaling	1.1E00	1.43E-01	-1.633	CHUK,MAPK14,NFKB2,NFKBIE,RELA,TRAF3	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	1.1E00	1.74E-01	0.000	AK9,APOBEC3G,NME6,NME7	
TCA Cycle II (Eukaryotic)	1.1E00	1.74E-01	-2.000	MDH1,OGDH,SDHC,SUCLG1	
Virus Entry via Endocytic Pathways	1.08E00	1.1E-01	-2.496	ABL1,ACTA2,AP1M1,AP2A2,AP3D1,CDC42,CLTB,DNM2,NRAS,PIK3R3,PIK3R5,PRKCI,RAP1A	
IL-1 Signaling	1.07E00	1.15E-01	-2.828	ADCY3,CHUK,ECSIT,GNAI2,GNB4,IL1R1,MAPK14,NFKB2,NFKBIE,PRKACA,RELA	
TYSND1 cleaves peroxisomal proteins	1.07E00	2.86E-01	NaN	ACAA1,AGPS	
Ceramide Biosynthesis	1.07E00	2.86E-01	NaN	KDSR,SPTSSA	
Arginine Degradation VI (Arginase 2 Pathway)	1.07E00	2.86E-01	NaN	ARG2,PYCR1	
Adenine and Adenosine Salvage III	1.07E00	2.86E-01	NaN	ADA,LACC1	
Glycogen Biosynthesis II (from UDP-D-Glucose)	1.07E00	2.86E-01	NaN	GYS1,UGP2	
Aspartate Degradation II	1.07E00	2.86E-01	NaN	GOT1,MDH1	
Clathrin-mediated endocytosis	1.07E00	1.08E-01	-2.138	AP2A2,APOB,CLTB,DNAJC6,DNM2,EPN1,FCHO2,GRB2,HIP1,RAB5C,SH3GL1,STON1,VAMP8,WASL	
Signaling by Insulin receptor	1.06E00	1.4E-01	-1.633	ATP6V0E1,ATP6V1B2,GRB2,MAPK3,NRAS,SHC1	
B Cell Activating Factor Signaling	1.06E00	1.4E-01	-2.236	CHUK,MAPK14,NFKB2,NFKBIE,RELA,TRAF3	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	1.06E00	9.31E-02	-2.556	AKT1,ATF2,CCL2,CEBPA,CHUK,CREB3,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,IL1R1,MAP2K2,MAPK14,MAPK3,MIF,NFKBIE,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKCI,RAF1,RAP1A,RELA,RIPK1,STAT3,TRADD,TRAF3,VEGFC	
TGF-β Signaling	1.05E00	1.13E-01	-0.302	CDC42,GRB2,MAP2K2,MAPK14,MAPK3,NRAS,RAF1,RAP1A,SMAD5,SOS2,TGFB2	
Caveolar-mediated Endocytosis Signaling	1.05E00	1.2E-01	-1.000	ABL1,ACTA2,ARCN1,COPB2,COPE,COPG1,DNM2,ITGA6,RAB5C	
Sulfur amino acid metabolism	1.04E00	1.67E-01	-1.000	AHCY,ETHE1,GOT1,TST	
Methionine Degradation I (to Homocysteine)	1.04E00	1.67E-01	-1.000	AHCY,AHCYL1,EEF1AKMT1,PRMT5	
SUMOylation of transcription cofactors	1.02E00	1.36E-01	-0.816	CBX4,PHC2,PIAS1,SAFB,SUMO2,UBE2I	
RAB geranylgeranylation	1.02E00	1.23E-01	-0.707	PTP4A2,RAB1A,RAB2A,RAB34,RAB44,RAB5C,RAB7A,RAB8A	
Transcriptional Regulation by E2F6	1.02E00	1.47E-01	-1.342	APAF1,EZH2,PCGF6,SUZ12,TFDP1	
Plasma lipoprotein assembly, remodeling, and clearance	1.02E00	1.18E-01	-3.000	ABCG1,AP2A2,APOA2,APOB,MYLIP,NR1H2,NR1H3,P4HB,PRKACA	
Macropinocytosis Signaling	1.02E00	1.18E-01	-1.414	ACTN4,ANKFY1,CDC42,NRAS,PIK3R3,PIK3R5,PRKCI,RAB34,RAP1A	
Glutaminergic Receptor Signaling Pathway (Enhanced)	1.01E00	9.23E-02	-2.191	ADCY3,AKT1,ATF2,CACNB1,CHUK,CREB3,DGKE,EIF4E,GLUD1,GNAI2,GOSR1,GOT1,HMOX1,MAPK14,MAPK3,MKNK1,MLST8,NFKB2,PDIA3,PIK3R3,PIK3R5,PLAAT4,PLB1,PLCD3,PRKACA,PRKCI,RPS6KB2,SCN1B,TGFB2,YKT6	
WNT/Ca+ pathway	9.94E-01	1.21E-01	-1.414	ATF2,CREB3,DVL3,NFKB2,PDIA3,PLCD3,RELA,ROR1	
Pulmonary Fibrosis Idiopathic Signaling Pathway	9.93E-01	9.2E-02	-1.461	ACTA2,AKT1,ATF2,BAX,BRAF,CTNNB1,EIF4EBP1,EZH1,EZH2,GRB2,LPAR1,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,RPS6KA1,RPS6KA2,RPS6KA5,RPS6KB2,SOS2,SRF,STAT3,STK38,SUZ12,TGFB2	
Signaling by NTRK2 (TRKB)	9.92E-01	1.6E-01	-2.000	GRB2,NRAS,PTPN11,SHC1	
Fcgamma receptor (FCGR) dependent phagocytosis	9.91E-01	1.02E-01	-2.500	ABL1,AHCYL1,CDC42,CRK,ELMO2,FGR,GRB2,HCK,IGKV3-20,LIMK1,MAPK3,NF2,SYK,VAV1,VAV3,WASL	
Interleukin-10 signaling	9.88E-01	1.33E-01	-2.449	CCL2,CCL4,CXCL10,CXCL2,IL1R1,STAT3	
Coronavirus Replication Pathway	9.88E-01	1.33E-01	-2.449	ARCN1,COPB2,COPE,COPG1,GSK3A,TUBA1B	
Signal regulatory protein family interactions	9.84E-01	1.88E-01	NaN	GRB2,PTPN11,PTPN6	
SUMOylation of DNA methylation proteins	9.84E-01	1.88E-01	NaN	CBX4,PHC2,UBE2I	
FOXO-mediated transcription of cell death genes	9.84E-01	1.88E-01	NaN	CITED2,FASLG,NFYC	
Extrinsic Prothrombin Activation Pathway	9.84E-01	1.88E-01	NaN	FGA,FGG,TFPI	
Superpathway of Citrulline Metabolism	9.84E-01	1.88E-01	NaN	ARG2,ASL,ASS1	
Adenosine Nucleotides Degradation II	9.84E-01	1.88E-01	NaN	ADA,LACC1,NT5C2	
Ethanol Degradation II	9.81E-01	1.43E-01	-2.236	ADH1B,AKR1A1,ALDH3B1,ALDH4A1,DHRS9	
IL-15 Production	9.73E-01	1.06E-01	-2.496	ABL1,DYRK1A,FES,FGR,HCK,JAK3,MAP2K5,MAP3K11,NFKB2,PRKCI,RELA,ROR1,SYK	
CSDE1 Signaling Pathway	9.72E-01	1.25E-01	-1.633	AKT1,APAF1,CCL2,CTNNB1,FUS,PIWIL4,PTBP1	
DNA Damage/Telomere Stress Induced Senescence	9.72E-01	1.25E-01	-0.378	ATM,CCNE1,CCNE2,H1-1,KAT5,MRE11,TERF2	
RAB GEFs exchange GTP for GDP on RABs	9.69E-01	1.12E-01	-1.265	AKT1,DENND1A,DENND1B,MON1B,RAB1A,RAB5C,RAB7A,RAB8A,TRAPPC2L,TRAPPC3	
Miro GTPase Cycle	9.63E-01	2.5E-01	NaN	RAP1GDS1,RHOT1	
Purine Ribonucleosides Degradation to Ribose-1-phosphate	9.63E-01	2.5E-01	NaN	ADA,LACC1	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	9.53E-01	1.3E-01	NaN	ASH2L,CCNF,PCGF6,PHB1,TDRD7,WWP2	
IL-23 Signaling Pathway	9.53E-01	1.3E-01	-2.449	AKT1,NFKB2,PIK3R3,PIK3R5,RELA,STAT3	
SNARE Signaling Pathway	9.46E-01	1.03E-01	0.000	ADCY3,CACNB1,GOSR1,MYL6B,PRKACA,RAB1A,RAB2A,RAB7A,RAB8A,SGTA,SNCG,STXBP3,STXBP4,YKT6	
Regulation of Cellular Mechanics by Calpain Protease	9.45E-01	1.11E-01	-0.447	ACTN4,CAST,CCNE1,CCNE2,CDK4,GRB2,ITGA6,MAPK3,NRAS,RAP1A	
IL-17A Signaling in Gastric Cells	9.44E-01	1.54E-01	NaN	CXCL10,MAPK14,MAPK3,RELA	
Cysteine Biosynthesis III (mammalia)	9.44E-01	1.54E-01	-1.000	AHCY,AHCYL1,EEF1AKMT1,PRMT5	
RHO GTPases Activate WASPs and WAVEs	9.41E-01	1.39E-01	-1.342	ABL1,CDC42,GRB2,MAPK3,WASL	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	9.41E-01	1.39E-01	-2.236	CITED2,CITED4,HSPD1,UBE2I,WWOX	
MIF-mediated Glucocorticoid Regulation	9.41E-01	1.39E-01	-2.236	MAPK3,MIF,NFKB2,NFKBIE,RELA	
Signaling by MET	9.4E-01	1.14E-01	-2.333	CRK,GRB2,NRAS,PTPN11,PTPN2,RAP1A,SH3GL1,SHC1,STAT3	
Oxytocin Signaling Pathway	9.27E-01	9.22E-02	-2.746	AKT1,ATF2,CACNB1,CAMKK2,CCDC51,CREB3,GJA1,GNAI2,GNB4,GRB2,MAP2K5,MAPK14,MAPK3,MYL6B,NFKB2,NRAS,PIK3R3,PIK3R5,PPP1R14A,PRKACA,PRKCI,RAF1,RAP1A,RELA,SHC1,SOS2	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	9.22E-01	1.76E-01	NaN	GRB2,NRAS,SHC1	
Isoleucine Degradation I	9.22E-01	1.76E-01	NaN	ACAT1,BCAT1,ECHS1	
iNOS Signaling	9.2E-01	1.28E-01	-2.449	CHUK,JAK3,MAPK14,NFKB2,NFKBIE,RELA	
Signaling by PDGF	9.11E-01	1.21E-01	-2.646	CRK,GRB2,NRAS,PTPN11,STAT3,STAT5A,STAT5B	
RUNX1 regulates megakaryocyte differentiation and platelet function	9.11E-01	1.21E-01	0.378	ASH2L,DPY30,MOV10,NR4A3,TNRC6A,TNRC6C,WDR5	
Integration of energy metabolism	9.09E-01	1.07E-01	-1.265	ACLY,ADCY3,AHCYL1,GNAI2,GNB4,MLX,PPP2CA,PPP2R5D,PRKACA,RAP1A,RAPGEF3	
Noradrenaline and Adrenaline Degradation	9.03E-01	1.35E-01	-2.236	ADH1B,AKR1A1,ALDH3B1,ALDH4A1,DHRS9	
Complement System	9.03E-01	1.35E-01	-2.000	C1QA,C1QC,C1S,C3,C3AR1	
BMAL1:CLOCK,NPAS2 activates circadian gene expression	8.98E-01	1.48E-01	-1.000	BMAL2,MED1,NOCT,RXRA	
Glycolysis I	8.98E-01	1.48E-01	-2.000	ENO1,GPI,PGAM1,TPI1	
Gluconeogenesis I	8.98E-01	1.48E-01	-2.000	ENO1,GPI,MDH1,PGAM1	
Oxytocin in Brain Signaling Pathway	8.9E-01	9.55E-02	-2.065	AKT1,ATF2,CACNB1,CAMKK2,CASP5,CREB3,GNAI2,GNB4,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PLAAT4,PLB1,PRKCI,RAF1,RAP1A	
Circadian Clock	8.83E-01	1.19E-01	-1.134	ATF2,CREM,CSNK1D,CUL1,MED1,RXRA,SKP1	
Abacavir ADME	8.74E-01	2.22E-01	NaN	ADAL,NT5C2	
Urea cycle	8.74E-01	2.22E-01	NaN	ARG2,ASS1	
Phosphatidylethanolamine Biosynthesis II	8.74E-01	2.22E-01	NaN	PCYT2,SELENOI	
Leucine Degradation I	8.74E-01	2.22E-01	NaN	BCAT1,MCCC1	
Folate Transformations I	8.74E-01	2.22E-01	NaN	MTHFS,SHMT1	
Gαi Signaling	8.73E-01	1E-01	-1.387	ADCY3,CCR4,GNAI2,GNB4,GRB2,LPAR1,MAPK3,NRAS,PRKACA,RAF1,RAP1A,SHC1,SOS2,STAT3	
PI Metabolism	8.67E-01	1.1E-01	-1.000	GDE1,GDPD1,MTMR14,MTMR6,PI4K2B,PIK3R3,PIK3R5,PITPNB,TNFAIP8L2	
Nicotinate metabolism	8.66E-01	1.67E-01	NaN	CD38,NADK,NNMT	
Human Embryonic Stem Cell Pluripotency	8.61E-01	9.45E-02	-1.606	AKT1,BRAF,CTNNB1,GRB2,JAK3,KLF4,MAP2K2,MAP2K5,NFYC,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A,SMAD5,SOS2,STAT3,TGFB2	
Epoxysqualene Biosynthesis	8.57E-01	5E-01	NaN	FDFT1	
4-hydroxyproline Degradation I	8.57E-01	5E-01	NaN	ALDH4A1	
Spermidine Biosynthesis I	8.57E-01	5E-01	NaN	SRM	
Sulfate Activation for Sulfonation	8.57E-01	5E-01	NaN	PAPSS2	
Thiosulfate Disproportionation III (Rhodanese)	8.57E-01	5E-01	NaN	TST	
Xanthine and Xanthosine Salvage	8.57E-01	5E-01	NaN	LACC1	
Cardiolipin Biosynthesis II	8.57E-01	5E-01	NaN	PGS1	
Glycine Biosynthesis I	8.57E-01	5E-01	NaN	SHMT1	
Glutamate Biosynthesis II	8.57E-01	5E-01	NaN	GLUD1	
Glutamate Degradation X	8.57E-01	5E-01	NaN	GLUD1	
Nucleosome assembly	8.56E-01	1.22E-01	-1.633	CENPA,CENPO,CENPW,CENPX,RSF1,RUVBL1	
Signaling by ALK	8.55E-01	1.43E-01	-2.000	JAK3,PTPN6,SHC1,STAT3	
Glyoxylate metabolism and glycine degradation	8.55E-01	1.43E-01	-2.000	ALDH4A1,NDUFAB1,OGDH,PXMP2	
WNK Renal Signaling Pathway	8.47E-01	1.04E-01	-1.134	AKT1,ANAPC10,CUL1,CUL3,ELOC,MAPK14,PIK3R3,PIK3R5,PRKCI,RPS6KA5,SKP1	
Superpathway of Methionine Degradation	8.32E-01	1.28E-01	-1.342	AHCY,AHCYL1,EEF1AKMT1,GOT1,PRMT5	
Assembly of RNA Polymerase II Complex	8.26E-01	1.2E-01	-2.449	ERCC2,GTF2A2,GTF2F1,POLR2C,POLR2F,TAF7	
Regulation of TP53 Activity through Methylation	8.14E-01	1.58E-01	NaN	ATM,KMT5A,PRMT5	
Metabolism of cofactors	8.14E-01	1.58E-01	NaN	AKT1,COQ5,GCH1	
FOXO-mediated transcription	8.14E-01	1.58E-01	NaN	AKT1,TXNIP,YWHAG	
NFE2L2 regulating anti-oxidant/detoxification enzymes	8.14E-01	1.58E-01	NaN	HMOX1,MAFK,PRDX1	
Role of JAK2 in Hormone-like Cytokine Signaling	8.02E-01	1.13E-01	-1.134	PTPN11,PTPN6,SHC1,STAT3,STAT5A,STAT5B,VEGFC	
RHOBTB3 ATPase cycle	7.98E-01	2E-01	NaN	CCNE1,CUL3	
Transcriptional regulation of granulopoiesis	7.97E-01	1.18E-01	-2.000	CDK4,CEBPA,PML,RXRA,STAT3,TFDP1	
Androgen Signaling	7.93E-01	9.47E-02	-1.890	CACNB1,ERCC2,GNAI2,GNB4,GTF2A2,GTF2F1,H3-3A/H3-3B,MAPK3,NFKB2,POLR2C,POLR2F,PRKACA,PRKCI,RELA,SHC1,TAF7	
α-Adrenergic Signaling	7.89E-01	1.01E-01	-1.890	ADCY3,GNAI2,GNB4,GYS1,MAP2K2,MAPK3,NRAS,PRKACA,PRKCI,RAF1,RAP1A	
Xenobiotic Metabolism CAR Signaling Pathway	7.87E-01	9.28E-02	-1.698	ABCC1,ALDH3B1,ALDH4A1,CITED2,DNAJC7,HS2ST1,MAP2K2,MAP2K5,MAPK3,MED1,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RXRA,SCAND1	
Actin Cytoskeleton Signaling	7.82E-01	9.02E-02	-2.400	ACTA2,ACTN4,ARPC5L,CDC42,CRK,GRB2,IQGAP3,ITGA6,LIMK1,MAP2K2,MAPK3,MYL6B,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,SHC1,SOS2,VAV1,VAV3,WASL	
Platelet homeostasis	7.78E-01	1.05E-01	-3.000	APOB,FGR,GNB4,MAPK14,PPP2CA,PPP2R5D,PPP2R5E,PTPN11,PTPN6	
Protein ubiquitination	7.77E-01	1.33E-01	0.000	UBA6,UBE2D2,UBE2E1,UBE2H	
Apoptotic execution phase	7.69E-01	1.15E-01	-2.449	CASP7,CASP8,CTNNB1,FNTA,H1-1,KPNB1	
DAG and IP3 signaling	7.67E-01	1.22E-01	-0.447	ADCY3,AHCYL1,CAMKK2,GRK2,PRKACA	
SUMOylation of transcription factors	7.66E-01	1.5E-01	NaN	PIAS1,SUMO2,UBE2I	
Apelin Cardiomyocyte Signaling Pathway	7.54E-01	1.01E-01	-2.530	AKT1,GNAI2,MAPK14,MAPK3,MYL6B,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKCI	
Molecular Mechanisms of Cancer	7.42E-01	8.06E-02	-2.528	ABL1,ADCY3,ADGRE1,AKT1,APAF1,ARHGEF11,ARHGEF2,ATM,BAK1,BAX,BRAF,C3AR1,CASP10,CASP7,CASP8,CCNE1,CCNE2,CCR4,CDC42,CDK4,CRK,CTNNB1,CYCS,E2F2,E2F4,E2F8,F2RL3,FADD,FASLG,GNAI2,GNB4,GPR141,GPR27,GPR4,GRB2,GSK3A,HAT1,HDAC4,HDAC7,IL1R1,ITGA6,JAK3,LAMTOR3,LPAR1,MAP2K2,MAPK14,MAPK3,MRE11,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKACA,PRKCI,PTPN11,RAF1,RAP1A,RAPGEF3,RBL1,RELA,RHOB,RHOQ,RHOT1,SHC1,SMAD5,SOS2,TFDP1,TGFB2	
Formation of WDR5-containing histone-modifying complexes	7.37E-01	1.19E-01	0.447	ASH2L,DPY30,PHF20,TASP1,WDR5	
RHOA Signaling	7.36E-01	9.68E-02	-1.508	ACTA2,ANLN,ARHGAP1,ARHGAP5,ARHGAP9,ARHGEF11,ARPC5L,CDC42EP4,LIMK1,LPAR1,MYL6B,PKN1	
Metallothioneins bind metals	7.31E-01	1.82E-01	NaN	MT1F,MT2A	
Phenylalanine and tyrosine metabolism	7.31E-01	1.82E-01	NaN	HPD,PCBD1	
Alpha-protein kinase 1 signaling pathway	7.31E-01	1.82E-01	NaN	ALPK1,TIFA	
RHO GTPases activate PAKs	7.21E-01	1.43E-01	NaN	CDC42,LIMK1,NF2	
L1CAM interactions	7.19E-01	9.6E-02	-2.309	AP2A2,CSNK2A2,CSNK2B,DNM2,LYPLA2,MAP2K2,MAPK3,RPS6KA1,RPS6KA2,RPS6KA5,SCN1B,TUBA1B	
G-protein beta:gamma signalling	7.06E-01	1.25E-01	-1.000	AKT1,CDC42,GNB4,PIK3R5	
Gαs Signaling	7.03E-01	9.52E-02	-0.632	ADCY3,ATF2,BRAF,CREB3,GNAI2,GNB4,HCK,MAP2K2,MAPK3,PRKACA,RAP1A,RAPGEF3	
Signaling by NOTCH1	7E-01	1.03E-01	0.000	CCNC,CDK8,CUL1,FBXW7,HDAC4,HDAC7,ITCH,SKP1	
RHO GTPases regulate CFTR trafficking	6.96E-01	3.33E-01	NaN	RHOQ	
Proline catabolism	6.96E-01	3.33E-01	NaN	ALDH4A1	
SUMOylation of nuclear envelope proteins	6.96E-01	3.33E-01	NaN	UBE2I	
NADH Repair	6.96E-01	3.33E-01	NaN	NAXE	
Serine Biosynthesis	6.96E-01	3.33E-01	NaN	PSAT1	
Guanine and Guanosine Salvage I	6.96E-01	3.33E-01	NaN	LACC1	
5-aminoimidazole Ribonucleotide Biosynthesis I	6.96E-01	3.33E-01	NaN	GART	
Coenzyme A Biosynthesis	6.96E-01	3.33E-01	NaN	COASY	
S-methyl-5'-thioadenosine Degradation II	6.96E-01	3.33E-01	NaN	LACC1	
Proline Degradation	6.96E-01	3.33E-01	NaN	ALDH4A1	
Tetrahydrobiopterin Biosynthesis I	6.96E-01	3.33E-01	NaN	GCH1	
L-cysteine Degradation III	6.96E-01	3.33E-01	NaN	GOT1	
Inosine-5'-phosphate Biosynthesis II	6.96E-01	3.33E-01	NaN	PAICS	
Geranylgeranyldiphosphate Biosynthesis	6.96E-01	3.33E-01	NaN	FNTB	
Adenine and Adenosine Salvage I	6.96E-01	3.33E-01	NaN	LACC1	
Tetrahydrobiopterin Biosynthesis II	6.96E-01	3.33E-01	NaN	GCH1	
Formaldehyde Oxidation II (Glutathione-dependent)	6.96E-01	3.33E-01	NaN	AKR1A1	
Glutamate Degradation II	6.96E-01	3.33E-01	NaN	GOT1	
Tyrosine Biosynthesis IV	6.96E-01	3.33E-01	NaN	PCBD1	
N-acetylglucosamine Degradation I	6.96E-01	3.33E-01	NaN	GNPDA1	
Aspartate Biosynthesis	6.96E-01	3.33E-01	NaN	GOT1	
NOD1/2 Signaling Pathway	6.88E-01	8.99E-02	-2.000	CCL2,CHUK,FASLG,HSPA1A/HSPA1B,HSPA6,MAP2K2,MAPK14,MAPK3,NFKB2,NFKBIE,RBCK1,RELA,SLC15A3,TBK1,TGFB2,TRAF3,TRIM27	
Corticotropin Releasing Hormone Signaling	6.82E-01	9.21E-02	-1.387	ADCY3,ATF2,BRAF,CACNB1,CREB3,FASLG,GNAI2,MAP2K2,MAPK14,MAPK3,PRKACA,PRKCI,RAF1,RAP1A	
CDX Gastrointestinal Cancer Signaling Pathway	6.82E-01	8.91E-02	1.213	AKT1,BLM,BRAF,CHUK,CTNNB1,FASLG,JAK3,MAP2K2,MAPK14,MAPK3,NCF1,NFKB2,PIK3R3,PIK3R5,PNN,RELA,STAT3,TGFB2	
Maturity Onset Diabetes of Young (MODY) Signaling	6.8E-01	1.01E-01	NaN	APOA2,APOB,APOH,APOL3,APOL4,CACNB1,NFKB2,OGDH	
TBC/RABGAPs	6.8E-01	1.14E-01	-1.342	RAB5C,RAB7A,RAB8A,TBC1D10B,TBC1D2	
MIF Regulation of Innate Immunity	6.8E-01	1.14E-01	-2.236	MAPK3,MIF,NFKB2,NFKBIE,RELA	
CGAS-STING Signaling Pathway	6.77E-01	9.29E-02	-1.387	ABCC1,ATP6V0E1,ATP6V1B2,BAX,CCL2,CHUK,FASLG,GJA1,GSDMD,NFKB2,RELA,TBK1,TGFB2	
Vitamin D (calciferol) metabolism	6.72E-01	1.67E-01	NaN	SUMO2,UBE2I	
HDR through MMEJ (alt-NHEJ)	6.72E-01	1.67E-01	NaN	LIG3,MRE11	
γ-glutamyl Cycle	6.72E-01	1.67E-01	NaN	CHAC2,GGCT	
Tumor Microenvironment Pathway	6.55E-01	8.94E-02	-2.000	AKT1,BRAF,CCL2,FASLG,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,STAT3,TGFB2,VEGFC	
Pathogen Induced Cytokine Storm Signaling Pathway	6.55E-01	8.36E-02	-3.772	AIM2,C3,CASP7,CASP8,CCL2,CCL4,CRP,CXCL10,CXCL2,CXCL9,FADD,FASLG,FGA,FGG,GSDMD,IL1R1,MAPK14,MAPK3,MLKL,NFKB2,NLRC4,RIPK1,STAT3,STAT5A,STAT5B,SYK,TBK1,TGFB2,TICAM1,TRADD,VEGFC	
GPER1 signaling	6.53E-01	1.11E-01	-1.342	ADCY3,GNAI2,GNB4,PRKACA,SHC1	
Gap junction trafficking and regulation	6.43E-01	1.18E-01	-2.000	CLTB,DNM2,GJA1,TUBA1B	
Nephrin family interactions	6.41E-01	1.3E-01	NaN	ACTN4,CD2AP,WASL	
Differential Regulation of Cytokine Production in Intestinal Epithelial Cells by IL-17A and IL-17F	6.41E-01	1.3E-01	NaN	CCL2,CCL4,LCN2	
Apelin Pancreas Signaling Pathway	6.27E-01	1.09E-01	0.447	NFKB2,PIK3R3,PIK3R5,PRKACA,RELA	
Processing of SMDT1	6.19E-01	1.54E-01	NaN	PHB1,PHB2	
Azathioprine ADME	6.19E-01	1.54E-01	NaN	IMPDH1,TPMT	
Cleavage and Polyadenylation of Pre-mRNA	6.19E-01	1.54E-01	NaN	CPSF3,CSTF3	
Assembly of RNA Polymerase I Complex	6.19E-01	1.54E-01	NaN	POLR1A,POLR2F	
Cholesterol Biosynthesis I	6.19E-01	1.54E-01	NaN	DHCR24,FDFT1	
NAD Phosphorylation and Dephosphorylation	6.19E-01	1.54E-01	NaN	ACP1,NADK	
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	6.19E-01	1.54E-01	NaN	DHCR24,FDFT1	
Guanosine Nucleotides Degradation III	6.19E-01	1.54E-01	NaN	LACC1,NT5C2	
Cholesterol Biosynthesis III (via Desmosterol)	6.19E-01	1.54E-01	NaN	DHCR24,FDFT1	
Nucleotide Excision Repair Pathway	6.13E-01	1.14E-01	NaN	ERCC2,POLR2C,POLR2F,RAD23B	
Response to elevated platelet cytosolic Ca2+	6.13E-01	9.09E-02	-1.155	ACTN4,APOH,FGA,FGG,LGALS3BP,NHLRC2,ORM1,ORM2,STX4,STXBP3,TGFB2,VEGFC	
RAS processing	6.05E-01	1.25E-01	NaN	FNTA,FNTB,NRAS	
Signaling by ERBB4	6E-01	1.02E-01	-0.816	GRB2,ITCH,NRAS,SHC1,STAT5A,WWOX	
Multiple Sclerosis Signaling Pathway	5.99E-01	8.56E-02	-2.065	BAX,BRAF,C1QA,C1QC,C3,CASP8,EZH2,FADD,FASLG,MAPK14,MAPK3,NFKB2,NR1H3,PARP10,PARP14,PARP4,STK38,SUZ12,TGFB2	
2-ketoglutarate Dehydrogenase Complex	5.87E-01	2.5E-01	NaN	OGDH	
Heme Biosynthesis from Uroporphyrinogen-III I	5.87E-01	2.5E-01	NaN	UROD	
Eumelanin Biosynthesis	5.87E-01	2.5E-01	NaN	MIF	
Glutathione Redox Reactions II	5.87E-01	2.5E-01	NaN	PDIA3	
Proline Biosynthesis I	5.87E-01	2.5E-01	NaN	PYCR1	
Oxidized GTP and dGTP Detoxification	5.87E-01	2.5E-01	NaN	RUVBL2	
Rapoport-Luebering Glycolytic Shunt	5.87E-01	2.5E-01	NaN	PGAM1	
L-cysteine Degradation I	5.87E-01	2.5E-01	NaN	GOT1	
N-acetylglucosamine Degradation II	5.87E-01	2.5E-01	NaN	GNPDA1	
Phenylalanine Degradation I (Aerobic)	5.87E-01	2.5E-01	NaN	PCBD1	
Fatty Acid β-oxidation III (Unsaturated, Odd Number)	5.87E-01	2.5E-01	NaN	ECI1	
CCR3 Signaling in Eosinophils	5.85E-01	8.96E-02	-2.333	GNAI2,GNB4,LIMK1,MAP2K2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,PRKCI,RAF1,RAP1A	
Synaptic Long Term Depression	5.81E-01	8.59E-02	-0.775	CACNB1,GNAI2,MAP2K2,MAPK3,NRAS,PDIA3,PLAAT4,PLB1,PLCD3,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RAF1,RAP1A	
Meiotic recombination	5.79E-01	1.04E-01	-0.447	ATM,BLM,CDK4,MLH1,MRE11	
Visual phototransduction	5.79E-01	1E-01	0.000	CAMKMT,DHRS9,FNTA,FNTB,NMT1,RGS9	
Carnitine metabolism	5.72E-01	1.43E-01	NaN	RXRA,SLC25A20	
Regulation of TP53 Activity through Association with Co-factors	5.72E-01	1.43E-01	NaN	AKT1,PHF20	
Glutamate and glutamine metabolism	5.72E-01	1.43E-01	NaN	GLUD1,PYCR1	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	5.72E-01	1.43E-01	NaN	GOT1,HPD	
Cholesterol biosynthesis	5.72E-01	1.2E-01	NaN	DHCR24,FDFT1,FDPS	
Neuroinflammation Signaling Pathway	5.59E-01	8.2E-02	-3.800	AKT1,ATF2,CASP8,CCL2,CHUK,CREB3,CRP,CTNNB1,CXCL10,FASLG,HMOX1,IL1R1,JAK3,MAPK14,MAPK3,NCF1,NFKB2,PIK3R3,PIK3R5,RELA,RIPK1,SYK,TBK1,TGFB2,TICAM1,TRAF3	
Detoxification of Reactive Oxygen Species	5.59E-01	1.08E-01	-1.000	CYCS,NCF1,P4HB,PRDX1	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	5.53E-01	9.3E-02	-2.828	CCL2,CCL4,CXCL10,MX1,NFKB2,OAS1,OAS2,TICAM1	
Signaling by ERBB2	5.35E-01	1E-01	-2.236	AKT1,GRB2,NRAS,RNF41,SHC1	
Netrin-1 signaling	5.35E-01	1E-01	-1.342	CDC42,MAPK14,PITPNA,PTPN11,WASL	
RNA Polymerase I Transcription	5.35E-01	1E-01	-2.236	ERCC2,MAPK3,POLR1A,POLR1H,POLR2F	
NoRC negatively regulates rRNA expression	5.34E-01	1.05E-01	-2.000	BAZ2A,SAP18,SAP30,SAP30L	
Fanconi Anemia Pathway	5.34E-01	1.05E-01	-2.000	CENPX,FANCE,FANCG,WDR48	
Response of EIF2AK1 (HRI) to heme deficiency	5.3E-01	1.33E-01	NaN	ATF5,TRIB3	
Telomere Extension by Telomerase	5.3E-01	1.33E-01	NaN	MRE11,TERF2	
Choline Biosynthesis III	5.3E-01	1.33E-01	NaN	HMOX1,PCYT1A	
Autism Signaling Pathway	5.25E-01	8.12E-02	-1.225	AKT1,ALDH3B1,ALDH4A1,BRAF,CACNB1,CAMKK2,CCL2,CTNNB1,DVL3,EIF4E,EIF4EBP1,FASLG,MAP2K2,MAPK3,MLST8,NRAS,PIK3R3,PIK3R5,PRKACA,RAF1,RAP1A,RPS6KA1,RXRA,SOS2,TGFB2	
Fatty acyl-CoA biosynthesis	5.11E-01	1.11E-01	NaN	ACLY,HACD1,SCD	
Tryptophan Degradation X (Mammalian, via Tryptamine)	5.11E-01	1.11E-01	NaN	AKR1A1,ALDH3B1,ALDH4A1	
NGF-stimulated transcription	5.1E-01	1.03E-01	-1.000	ATF2,DNM2,EGR2,SRF	
Type II Diabetes Mellitus Signaling	5.07E-01	8.5E-02	-3.162	AKT1,CACNB1,CHUK,MAPK3,NFKB2,NFKBIE,NSMAF,PIK3R3,PIK3R5,PRKCI,RELA,SOCS4,TRADD	
Arsenate Detoxification I (Glutaredoxin)	5.05E-01	2E-01	NaN	LACC1	
Proline Biosynthesis II (from Arginine)	5.05E-01	2E-01	NaN	PYCR1	
Pentose Phosphate Pathway (Oxidative Branch)	5.05E-01	2E-01	NaN	PGLS	
Tetrahydrofolate Salvage from 5,10-methenyltetrahydrofolate	5.05E-01	2E-01	NaN	GART	
CMP-N-acetylneuraminate Biosynthesis I (Eukaryotes)	5.05E-01	2E-01	NaN	NANS	
Trans, trans-farnesyl Diphosphate Biosynthesis	5.05E-01	2E-01	NaN	FDPS	
dTMP De Novo Biosynthesis	5.05E-01	2E-01	NaN	SHMT1	
Tyrosine Degradation I	5.05E-01	2E-01	NaN	HPD	
Folate Polyglutamylation	5.05E-01	2E-01	NaN	SHMT1	
Beta-catenin independent WNT signaling	5.02E-01	8.82E-02	-2.121	AP2A2,CLTB,CTNNB1,DVL3,GNB4,MOV10,ROR1,TNRC6A,TNRC6C	
SRP-dependent cotranslational protein targeting to membrane	4.99E-01	8.7E-02	-1.265	RPL22L1,RPL26L1,RPN2,RPS19,RPS27L,SEC11A,SRP19,SRP68,SSR1,SSR3	
Regulation of Actin-based Motility by Rho	4.99E-01	8.7E-02	-1.667	ACTA2,ARPC5L,CDC42,ITGA6,LIMK1,MYL6B,RHOB,RHOQ,RHOT1,WASL	
IL-27 Signaling Pathway	4.97E-01	8.59E-02	-2.111	AKT1,ATG13,IL1R1,JAK3,MAPK14,NFKB2,PIK3R3,PIK3R5,RELA,STAT3,TRIM69	
IL-13 Signaling Pathway	4.86E-01	8.62E-02	-2.530	AKT1,CTNNB1,FGR,HCK,MAPK14,MAPK3,PIK3R3,PIK3R5,STAT3,TGFB2	
Amyotrophic Lateral Sclerosis Signaling	4.86E-01	8.62E-02	-1.414	APAF1,BAX,CACNB1,CASP7,CYCS,NEFH,PIK3R3,PIK3R5,RAB5C,VEGFC	
Macroautophagy	4.85E-01	9.23E-02	-1.633	ATG13,ATG4C,LAMTOR3,MLST8,RB1CC1,RRAGA	
PXR/RXR Activation	4.85E-01	9.23E-02	-0.816	AKT1,PAPSS2,PRKACA,RELA,RXRA,SCD	
Energy dependent regulation of mTOR by LKB1-AMPK	4.57E-01	1.03E-01	NaN	LAMTOR3,MLST8,RRAGA	
Transcriptional regulation of pluripotent stem cells	4.56E-01	1.18E-01	NaN	KLF4,STAT3	
FOXO-mediated transcription of cell cycle genes	4.56E-01	1.18E-01	NaN	GADD45A,KLF4	
Germ layer formation at gastrulation	4.56E-01	1.18E-01	NaN	CTNNB1,TRIM33	
Activin Inhibin Signaling Pathway	4.51E-01	8.06E-02	-1.698	AKT1,ATF2,CEBPA,CHUK,CTNNB1,IL1R1,LIMK1,MAP2K2,MAP2K5,MAPK14,MAPK3,NFKB2,PIK3R3,PIK3R5,SMAD5,STAT3,TGFB2	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	4.44E-01	9.52E-02	-2.000	CHUK,ECSIT,FGA,FGG	
Synthesis of Lipoxins (LX)	4.41E-01	1.67E-01	NaN	ALOX5	
The citric acid (TCA) cycle and respiratory electron transport	4.38E-01	9.09E-02	-2.236	IDH2,OGDH,RXRA,SDHC,SUCLG1	
Amino acids regulate mTORC1	4.38E-01	9.09E-02	-1.342	ATP6V0E1,ATP6V1B2,LAMTOR3,MLST8,RRAGA	
Nitric Oxide Signaling in the Cardiovascular System	4.37E-01	8.33E-02	-2.121	AKT1,ARG2,CACNB1,MAP2K2,MAPK3,PIK3R3,PIK3R5,PRKACA,PRKCI,VEGFC	
Selenoamino acid metabolism	4.36E-01	8.41E-02	-2.333	AHCY,NNMT,PAPSS2,RPL22L1,RPL26L1,RPS19,RPS27L,SARS1,SEPHS2	
Post-translational protein phosphorylation	4.36E-01	8.41E-02	-2.333	APOA2,APOB,C3,DNAJC3,FAM20A,FGA,FGG,LGALS1,P4HB	
Netrin Signaling	4.35E-01	8.09E-02	-2.138	AKT1,ARPC5L,CACNB1,CDC42,GOSR1,MAP2K2,MAPK3,NFKB2,PIK3R3,PIK3R5,PRKACA,PRKCI,WASL,YKT6	
Regulation of TP53 Activity through Acetylation	4.33E-01	1E-01	NaN	AKT1,PIN1,PML	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	4.33E-01	1E-01	NaN	LCLAT1,MBOAT2,PGS1	
Parkinson's Signaling Pathway	4.3E-01	7.82E-02	2.449	ACTA2,ALDH3B1,ALDH4A1,ATP6V0E1,ATP6V1B2,CACNB1,FASLG,MAPK14,NDUFA13,NDUFA2,NDUFA8,NDUFAB1,NDUFB10,NDUFB3,NDUFB7,NDUFB8,NDUFS3,NDUFS7,NDUFS8,NDUFV3,NFKB2,TGFB2,TUBA1B,TUBG1	
Axonal Guidance Signaling	4.25E-01	7.65E-02	NaN	ABL1,ADAM32,ADAMTS9,AKT1,ARHGEF11,ARPC5L,CDC42,COPS5,CRK,EIF4E,FES,GNAI2,GNB4,GRB2,ITGA6,LIMK1,MAP2K2,MAPK3,MKNK1,MYL6B,MYSM1,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,PSMD14,PTPN11,RAF1,RAP1A,RGS3,SHC1,SOS2,TUBA1B,TUBG1,VEGFC,WASL	
Aggrephagy	4.24E-01	9.3E-02	0.000	IFT88,PCNT,TUBA1B,VCP	
RORA activates gene expression	4.24E-01	1.11E-01	NaN	MED1,RXRA	
Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F	4.24E-01	1.11E-01	NaN	CCL2,CCL4	
Agrin Interactions at Neuromuscular Junction	4.2E-01	8.7E-02	0.000	ACTA2,CDC42,GABPB1,MAPK3,NRAS,RAP1A	
Eukaryotic Translation Initiation	4.14E-01	8.2E-02	-1.897	EIF2B1,EIF3I,EIF3J,EIF4E,EIF4EBP1,EIF4G1,RPL22L1,RPL26L1,RPS19,RPS27L	
G-Protein Coupled Receptor Signaling	4.1E-01	7.54E-02	-2.885	ADCY3,ADGRE1,AKT1,APEX1,ATF2,BRAF,C3AR1,CCR4,CDC42,CHUK,CREB3,CRK,CTNNB1,F2RL3,GDE1,GDPD1,GNAI2,GNB4,GPR141,GPR27,GPR4,GRB2,GRK2,KCNH2,LPAR1,MAP2K2,MAP2K5,MAP3K11,MAP3K3,MAPK14,MAPK3,MKNK1,MYL6B,NFKB2,NFKBIE,NRAS,PDE12,PDE4A,PDE4D,PDE7A,PIK3R3,PIK3R5,PREX1,PRKACA,RAF1,RAP1A,RAPGEF3,RELA,RPS6KA1,SHC1,SOS2,SRF,STAT3	
Macrophage Classical Activation Signaling Pathway	4.1E-01	7.94E-02	-0.277	CHUK,CXCL10,CXCL9,EZH2,FASLG,NFKB2,NFKBIE,PARP14,RELA,SDHC,STAT3,STK38,SUZ12,TGFB2,TICAM1	
MyD88 dependent cascade initiated on endosome	4.1E-01	9.68E-02	NaN	CHUK,ECSIT,TICAM1	
Sonic Hedgehog Signaling	4.1E-01	9.68E-02	NaN	DYRK1A,GRK2,PRKACA	
Retinoid metabolism and transport	4.05E-01	9.09E-02	-2.000	APOA2,APOB,PLB1,SDC3	
HOTAIR Regulatory Pathway	4.03E-01	7.98E-02	-1.155	AKT1,ATXN1,CTNNB1,EZH2,H3-3A/H3-3B,NFKB2,PIK3R3,PIK3R5,RELA,SRF,STAT3,STK38,SUZ12	
Sperm Motility	4.03E-01	7.78E-02	-1.667	ABL1,DYRK1A,FES,FGR,GNAI2,GNB4,HCK,JAK3,MAP2K5,MAP3K11,PDE4A,PDE4D,PDIA3,PLAAT4,PLB1,PLCD3,PRKACA,PRKCI,ROR1,SYK	
Interleukin-4 and Interleukin-13 signaling	4E-01	8.18E-02	-0.333	AKT1,ALOX5,CCL2,FASLG,HMOX1,JAK3,LCN2,SAA1,STAT3	
Semaphorin Neuronal Repulsive Signaling Pathway	4E-01	8E-02	0.000	AKT1,FES,ITGA6,LIMK1,MAP2K2,MAP2K5,MYL6B,PDE4A,PDE4D,PIK3R3,PIK3R5,PRKACA	
RHO GTPases activate CIT	3.95E-01	1.05E-01	NaN	PRC1,RHOB	
RHO GTPases Activate ROCKs	3.95E-01	1.05E-01	NaN	LIMK1,RHOB	
Activation of NMDA receptors and postsynaptic events	3.94E-01	8.33E-02	-2.449	CAMKK2,MAPK3,NRAS,PRKACA,RPS6KA1,RPS6KA2,TUBA1B	
Transcriptional Regulatory Network in Embryonic Stem Cells	3.94E-01	7.93E-02	-2.496	AKT1,CTNNB1,JAK3,KLF4,MAP2K2,MAPK3,NRAS,PIK3R3,PIK3R5,RAP1A,SMAD5,STAT3,TGFB2	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	3.93E-01	8.06E-02	-1.897	APOA2,APOB,C3,DNAJC3,FAM20A,FGA,FGG,IGFBP2,LGALS1,P4HB	
Aryl hydrocarbon receptor signalling	3.89E-01	1.43E-01	NaN	AIP	
Trehalose Degradation II (Trehalase)	3.89E-01	1.43E-01	NaN	HK3	
Phosphatidylcholine Biosynthesis I	3.89E-01	1.43E-01	NaN	PCYT1A	
Ceramide Degradation	3.89E-01	1.43E-01	NaN	ASAH1	
Glycoaminoglycan-protein Linkage Region Biosynthesis	3.89E-01	1.43E-01	NaN	B3GAT1	
MSP-RON Signaling Pathway	3.89E-01	8.62E-02	NaN	ACTA2,CCL2,PIK3R3,PIK3R5,RPS6KA2	
Thrombin signalling through proteinase activated receptors (PARs)	3.88E-01	9.38E-02	NaN	F2RL3,GNB4,MAPK3	
RHOGDI Signaling	3.76E-01	7.73E-02	2.138	ACTA2,ARHGAP1,ARHGAP5,ARHGAP9,ARHGEF11,ARHGEF2,ARPC5L,CDC42,GNAI2,GNB4,ITGA6,LIMK1,MYL6B,RHOB,RHOQ,RHOT1,WASL	
Glycerophospholipid biosynthesis	3.73E-01	8.08E-02	0.000	CSNK2A2,CSNK2B,LCLAT1,MBOAT2,OSBPL5,PCYT2,PITPNB,SELENOI	
Synthesis, secretion, and deacylation of Ghrelin	3.68E-01	1E-01	NaN	KLF4,SEC11A	
Interleukin-12 family signaling	3.68E-01	1E-01	NaN	P4HB,STAT3	
Valine Degradation I	3.68E-01	1E-01	NaN	BCAT1,ECHS1	
Signal amplification	3.68E-01	9.09E-02	NaN	GNAI2,GNB4,MAPK14	
Airway Inflammation in Asthma	3.68E-01	9.09E-02	NaN	CCL2,RNASE3,TGFB2	
ROBO SLIT Signaling Pathway	3.62E-01	7.87E-02	0.632	ABL1,AKT1,ARPC5L,CDC42,CTNNB1,FGR,HCK,PRKACA,VEGFC,WASL	
Osteoarthritis Pathway	3.58E-01	7.63E-02	-1.500	ATF2,CASP10,CASP5,CASP7,CASP8,CHUK,CREB3,CTNNB1,FADD,GREM1,HDAC4,IL1R1,ITGA6,NFKB2,RELA,SMAD5,SP1,VEGFC	
Xenobiotic Metabolism AHR Signaling Pathway	3.57E-01	8.05E-02	-0.378	AIP,ALDH3B1,ALDH4A1,HDAC4,NFKB2,RELA,SENP1	
Hepatic Cholestasis	3.54E-01	7.62E-02	-0.728	ABCC1,ADCY3,AKT1,CHUK,FASLG,IL1R1,MAP2K2,MAPK3,NFKB2,NFKBIE,NR1H2,NR1H3,PRKACA,PRKCI,RELA,RXRA,TGFB2	
TR/RXR Activation	3.52E-01	7.81E-02	-1.897	AKT1,ENO1,FGA,H3-3A/H3-3B,MED1,PIK3R3,PIK3R5,RPS6KB2,RXRA,VEGFC	
Neuropathic Pain Signaling in Dorsal Horn Neurons	3.51E-01	7.92E-02	-2.121	KCNH2,MAPK3,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI	
Late endosomal microautophagy	3.48E-01	8.82E-02	NaN	IFT88,MVB12A,PCNT	
Fatty Acid β-oxidation I	3.48E-01	8.82E-02	NaN	ACAA1,ECHS1,ECI1	
rRNA modification in the mitochondrion	3.46E-01	1.25E-01	NaN	MTERF4	
Histidine catabolism	3.46E-01	1.25E-01	NaN	HAL	
Histidine Degradation III	3.46E-01	1.25E-01	NaN	HAL	
Inositol Pyrophosphates Biosynthesis	3.46E-01	1.25E-01	NaN	PPIP5K2	
NCAM signaling for neurite out-growth	3.45E-01	8.2E-02	-0.447	CACNB1,GRB2,MAPK3,NRAS,RPS6KA5	
Kinesins	3.45E-01	8.2E-02	-1.342	KIF1C,KIF20B,KIF23,KIF2C,TUBA1B	
eNOS Signaling	3.45E-01	7.69E-02	-0.577	ADCY3,AKT1,CASP8,DNM2,HSPA1A/HSPA1B,HSPA6,LPAR1,PIK3R3,PIK3R5,PRKACA,PRKCI,VEGFC	
Orexin Signaling Pathway	3.44E-01	7.56E-02	-1.414	ADCY3,AKT1,ATP6V0E1,ATP6V1B2,CACNB1,GNB4,MAPK14,MAPK3,MLST8,NFKB2,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,PTPN11,SMAD5	
Histamine Degradation	3.43E-01	9.52E-02	NaN	ALDH3B1,ALDH4A1	
Fatty Acid α-oxidation	3.43E-01	9.52E-02	NaN	ALDH3B1,ALDH4A1	
Endoplasmic Reticulum Stress Pathway	3.43E-01	9.52E-02	NaN	CASP7,DNAJC3	
Wound Healing Signaling Pathway	3.42E-01	7.54E-02	-1.606	ACTA2,CHUK,FASLG,GRB2,IL1R1,ITGA6,MAP2K2,MAP2K5,MAPK3,NFKB2,NFKBIE,NRAS,RAF1,RAP1A,SHC1,SOS2,TGFB2,TRADD,VEGFC	
PRC2 methylates histones and DNA	3.3E-01	8.57E-02	NaN	EZH2,PHF19,SUZ12	
Coagulation System	3.3E-01	8.57E-02	NaN	FGA,FGG,TFPI	
Pre-NOTCH Expression and Processing	3.27E-01	7.89E-02	NaN	MOV10,PRKCI,TFDP1,TMED2,TNRC6A,TNRC6C	
Nonhomologous End-Joining (NHEJ)	3.23E-01	8.16E-02	1.000	ABRAXAS1,ATM,KAT5,MRE11	
Interconversion of nucleotide di- and triphosphates	3.2E-01	9.09E-02	NaN	AK2,AK9	
Chaperone Mediated Autophagy	3.2E-01	9.09E-02	NaN	IFT88,PCNT	
Putrescine Degradation III	3.2E-01	9.09E-02	NaN	ALDH3B1,ALDH4A1	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	3.19E-01	7.46E-02	NaN	AKT1,CHUK,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,IL1R1,MAPK14,MAPK3,NFKBIE,PIK3R3,PIK3R5,RELA,SMAD5,TNFRSF11A,TRADD	
Transcriptional Regulation by MECP2	3.18E-01	7.94E-02	NaN	FKBP5,MOV10,PRKACA,TNRC6A,TNRC6C	
IL-17 Signaling	3.16E-01	7.49E-02	-1.069	AKT1,ATF2,CCL2,FASLG,LCN2,MAPK14,MAPK3,NRAS,PIK3R3,PIK3R5,RAP1A,RELA,TGFB2,VEGFC	
Factors involved in megakaryocyte development and platelet production	3.12E-01	7.69E-02	-0.378	ABL1,AK3,CABLES2,CAPZA2,CDC42,MAFK,PRKACA	
RHO GTPases Activate Rhotekin and Rhophilins	3.1E-01	1.11E-01	NaN	RHOB	
Lysine catabolism	3.1E-01	1.11E-01	NaN	OGDH	
Sphingosine and Sphingosine-1-phosphate Metabolism	3.1E-01	1.11E-01	NaN	ASAH1	
Sucrose Degradation V (Mammalian)	3.1E-01	1.11E-01	NaN	TPI1	
Heme Biosynthesis II	3.1E-01	1.11E-01	NaN	UROD	
Atherosclerosis Signaling	3.07E-01	7.52E-02	-3.162	ALOX5,APOA2,APOB,CCL2,NFKB2,ORM1,ORM2,PLAAT4,PLB1,RELA	
HEY1 Signaling Pathway	3.04E-01	7.45E-02	-1.155	AKT1,BAX,E2F2,E2F4,E2F8,GRB2,PIK3R3,PIK3R5,SMAD5,SRF,TGFB2,VEGFC	
Role of WNT/GSK-3β Signaling in the Pathogenesis of Influenza	3.04E-01	7.69E-02	NaN	CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,DVL3	
Toll-like Receptor Signaling	3.04E-01	7.69E-02	-2.000	CHUK,ECSIT,MAPK14,NFKB2,RELA,TICAM1	
tRNA processing in the mitochondrion	2.99E-01	8.7E-02	NaN	MT-TG,TRNT1	
Apelin Cardiac Fibroblast Signaling Pathway	2.99E-01	8.7E-02	NaN	AKT1,TGFB2	
Breast Cancer Regulation by Stathmin1	2.89E-01	7.24E-02	-1.852	ADGRE1,ARHGEF11,ARHGEF2,ATF2,C3AR1,CCR4,CDK4,CREB3,E2F2,E2F4,E2F8,F2RL3,GNB4,GPR141,GPR27,GPR4,GRB2,LPAR1,MAP2K2,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R5D,PPP2R5E,PRKACA,PRKCI,RAF1,RAP1A,RB1CC1,SHC1,SOS2,STAT3,TGFB2,TUBA1B,TUBG1,VEGFC	
B-WICH complex positively regulates rRNA expression	2.82E-01	7.69E-02	-2.000	BAZ1B,POLR1A,POLR1H,POLR2F	
Dilated Cardiomyopathy Signaling Pathway	2.82E-01	7.33E-02	0.333	ACTA2,ADCY3,AKT1,BAX,CACNB1,MAP3K3,MAPK14,MAPK3,MYL6B,PRKACA,PTPN11	
Interleukin-6 family signaling	2.8E-01	8.33E-02	NaN	PTPN11,STAT3	
Glycogen metabolism	2.8E-01	8.33E-02	NaN	GYS1,UGP2	
ATF6 (ATF6-alpha) activates chaperone genes	2.78E-01	1E-01	NaN	NFYC	
Ketone body metabolism	2.78E-01	1E-01	NaN	ACAT1	
mRNA Editing	2.78E-01	1E-01	NaN	ADAR	
Citrulline Biosynthesis	2.78E-01	1E-01	NaN	ARG2	
Ketolysis	2.78E-01	1E-01	NaN	ACAT1	
Signaling by TGF-beta Receptor Complex	2.69E-01	7.55E-02	2.000	FKBP1A,LTBP3,TGFB2,XPO1	
Formation of Fibrin Clot (Clotting Cascade)	2.67E-01	7.69E-02	NaN	FGA,FGG,TFPI	
Antigen Presentation Pathway	2.67E-01	7.69E-02	NaN	PDIA3,PSMB5,TAP1	
Incretin synthesis, secretion, and inactivation	2.62E-01	8E-02	NaN	CTNNB1,SEC11A	
MyD88 cascade initiated on plasma membrane	2.62E-01	8E-02	NaN	CHUK,ECSIT	
Ethanol Degradation IV	2.62E-01	8E-02	NaN	ALDH3B1,ALDH4A1	
RHO GTPases activate KTN1	2.51E-01	9.09E-02	NaN	CDC42	
Aspartate and asparagine metabolism	2.51E-01	9.09E-02	NaN	GOT1	
Pexophagy	2.51E-01	9.09E-02	NaN	ATM	
Ketogenesis	2.51E-01	9.09E-02	NaN	ACAT1	
Oleate Biosynthesis II (Animals)	2.51E-01	9.09E-02	NaN	SCD	
Pentose Phosphate Pathway	2.51E-01	9.09E-02	NaN	PGLS	
Glycogen Degradation II	2.51E-01	9.09E-02	NaN	TYMP	
Dolichyl-diphosphooligosaccharide Biosynthesis	2.51E-01	9.09E-02	NaN	ALG8	
GDP-glucose Biosynthesis	2.51E-01	9.09E-02	NaN	HK3	
Glycine Betaine Degradation	2.51E-01	9.09E-02	NaN	SHMT1	
Phospholipases	2.5E-01	7.25E-02	-1.342	HMOX1,PDIA3,PLAAT4,PLB1,PLCD3	
Signaling by BMP	2.45E-01	7.69E-02	NaN	SMAD5,ZFYVE16	
D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis	2.45E-01	7.69E-02	NaN	PI4K2B,PLCD3	
Syndecan interactions	2.29E-01	7.41E-02	NaN	ITGA6,SDC3	
Cardiomyocyte Differentiation via BMP Receptors	2.29E-01	7.41E-02	NaN	ATF2,SMAD5	
NAD Salvage Pathway II	2.29E-01	7.41E-02	NaN	ACP1,NT5C2	
Presynaptic depolarization and calcium channel opening	2.27E-01	8.33E-02	NaN	CACNB1	
GP1b-IX-V activation signalling	2.27E-01	8.33E-02	NaN	RAF1	
Hematopoiesis from Multipotent Stem Cells	2.27E-01	8.33E-02	NaN	KITLG	
Glucose and Glucose-1-phosphate Degradation	2.27E-01	8.33E-02	NaN	HK3	
Mitochondrial iron-sulfur cluster biogenesis	2.06E-01	7.69E-02	NaN	FDXR	
Metabolism of folate and pterines	2.06E-01	7.69E-02	NaN	SHMT1	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	2.06E-01	7.69E-02	NaN	STAT3	
Dissolution of Fibrin Clot	2.06E-01	7.69E-02	NaN	SERPINB8	
Glycogen Degradation III	2.06E-01	7.69E-02	NaN	TYMP	
Neurovascular Coupling Signaling Pathway	-0E00	2.16E-02	-2.236	CACNB1,GJA1,PLAAT4,PLB1,PRKACA	
Oxytocin in Spinal Neurons Signaling Pathway	-0E00	2.86E-02	NaN	CAMKK2	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	-0E00	6.97E-02	-0.243	AKT1,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,CTNNB1,FASLG,JAK3,MAPK3,PIK3R3,PIK3R5,SMAD5,STAT3,STAT5A,STAT5B,TGFB2,VEGFC	
S100 Family Signaling Pathway	-0E00	5.57E-02	-1.982	ABCC1,ADGRE1,AKT1,ATF2,ATP5F1A,ATP5F1E,ATP5PO,BRAF,C3AR1,CACNB1,CASP7,CCL4,CCR4,CHUK,COPS5,CREB3,CTNNB1,F2RL3,GPR141,GPR27,GPR4,LPAR1,MAP2K2,MAP2K5,MAPK14,MAPK3,NCF1,NFKB2,PDIA3,PIK3R3,PIK3R5,PLCD3,PRKACA,PRKCI,RAF1,SMAD5,SP1,STAT3,STK38,TBK1,TGFB2,TRAF3,VEGFC	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	3.94E-02	1.800	AKT1,ATP6V0E1,ATP6V1B2,CHUK,FCER1G,HSPA1A/HSPA1B,HSPA6,IDH2,ITCH,MAPK14,MARCHF5,MLST8,NFKB2,PEA15,PIK3R3,PIK3R5,PSMA5,PSMB10,PSMB4,PSMB5,RCAN1,RELA,TBK1,TPT1,TRBV7-4	
ABRA Signaling Pathway	-0E00	6.52E-02	0.000	ACTA2,ESRRA,LIMK1,PPP1R14A,SRF,VEGFC	
Adrenergic Receptor Signaling Pathway (Enhanced)	-0E00	5.5E-02	-0.302	ADCY3,ATP6V0E1,ATP6V1B2,CACNB1,FASLG,GNAI2,PDIA3,PLCD3,PRKACA,PRKCI,TGFB2	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	5.04E-02	-1.890	ADCY3,CACNB1,GLUD1,GNAI2,GNB4,GOT1,PRKACA	
ISGylation Signaling Pathway	-0E00	2.78E-02	NaN	NFKB2,TBK1,TRIM25	
NFKBIE Signaling Pathway	-0E00	2.67E-02	-1.155	CHUK,FASLG,FCER1G,MAP3K3,NFKB2,NFKBIE,PPP6C,PPP6R3,RELA,RIPK1,TRADD,TRBV7-4	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	4.28E-02	0.378	ABCG1,ALDH3B1,ALDH4A1,ECSIT,HS2ST1,IL1R1,NR1H2,NR1H3,PAPSS2,RXRA,XPO1	
PI3K Cascade	-0E00	6.82E-02	NaN	GRB2,PTPN11,TRIB3	
G alpha (i) signalling events	-0E00	5.43E-02	-1.604	ADCY3,C3,C3AR1,CCL4,CCR4,CXCL10,CXCL2,CXCL9,GNAI2,GNB4,LPAR1,RGS3,RGS9,SAA1	
Effects of PIP2 hydrolysis	-0E00	3.7E-02	NaN	DGKE	
Signaling by NODAL	-0E00	4.35E-02	NaN	MAPK3	
Meiotic synapsis	-0E00	5.45E-02	NaN	SYNE1,TERF2,UBE2I	
Potassium Channels	-0E00	2.91E-02	NaN	GNB4,KCNAB2,KCNH2	
Degradation of the extracellular matrix	-0E00	1.52E-02	NaN	ADAMTS9	
Extracellular matrix organization	-0E00	1.89E-02	NaN	ITGA6,TGFB2	
Antimicrobial peptides	-0E00	5.88E-02	NaN	LCN2,RNASE3	
Signaling by Activin	-0E00	5.88E-02	NaN	MAPK3	
Elastic fibre formation	-0E00	4.55E-02	NaN	LTBP3,TGFB2	
Eukaryotic Translation Elongation	-0E00	4.21E-02	-2.000	RPL22L1,RPL26L1,RPS19,RPS27L	
Glycosaminoglycan metabolism	-0E00	6.25E-02	-0.447	B3GAT1,B4GALT2,PAPSS2,SDC3,SLC35D2	
Collagen biosynthesis and modifying enzymes	-0E00	2.99E-02	NaN	CRTAP,P4HB	
Toll-like Receptor Cascades	-0E00	6.45E-02	NaN	DNM2,EEA1	
Complement cascade	-0E00	5.19E-02	-2.449	C1QA,C1QC,C1S,C3,C3AR1,CRP,IGKV3-20	
Regulation of beta-cell development	-0E00	2.38E-02	NaN	AKT1	
Bile acid and bile salt metabolism	-0E00	6.45E-02	NaN	OSBP,RXRA	
Metabolism of steroid hormones	-0E00	2.86E-02	NaN	FDXR	
Metabolism of water-soluble vitamins and cofactors	-0E00	6.78E-02	0.000	COASY,LMBRD1,MCCC1,PDXK	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	3.96E-02	-2.121	C3,CD300A,HCST,IGKV3-20,LILRB4,MICB,NPDC1,SLAMF7	
Assembly of collagen fibrils and other multimeric structures	-0E00	1.64E-02	NaN	ITGA6	
Cell surface interactions at the vascular wall	-0E00	5.69E-02	-1.732	APOB,FCER1G,GRB14,GRB2,IGKV3-20,ITGA6,MIF,NRAS,PTPN11,PTPN6,SDC3,SHC1	
Generic Transcription Pathway	-0E00	4.21E-02	-0.943	CCNC,CDK8,ESRRA,HDAC4,HDAC7,MED1,MED13,NR1H2,NR1H3,NR4A3,RXRA,ZKSCAN1,ZNF154,ZNF2,ZNF213,ZNF566,ZNF607,ZNF737	
Phase I - Functionalization of compounds	-0E00	3.92E-02	-2.000	ADH1B,CYB5B,FDXR,RXRA	
Arachidonic acid metabolism	-0E00	6.67E-02	NaN	ABCC1,ALOX5,EPHX2	
Integrin cell surface interactions	-0E00	3.53E-02	NaN	FGA,FGG,ITGA6	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	-0E00	6.67E-02	NaN	CBR1	
Binding and Uptake of Ligands by Scavenger Receptors	-0E00	3.57E-02	-2.000	APOB,HSPH1,IGKV3-20,SAA1	
EPH-Ephrin signaling	-0E00	6.38E-02	-0.816	AP2A2,CDC42,CLTB,LIMK1,VAV3,WASL	
WNT ligand biogenesis and trafficking	-0E00	3.85E-02	NaN	VPS35	
Class A/1 (Rhodopsin-like receptors)	-0E00	3.79E-02	-1.732	C3,C3AR1,CCL2,CCL4,CCR4,CXCL10,CXCL2,CXCL9,F2RL3,GPR4,LPAR1,SAA1	
Class B/2 (Secretin family receptors)	-0E00	2.08E-02	NaN	ADGRE1,GNB4	
Semaphorin interactions	-0E00	6.25E-02	-2.000	ARHGEF11,FES,LIMK1,RHOB	
Unfolded Protein Response (UPR)	-0E00	5.56E-02	NaN	CREB3	
Olfactory Signaling Pathway	-0E00	2.7E-02	NaN	ADCY3,OR2W3	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	-0E00	3.12E-02	NaN	AP2A2	
G alpha (q) signalling events	-0E00	4.6E-02	-1.414	F2RL3,GNB4,GPR4,GRK2,LPAR1,PIK3R3,RGS3,SAA1	
G alpha (s) signalling events	-0E00	5.52E-02	-0.707	ADCY3,GNAI2,GNB4,GPR27,GRK2,PDE4A,PDE4D,PDE7A	
G alpha (z) signalling events	-0E00	6.25E-02	NaN	ADCY3,GNAI2,GNB4	
Transport of bile salts and organic acids, metal ions and amine compounds	-0E00	3.61E-02	NaN	SLC16A7,SLC22A4,SLC30A5	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	1.92E-02	NaN	SLC15A3,SLC17A5	
Transport of vitamins, nucleosides, and related molecules	-0E00	2.44E-02	NaN	SLC35D2	
Sphingolipid metabolism	-0E00	4.6E-02	-1.000	ALDH3B1,KDSR,OSBP,SPTSSA	
Vasopressin regulates renal water homeostasis via Aquaporins	-0E00	6.98E-02	NaN	ADCY3,GNB4,PRKACA	
Smooth Muscle Contraction	-0E00	4.65E-02	NaN	ACTA2,MYL6B	
Cell junction organization	-0E00	4.35E-02	-1.000	CTNNB1,ITGA6,PRKCI,TESK1	
Other interleukin signaling	-0E00	4.17E-02	NaN	STX4	
Activation of kainate receptors upon glutamate binding	-0E00	3.33E-02	NaN	GNB4	
O-linked glycosylation	-0E00	2.7E-02	NaN	ADAMTS9,C1GALT1,GALNT3	
Miscellaneous transport and binding events	-0E00	3.85E-02	NaN	MRS2	
Signaling by Retinoic Acid	-0E00	4.55E-02	NaN	DHRS9,RXRA	
Cardiac conduction	-0E00	4.62E-02	1.000	AHCYL1,AKAP9,CACNB1,KCNH2,PRKACA,SCN1B	
Activated PKN1 stimulates transcription of AR regulated genes KLK2 and KLK3	-0E00	3.57E-02	NaN	PKN1	
TNFs bind their physiological receptors	-0E00	3.45E-02	NaN	FASLG	
Surfactant metabolism	-0E00	4.35E-02	NaN	CCDC59	
rRNA processing	-0E00	3.12E-02	NaN	MT-TG	
Neurexins and neuroligins	-0E00	5.26E-02	NaN	APBA2,DLGAP4,HOMER3	
Keratinization	-0E00	4.67E-03	NaN	KRT23	
Mitotic Telophase/Cytokinesis	-0E00	6.67E-02	NaN	KIF23	
Eukaryotic Translation Termination	-0E00	5.32E-02	-2.236	RPL22L1,RPL26L1,RPS19,RPS27L,TRMT112	
Platelet Adhesion to exposed collagen	-0E00	6.67E-02	NaN	FCER1G	
Carboxyterminal post-translational modifications of tubulin	-0E00	6.67E-02	NaN	AGBL3,TTL,TUBA1B	
Triglyceride metabolism	-0E00	2.94E-02	NaN	PRKACA	
Signaling by NOTCH3	-0E00	2E-02	NaN	WWP2	
Peroxisomal protein import	-0E00	6.35E-02	0.000	ACAA1,AGPS,EPHX2,UBE2D2	
Class I peroxisomal membrane protein import	-0E00	5E-02	NaN	PXMP2	
Assembly and cell surface presentation of NMDA receptors	-0E00	2.33E-02	NaN	TUBA1B	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	-0E00	6.9E-02	NaN	EGR2,SMARCA4	
Response of EIF2AK4 (GCN2) to amino acid deficiency	-0E00	5.83E-02	-1.633	ATF2,RPL22L1,RPL26L1,RPS19,RPS27L,TRIB3	
Sensory processing of sound by inner hair cells of the cochlea	-0E00	5.8E-02	-1.000	CAPZA2,CLIC5,TPRN,TRIOBP	
Sensory processing of sound by outer hair cells of the cochlea	-0E00	5.45E-02	NaN	CLIC5,TPRN,TRIOBP	
Sensory perception of taste	-0E00	2.13E-02	NaN	SCN1B	
Expression and translocation of olfactory receptors	-0E00	2.51E-03	NaN	OR2W3	
Amyloid fiber formation	-0E00	2.74E-02	NaN	FGA,SAA1	
GABA receptor activation	-0E00	5E-02	NaN	ADCY3,GNAI2,GNB4	
Formation of paraxial mesoderm	-0E00	4.35E-02	NaN	CTNNB1	
Formation of axial mesoderm	-0E00	7.14E-02	NaN	CTNNB1	
Ion channel transport	-0E00	3.83E-02	-1.134	ATP6V0E1,ATP6V1B2,C8orf44-SGK3/SGK3,MLKL,RAF1,RIPK1,TRPM7	
Formation of definitive endoderm	-0E00	5.56E-02	NaN	CTNNB1	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	-0E00	5.67E-02	NaN	ACTA2,BAX,CCL2,CXCL9,FASLG,IL1R1,MYL6B,NFKB2,RELA,TGFB2,VEGFC	
FXR/RXR Activation	-0E00	5.35E-02	1.265	AKT1,APOB,CASP8,FASLG,HMOX1,NFKB2,NR1H3,RXRA,TGFB2,TXNIP	
BBSome Signaling Pathway	-0E00	5.73E-02	-0.200	ADGRE1,C3AR1,CCDC66,CCR4,CCT6A,CCT7,CCT8,CUL3,DVL3,EZH2,F2RL3,GPR141,GPR27,GPR4,IFT57,IFT74,IFT80,IFT88,LPAR1,MAPK14,PCGF6,PHF19,PJA2,PRKACA,RAB5C,RAB8A,STAT3,TCP1	
WNT/SHH Axonal Guidance Signaling Pathway	-0E00	6.04E-02	-1.667	ADCY3,CTNNB1,FGR,HCK,PIK3R3,PIK3R5,PRKACA,PRKCI,YWHAG	
Role of NFAT in Regulation of the Immune Response	-0E00	3.38E-02	-1.961	AKT1,ATF2,CHUK,CSNK1A1,CSNK1D,CSNK1G1,CSNK1G3,FCER1G,GNAI2,GNB4,GRB2,GSK3A,IGKV3-20,IPO5,KPNA3,KPNA5,KPNB1,LAT,LCP2,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RCAN1,RCAN3,RELA,SOS2,SYK,TRBV7-4,XPO1	
FcγRIIB Signaling in B Lymphocytes	-0E00	1.88E-02	-2.121	AKT1,CACNB1,GRB2,IGKV3-20,NRAS,PIK3R3,PIK3R5,RAP1A,SHC1,SYK	
CCR5 Signaling in Macrophages	-0E00	1.8E-02	-2.000	CACNB1,CCL4,FASLG,FCER1G,GNAI2,GNB4,MAPK14,PRKCI,TRBV7-4	
Calcium-induced T Lymphocyte Apoptosis	-0E00	6.52E-03	NaN	FCER1G,PRKCI,TRBV7-4	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	2.12E-02	-1.134	APAF1,CASP7,CASP8,CYC1,CYCS,FADD,FASLG,FCER1G,TRBV7-4	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	5.08E-02	NaN	CCL2,FASLG,LCN2,ORM1,ORM2,TGFB2	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	4.77E-02	0.378	AKT1,AP1M1,AP2A2,CLTB,FCER1G,FGR,GRB2,GSK3A,HCK,HMOX1,LAT,LCP2,MAPK14,MAPK3,NFKB2,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PTPN11,RAP1A,TGFB2,TRBV7-4,VAV1,VAV3	
T Helper Cell Differentiation	-0E00	6.37E-03	NaN	FCER1G,STAT3,TRBV7-4	
CD28 Signaling in T Helper Cells	-0E00	3.68E-02	-2.000	AKT1,ARPC5L,CDC42,CHUK,FCER1G,GRB2,LAT,LCP2,MAP2K2,NFKB2,NFKBIE,PIK3R3,PIK3R5,PTPN11,PTPN6,RELA,SYK,TRBV7-4,VAV1	
IL-15 Signaling	-0E00	3.8E-02	-3.900	AKT1,IGKV3-20,JAK3,MAP2K2,MAPK14,MAPK3,MLST8,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RELA,RPS6KB2,SHC1,STAT3,STAT5A,STAT5B,SYK	
Dendritic Cell Maturation	-0E00	2.52E-02	-2.496	AKT1,ATF2,CHUK,CREB3,FCER1G,MAPK14,MAPK3,NFKB2,NFKBIE,PDIA3,PIK3R3,PIK3R5,PLCD3,RELA,TRBV7-4	
Cellular Effects of Sildenafil (Viagra)	-0E00	5.67E-02	-1.761	ACTA2,ADCY3,ADGRE1,AKT1,ATF2,C3AR1,CACNB1,CASP8,CCR4,CREB3,CRP,F2RL3,FADD,FASLG,GNAI2,GNB4,GPR141,GPR27,GPR4,KCNH2,LPAR1,MAPK14,MAPK3,MYL6B,NFKB2,PIK3R3,PIK3R5,PPP1R10,PPP1R14A,PPP1R14B,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKACA,SMAD5,TGFB2,VEGFC	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	5.88E-02	-0.333	ATF2,CREB3,CTNNB1,MAPK14,PDIA3,PLCD3,PRKCI,SMAD5,TGFB2	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	2.76E-02	-2.714	AKT1,CHUK,FCER1G,GRB2,LAT,LCP2,NFKB2,NFKBIE,PIK3R3,PIK3R5,RELA,SHC1,TRBV7-4,VAV1	
Lipid Antigen Presentation by CD1	-0E00	9.64E-03	1.000	AP2A2,FCER1G,PDIA3,TRBV7-4	
CREB Signaling in Neurons	-0E00	5.6E-02	-1.095	ADCY3,ADGRE1,AKT1,ATF2,C3AR1,CACNB1,CCR4,CREB3,F2RL3,GNAI2,GNB4,GPR141,GPR27,GPR4,GRB2,LPAR1,MAP2K2,MAPK3,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,POLR2C,POLR2F,PRKACA,PRKCI,RAF1,RAP1A,RPS6KA1,SHC1,SOS2,TGFB2,TNFRSF11A	
Type I Diabetes Mellitus Signaling	-0E00	3.73E-02	-2.500	APAF1,CASP8,CHUK,CYC1,CYCS,FADD,FASLG,FCER1G,HSPD1,IL1R1,MAPK14,NFKB2,NFKBIE,PIAS1,RELA,RIPK1,SOCS4,TRADD,TRBV7-4	
Basal Cell Carcinoma Signaling	-0E00	2.78E-02	NaN	CTNNB1,DVL3	
Primary Immunodeficiency Signaling	-0E00	6.56E-02	NaN	ADA,JAK3,RFXANK,TAP1	
Allograft Rejection Signaling	-0E00	6.15E-03	NaN	FASLG,FCER1G,TRBV7-4	
Autoimmune Thyroid Disease Signaling	-0E00	6.54E-03	NaN	FASLG,FCER1G,TRBV7-4	
Graft-versus-Host Disease Signaling	-0E00	6.73E-03	NaN	FASLG,FCER1G,TRBV7-4	
p70S6K Signaling	-0E00	4.15E-02	-1.342	AKT1,F2RL3,GNAI2,GRB2,IGKV3-20,MAP2K2,MAPK3,NRAS,PDIA3,PIK3R3,PIK3R5,PLCD3,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PRKCI,RAF1,RAP1A,SHC1,SOS2,SYK,YWHAG	
G Protein Signaling Mediated by Tubby	-0E00	2.14E-02	-0.632	ABL1,FCER1G,GNAI2,GNB4,GRB2,LAT,LCP2,TRBV7-4,VAV1,VAV3	
Communication between Innate and Adaptive Immune Cells	-0E00	5.36E-03	NaN	CCL4,CXCL10,FCER1G,IGKV3-20,TRBV7-4	
Crosstalk between Dendritic Cells and Natural Killer Cells	-0E00	5.49E-02	-2.000	ACTA2,FASLG,MICB,NFKB2,RELA	
Systemic Lupus Erythematosus Signaling	-0E00	2.63E-02	NaN	AKT1,CD2BP2,CREM,FCER1G,GRB2,IGKV3-20,LAT,LSM4,LSM5,LSM7,MAPK3,NRAS,PIK3R3,PIK3R5,PRPF4,PTPN6,RAP1A,RNU4-1,SART1,SF3B4,SNRNP48,SNRPB,SNRPD2,SNRPE,SNRPN,SOS2,TRBV7-4,TXNL4A	
CDC42 Signaling	-0E00	3.47E-02	-1.387	ARPC5L,ATF2,CDC42,CLIP1,EXOC3,EXOC6B,EXOC7,EXOC8,FCER1G,IQGAP3,ITGA6,LIMK1,MAP3K11,MAPK14,MYL6B,PRKCI,RAF1,TRBV7-4,VAV1,WASL	
FAK Signaling	-0E00	3.77E-02	-1.121	ADGRE1,AKT1,ARPC5L,C3AR1,CCR4,CRK,CTNNB1,ELF2,F2RL3,FCER1G,GIT2,GPR141,GPR27,GPR4,GRB2,GSK3A,IL1R1,ITGA6,LPAR1,MAP2K2,MAP2K5,MAPK14,MAPK3,NEDD9,NFKB2,NRAS,PIK3R3,PIK3R5,RAF1,RAP1A,RB1CC1,SH3GL1,SOCS4,SOS2,SP1,TGFB2,TRBV7-4,USF1,WASL	
Phospholipase C Signaling	-0E00	3.12E-02	-2.502	ADCY3,ARHGEF11,ARHGEF2,ATF2,CDC42,CREB3,FCER1G,GNB4,GRB2,HDAC4,HDAC7,HMOX1,IGKV3-20,ITGA6,LAT,LCP2,MAP2K2,MAPK3,MYL6B,NFKB2,NRAS,PLCD3,PPP1R14A,PRKCI,RAF1,RAP1A,RAPGEF3,RELA,RHOB,RHOQ,RHOT1,SHC1,SOS2,SYK,TRBV7-4	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	8.53E-03	NaN	CHUK,FASLG,FCER1G,IGKV3-20,NFKB2,RELA,TRAF3,TRBV7-4	
B Cell Development	-0E00	2.05E-03	NaN	IGKV3-20	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00	1.64E-02	NaN	PRKACA,PRSS57	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	3.68E-02	-1.213	CHUK,FCER1G,GRB2,LAT,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,RAF1,RAP1A,RELA,SOS2,TGFB2,TRBV7-4,VAV1,VAV3	
NUR77 Signaling in T Lymphocytes	-0E00	2.53E-02	-0.577	APAF1,CYCS,ESRRA,FASLG,FCER1G,HDAC7,MAP2K2,MAP2K5,MAP3K3,MAPK3,PRKCI,RXRA,TRBV7-4	
PKCθ Signaling in T Lymphocytes	-0E00	3.58E-02	-1.886	CACNB1,CHUK,FCER1G,GRB2,LAT,LCP2,MAP3K11,MAP3K3,MAPK3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,RAP1A,RELA,SOS2,TRBV7-4,VAV1,VAV3	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	-0E00	4.35E-02	NaN	FDPS	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	2.11E-02	1.890	CCNE1,CCNE2,CUL1,FCER1G,RPS6KA1,SKP1,SKP2,TGFB2,TRBV7-4	
OX40 Signaling Pathway	-0E00	1.26E-02	-0.447	FCER1G,NFKB2,NFKBIE,RELA,TRAF3,TRBV7-4	
PI3K Signaling in B Lymphocytes	-0E00	3.74E-02	-2.837	ABL1,AKT1,ATF2,ATF5,C3,CHUK,IGKV3-20,MAP2K2,MAPK3,NFKB2,NFKBIE,NRAS,PDIA3,PIK3AP1,PLCD3,PRKCI,RAF1,RAP1A,RELA,SYK,VAV1,VAV3	
Inhibition of Angiogenesis by TSP1	-0E00	5.88E-02	NaN	AKT1,MAPK14	
Intrinsic Prothrombin Activation Pathway	-0E00	4.76E-02	NaN	FGA,FGG	
Hematopoiesis from Pluripotent Stem Cells	-0E00	6.71E-03	NaN	FCER1G,KITLG,TRBV7-4	
nNOS Signaling in Neurons	-0E00	2.13E-02	NaN	PRKCI	
nNOS Signaling in Skeletal Muscle Cells	-0E00	2.08E-02	NaN	CACNB1	
Heparan Sulfate Biosynthesis	-0E00	3.3E-02	NaN	AARS1,B3GAT1,HS2ST1	
Retinoate Biosynthesis I	-0E00	4.65E-02	NaN	ADH1B,DHRS9	
Dopamine Degradation	-0E00	6.25E-02	NaN	ALDH3B1,ALDH4A1	
Chondroitin Sulfate Degradation (Metazoa)	-0E00	6.25E-02	NaN	CEMIP	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	2.38E-02	NaN	AARS1,HS2ST1	
Glutaryl-CoA Degradation	-0E00	6.25E-02	NaN	ACAT1	
CDP-diacylglycerol Biosynthesis I	-0E00	7.14E-02	NaN	LCLAT1,MBOAT2	
The Visual Cycle	-0E00	4.17E-02	NaN	DHRS9	
Triacylglycerol Degradation	-0E00	3.33E-02	NaN	AARS1,PLB1	
Leukotriene Biosynthesis	-0E00	7.14E-02	NaN	ALOX5	
Chondroitin Sulfate Biosynthesis	-0E00	3.28E-02	NaN	B3GAT1,HS2ST1	
Dermatan Sulfate Biosynthesis	-0E00	3.17E-02	NaN	B3GAT1,HS2ST1	
Dermatan Sulfate Biosynthesis (Late Stages)	-0E00	2E-02	NaN	HS2ST1	
Dermatan Sulfate Degradation (Metazoa)	-0E00	5.88E-02	NaN	CEMIP	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	-0E00	4.55E-02	NaN	INPP1	
Serotonin Degradation	-0E00	6.85E-02	-2.236	ADH1B,AKR1A1,ALDH3B1,ALDH4A1,DHRS9	
D-myo-inositol (1,4,5)-trisphosphate Degradation	-0E00	6.25E-02	NaN	INPP1	
Retinol Biosynthesis	-0E00	4.08E-02	NaN	DHRS9,PLB1	
Tryptophan Degradation III (Eukaryotic)	-0E00	4.35E-02	NaN	ACAT1	
Triacylglycerol Biosynthesis	-0E00	5.36E-02	NaN	LCLAT1,MBOAT2,PLPP5	
Methylglyoxal Degradation III	-0E00	6.45E-02	NaN	AKR1A1,PTGR3	
Chondroitin Sulfate Biosynthesis (Late Stages)	-0E00	1.89E-02	NaN	HS2ST1	
Histidine Degradation VI	-0E00	4.35E-02	NaN	HAL	
Stearate Biosynthesis I (Animals)	-0E00	2.82E-02	NaN	DHCR24,PTGR3	
Acetone Degradation I (to Methylglyoxal)	-0E00	2.38E-02	NaN	PTGR3	
Oxidative Ethanol Degradation III	-0E00	3.57E-02	NaN	ALDH3B1,ALDH4A1	
Agranulocyte Adhesion and Diapedesis	-0E00	5.24E-02	NaN	ACTA2,CCL2,CCL4,CCR4,CXCL10,CXCL2,CXCL9,GNAI2,IL1R1,MYL6B,PODXL	
Granulocyte Adhesion and Diapedesis	-0E00	4.76E-02	NaN	CCL2,CCL4,CCR4,CXCL10,CXCL2,CXCL9,GNAI2,IL1R1,SDC3	
Role of p14/p19ARF in Tumor Suppression	-0E00	6.67E-02	NaN	PIK3R3,PIK3R5	
TEC Kinase Signaling	-0E00	4.33E-02	-2.982	ACTA2,CDC42,FADD,FASLG,FCER1G,FGR,GNAI2,GNB4,HCK,ITGA6,JAK3,NFKB2,PIK3R3,PIK3R5,PRKCI,RELA,RHOB,RHOQ,RHOT1,STAT3,STAT5A,STAT5B,TRBV7-4,VAV1,VAV3	
PCP (Planar Cell Polarity) Pathway	-0E00	5E-02	NaN	ATF2,DVL3,VANGL1	
SAPK/JNK Signaling	-0E00	3.98E-02	-1.414	ATF2,CDC42,CRK,FADD,FCER1G,GADD45A,GNB4,GRB2,MAP3K11,MAP3K3,MAP4K5,NRAS,PIK3R3,PIK3R5,RAP1A,RIPK1,SHC1,SOS2,TRADD,TRBV7-4	
GABA Receptor Signaling	-0E00	4.55E-02	NaN	ADCY3,AP2A2,CACNB1,GNAI2,GNB4,KCNH2	
IL-4 Signaling	-0E00	3.99E-02	-1.460	AKT1,ATF2,CREB3,EIF4EBP1,FCER1G,GNAI2,GRB2,JAK3,MAPK14,MAPK3,MLST8,NFKB2,NRAS,PIK3R3,PIK3R5,PTPN6,RAP1A,RPS6KA1,RPS6KB2,SOS2,STAT3,TGFB2,TRBV7-4	
B Cell Receptor Signaling	-0E00	4.89E-02	-2.921	ABL1,AKT1,ATF2,CDC42,CHUK,CREB3,GRB2,GSK3A,IGKV3-20,MAP2K2,MAP3K11,MAP3K3,MAPK14,MAPK3,NFKB2,NFKBIE,NRAS,PIK3AP1,PIK3R3,PIK3R5,PTPN11,PTPN6,RAF1,RAP1A,RELA,RPS6KB2,SHC1,SOS2,SYK,VAV1,VAV3	
Phototransduction Pathway	-0E00	3.7E-02	NaN	PRKACA,RGS9	
Glutamate Receptor Signaling	-0E00	3.03E-02	NaN	GNB4,HOMER3	
NF-κB Signaling	-0E00	4.38E-02	-2.449	AKT1,BRAF,CASP8,CHUK,CSNK2A2,CSNK2B,FADD,FCER1G,IL1R1,MAP3K3,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PRKACA,RAF1,RAP1A,RELA,RIPK1,TBK1,TNFRSF11A,TRADD,TRAF3,TRBV7-4	
T Cell Receptor Signaling	-0E00	4.71E-02	-0.928	AKT1,ATF2,CHUK,CTNNB1,DUSP5,FCER1G,GRB2,GSK3A,LAT,LCP2,MAP2K2,MAPK14,MAPK3,MLST8,NFKB2,NFKBIE,NRAS,PIK3R3,PIK3R5,PTPN11,PTPN6,PTPN7,RAF1,RAP1A,RELA,SOS2,TRBV7-4,VAV1,VAV3	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	-0E00	6.67E-02	0.447	ADCY3,GNAI2,PDIA3,PLCD3,PRKACA	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	-0E00	5.93E-02	0.378	ADCY3,CACNB1,GNAI2,PDIA3,PLCD3,PRKACA,PRKCI	
Gustation Pathway	-0E00	2.46E-02	1.342	ADCY3,CACNB1,KCNH2,PRKACA,SCN1B	
Phagosome Formation	-0E00	6.03E-02	-2.469	ADGRE1,AKT1,AP1M1,ARPC5L,C3,C3AR1,CCR4,CDC42,CLIP1,ELMO2,F2RL3,FCER1G,FGR,GPR141,GPR27,GPR4,GRB2,HCK,HMOX1,ITGA6,LAT,LIMK1,LPAR1,MAP2K2,MAP2K5,MAPK3,MYL6B,NRAS,PIK3R3,PIK3R5,PLAAT4,PLB1,PRKCI,RAF1,RAP1A,RAPGEF3,RPS6KB2,SOS2,SYK,VAV1,VAV3,WASL	
Th1 and Th2 Activation Pathway	-0E00	5.81E-02	NaN	CCR4,GRB2,HAVCR2,JAK3,PIK3R3,PIK3R5,STAT3,STAT5A,STAT5B,VAV1	
Th1 Pathway	-0E00	5.74E-02	-2.646	GRB2,HAVCR2,JAK3,PIK3R3,PIK3R5,STAT3,VAV1	
Th2 Pathway	-0E00	5.84E-02	-2.121	CCR4,GRB2,JAK3,PIK3R3,PIK3R5,STAT5A,STAT5B,VAV1	
Th17 Activation Pathway	-0E00	1.45E-02	-1.633	FCER1G,IL1R1,JAK3,NFKB2,RELA,STAT3,TRBV7-4	
Endocannabinoid Neuronal Synapse Pathway	-0E00	6.04E-02	-0.707	ADCY3,CACNB1,GNAI2,GNB4,MAPK14,MAPK3,PDIA3,PLCD3,PRKACA	
Apelin Liver Signaling Pathway	-0E00	5E-02	NaN	GSK3A	
Apelin Adipocyte Signaling Pathway	-0E00	6.59E-02	-1.342	ADCY3,GNAI2,MAPK14,MAPK3,NCF1,PRKACA	
Apelin Muscle Signaling Pathway	-0E00	6.25E-02	NaN	AKT1,GNAI2,GNB4	
T Cell Exhaustion Signaling Pathway	-0E00	3.17E-02	-1.155	AKT1,FCER1G,HAVCR2,JAK3,MAPK3,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,PTPN11,PTPN6,RAP1A,STAT3,TRBV7-4	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	5.91E-02	-1.183	AKT1,ATF2,CASP10,CASP5,CASP7,CASP8,CDC42,CREB3,CREM,FASLG,FCER1G,GADD45A,GNAI2,GRB2,LAT,MAP2K2,MAP2K5,MAPK3,MLST8,NRAS,PIK3R3,PIK3R5,PPP2CA,PPP2R2A,PPP2R2D,PPP2R5D,PPP2R5E,RAP1A,RHOB,RHOQ,RHOT1,RPS6KB2,SOS2,SP1,STAT3,SYK,TRBV7-4,VAV1	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	4.29E-02	-2.556	AKT1,CTNNB1,FASLG,FGR,GRB2,HCK,IGKV3-20,LILRB4,MAP2K2,MAPK3,NFKB2,NRAS,PIK3AP1,PIK3R3,PIK3R5,PLAAT4,PRKCI,PTPN11,PTPN6,RAF1,RAP1A,RELA,SHC1,SOS2,STAT3,SYK,TBK1,TGFB2,TICAM1,TRAF3,VAV1	
White Adipose Tissue Browning Pathway	-0E00	6.52E-02	-0.333	ADCY3,ATF2,CACNB1,CAMKK2,CREB3,FCER1G,MAPK14,PRKACA,RXRA	
Xenobiotic Metabolism PXR Signaling Pathway	-0E00	6.67E-02	-1.387	ALDH3B1,ALDH4A1,CITED2,DNAJC7,HS2ST1,MED1,PPP1R10,PPP1R14A,PPP1R14B,PRKACA,PRKCI,RXRA,SCAND1	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	-0E00	4.6E-02	-2.000	CTNNB1,DVL3,NFKB2,RELA	
Calcium Signaling	-0E00	5.91E-02	-0.378	ACTA2,ATF2,CACNB1,CAMKK2,CREB3,HDAC4,HDAC7,MAPK3,MYL6B,PRKACA,RAP1A,RCAN1,RCAN3	
